BPPI Proc Tender-156 - 17072020

Tender Ref. No.
: BPPI/DRUG/RC-156/2020 Dated: 17/07/2020
BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA

(Set up under the Department of Pharmaceuticals, Govt. of India)
8th Floor, Videocon Tower, Block E1
Jhandewalan Extension, New Delhi-110055
Telephone: 011- 011-49431800/49431812/49431829/49431854;
Website: janaushadhi.gov.in
e- TENDER FOR SUPPLY OF DRUGS

TO
BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA
(BPPI) FOR TWO YEARS
RATE CONTRACT
LAST DATE FOR ONLINE SUBMISSION OF TENDER: 10/08/2020
BPPI/DRUG/RC-156/2020 1
BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA (BPPI)
(SET UP UNDER THE DEPARTMENT OF PHARMACEUTICALS, GOVERNMENT OF INDIA)
Regd. Office: Core No. 6, First Floor, SCOPE Complex, Lodi Road, New Delhi-110003
Working Office: 8th Floor, Videocon Tower, Block E1, Jhandewalan Extension, New Delhi-110055
Telephone: 011- 49431800/49431812/49431829/49431854;
Website: janaushadhi.gov.in
e-TENDER FOR TWO YEARS RATE CONTRACT
FOR SUPPLY OF DRUGS TO BUREAU OF PHARMA PSU OF INDIA
Tender Reference BPPI/DRUG/RC-156/2020 Dt.

17/07/2020
Tender Website
https://eprocure.gov.in
Date of availability of tender documents On 17/07/2020 (Friday)

on website
Doubts and queries regarding Tender document
should be sent by e-mail to e-mail id
“proc6@janaushadhi.gov.in On 23/07/2020 upto 17.00 Hours
proc9@janausadhi.gov.in,
proc8@janausadhi.gov.in”
by the likely bidders latest by
Time and date and place pre-bid meeting On 24/07/2020 (Friday) at 11:00
AM
Bureau of Pharma PSUs of India,
8th Floor, Videocon Tower, Block-E1,
Jhandewalan Extension, New Delhi-
110055
Last date and time for submission of On 10/08/2020 up to 17.00 Hours.
Online Bid i.e. Bid Submission End Date and
time
Last Date and time for submission On 14/08/2020 by 17.00 Hours
of EMD and Original Required Documents
as per ANNEXURE I (Check List), in
physical Form in office of Bureau of
Pharma PSUs of India, 8th Floor,
Videocon Tower, Block-E1,
110055
Time and date of opening of Technical
On 17/08/2020 at 11.30 Hours (day)
Bid
Place of opening of tender Bureau of Pharma PSUs of India,
110055
Opening of Tender Online on https://eprocure.gov.in
Address for Communication Bureau of Pharma PSUs of India,

110055
Cost of the Tender Document Free of cost
Contact Person for clarification if any 1. Sh. P. K. Thakur
Sr. Executive (Procurement)
Phone: - 011-49431829
Email: - proc6@janaushadhi.gov.in
2. Sh. Manik Bera,

Dy. Manager (Procurement)
Phone: - 011-49431854
3. Sh. Pritam Singh

Manager (Procurement)
Phone: - 011-49431812
The tender document can be downloaded free of cost from the CPPP e‐Procurement Portal
https://eprocure.gov.in and from the website of BPPI: janaushadhi.gov.in.
Note: The bidders shall be solely responsible for checking these websites at least 3 days
prior to closing date of submission of tender for any addendum/amendment issued
subsequently to the bid document and take into consideration the same while preparing
and submitting the bids. Bids will be opened online.
TABLE OF CONTENTS
Sl. Description Page
No. No.
1. Tendering System 7
2. Last Date and time for submission of ONLINE Tender 8
3.1. Eligibility Criteria (Technical Bid -Cover “A”) 8
4. General Conditions 10
5. Price Bid – Cover “B” (Financial Bid/BOQ) 11
6. Earnest Money Deposit 12
7. Guidelines for The Preparation of Tender 13
8. Period of validity of tender 13
9. Amendment of tender documents 13
10. Method of submission of tender 14
11. Modification and withdrawal of bids 14
12. Opening of tender 14
13. Evaluation of tender 15
14. Inspection of manufacturing facilities 15
15. Acceptance /rejection of bids 15
16. Award of contract 16
17. Performance security deposit 16
Methodology for placing orders,
18. 16 & 18
(v). Fall Clause
19. Supply Conditions 18
20. Logograms 20
21. Packing 21
22. Quality testing & quality control 22
23. Payment provision 23
24. Handling & Testing Charges 24
25. Liquidated Damages and other penalties 24
26. Deduction and other penalties on account of Quality failure 25
Blacklisting in the event of withdrawal from the tender, and Non-Adherence to the
27. 26
Quality Standards and supply schedule
28. Saving Clause 27
29. Resolution of Disputes 27
30. Contacting the Purchaser by the Bidder 28
31. Fraudulent and Corrupt Practices 28
32. Jurisdiction 30
33. ANNEXURE - I (Check List) 31
34. ANNEXURE - II (Declaration for eligibility in participating the tender) 33
35. ANNEXURE - III (Details of EMD submitted) 35
36. ANNEXURE - IV – (A certificate from CA or Company Secretary). 36
37. ANNEXURE - V (Mandate Form) 38
ANNEXURE -VI (Details of Manufacturing License & Market Standing
38. 40
Certificate)
39. ANNEXURE - VII (Declaration for Logogram) 41
40. ANNEXURE - VIII (Packing Specifications) 45
41. ANNEXURE - IX (BARCODE REQUIREMENTS) 47
42. ANNEXURE - X (Bank Guarantee format for submission of EMD) 53
43. ANNEXURE - XI (Letter of acceptance of tender for Rate Contract) 54
44. ANNEXURE - XII (Details of requirements for Drugs) 55
45. ANNEXURE - XIII (Details for Shelf Life & Manufacturing Capacity) 102
46. ANNEXURE - XIV (Shape, Colour, Packing Type etc. of drugs) 103
-----------------------------
e-TENDER FOR RATE CONTRACT FOR THE SUPPLY OF DRUGS TO
PRADHAN MANTRI BHARTIYA JANAUSHADHI PARIYOJANA (PMBJP) is the initiative of

Department of Pharmaceuticals, Ministry of Chemical and Fertilizer, Government of India launching
with the noble objective of making quality generic medicines available at affordable prices for all,
particularly the poor and disadvantaged, through specialized outlets called PRADHAN MANTRI
BHARTRIYA JANAUSHADHI KENDRA (PMBJK). BPPI was established in December 2008 under
the Department of Pharmaceuticals, Government of India, with the support of all the CPSUs, and
identified as the executing agency for PMBJP.
The Bureau has been registered as an independent society under the Societies Registration Act, 1860,
in April 2010.
At present, more than 6400 stores are functional. It is proposed to channelize efforts to popularize
PMBJP and ensure availability of the complete basket of medicines at affordable prices.
Tender Inviting Authority – C.E.O, Bureau of Pharma Public Sector Undertakings of India, 8th
Floor, Videocon Tower, Block E1, Jhandewalan Extension, New Delhi-110055 (hereinafter referred
as Tender Inviting Authority unless the context otherwise requires).
Tender Accepting Authority – CEO, Bureau of Pharma Public Sector Undertakings of India
(hereinafter referred as BPPI unless the context otherwise requires).
Tender Inviting Authority Invites Tender for the supply of Drugs to BUREAU OF PHARMA
PUBLIC SECTOR UNDERTAKINGS OF INDIA for Two Years.
------------------------------
1.TENDERING SYSTEM:
The Bids are to be submitted in two Parts i.e.

i. Technical Bid (Cover “A”)
ii. Financial Bid / Price Bid (Cover “B”)
i. The TECHNICAL BID shall contain the complete technical details of the firm and the documents to
provide the eligibility and competency of the bidder and shall be submitted online only in the manner
prescribed in Bid document.
The documents like Tender Document and EMD shall be submitted before the specified schedule at
the office of BPPI super scribed, “Tender Documents & Earnest Money Deposit for Tender
Reference No.-BPPI/DRUG/RC-156/2020 dated 17/07/2020 for the procurement of Drugs for
the year 2019-2021”. However complete hard copy of uploaded tender shall be provided by the
bidder firm along-with the mandatory required documents as per clause 3 of Bid and EMD for
evaluation purpose only. This hard copy shall under no case substitute/modify the provisions of e-
tender system.
ii. The Financial Bid/Price Bid shall be valid for a period of 150 days from the date of opening of
Technical Bid. Prior to the expiry of the bid validity, the Tender Inviting Authority may request the
Tenderers to extend the bid validity for further period as deemed fit on their original quoted prices
and all terms & conditions. However, BPPI reserves the right to place purchase orders at the quoted
rate till such period.
a) The Tenderer shall fill in the rate per unit size, % age rate of GST in respective column of BOQ
for the items quoted.
b) In determining the lowest evaluated price, the rate quoted per unit size exclusive of GST as
indicated in column No. 7 of the BOQ shall be taken into consideration.
c) Tender has been called for in the Generic name of drugs. The Tenderers should quote the rates
for the generic products only. The composition, strength and packing of each product should be as
per specifications given in ANNEXURE-XII and Shape, Colour, Packing Type etc. of drugs
should be as per ANNEXURE XIV (attached). Any variation, if found, will result in rejection of
the tender.
d) Rates (inclusive of customs duty, packing & forwarding charges, transportation, insurance and
any incidental charges, but exclusive GST should be quoted for each of the required drugs,
medicines etc., on door delivery basis according to the unit ordered. Tender for the supply of
drugs, medicines, etc. with cross conditions like “AT CURRENT MARKET RATES” shall not be
accepted. Handling, clearing, transport charges etc., will not be paid separately. The delivery
should be made as stipulated in the purchase order placed with Tenderers.
e) The price quoted by the tenderers shall not, in any case exceed the DPCO controlled price, if any,
fixed by the Central/State Government, the Maximum Retail Price (MRP) and the selling price of
the tenderer.
In case any tenderer quotes higher than the DPCO controlled price, competent authority
shall be informed for appropriate action.
2. LAST DATE AND TIME FOR SUBMISSION OF ONLINE TENDER:
i. (a) Online Bids [in two separate Cover {Technical bid (Cover “A”) and price bid (Cover “B”)}] shall
be submitted till 17.00 Hours Up to 10/08/2020 (Monday) on CPP portal i.e., https://eprocure.gov.in.
(b) Hard copy of complete required documents as Per Clause 3. Eligibility Criteria of Bid and EMD
shall be submitted as before the specified schedule at the below mentioned address of BPPI with super
scribed, “Tender Document & Earnest Money Deposit for Tender Reference No.-
BPPI/DRUG/RC-156/2020 dated 17/07/2020 for the procurement of Drugs for the year 2020-
2022”
“Bureau of Pharma PSUs of India, (BPPI)
Jhandewalan Extension, New Delhi-110055”
ii. Late Tender: -There is NO PROVISION of uploading late tender beyond stipulated date & time in
the e-tendering system.
3. ELIGIBILITY CRITERIA (TECHNICAL BID -COVER “A”):

Minimum Eligibility criteria along with list of documents to be submitted in Cover ‘A’. Bidders should
meet the following criteria to be eligible for bidding and relevant papers/documents must be submitted by
them in their technical bid (Cover- ‘A’) in support of their eligibility for the tender.
A) EMD (Earnest Money Deposit): EMD of Rs.10,00,000/‐ (Rupees Ten Lakh only as specified in
Clause 6 of the Tender document in the form of Bank Guarantee or National Electronic Fund
Transfer (NEFT) or Bankers Cheque or Demand Draft from Nationalized/Scheduled Bank
favoring “Bureau of Pharma Public Sector Undertakings of India “payable at Delhi which is to be
submitted in original to BPPI, New Delhi on or before the date and time stipulated in tender
document. Name & full address of the bidder may be written at the back of the Demand Draft/Pay
Order. Signed and scanned soft copy of the EMD instrument must be uploaded (ANNEXURE III) to
the e‐Procurement portal.
EMD in any other form like Cheque/cash/postal order etc. will not be accepted. The Bid (in case
not exempted for EMD as mentioned in tender document) without EMD shall be summarily
rejected.
Account Details for National Electronic Fund Transfer (NEFT):

Bank Name: Bank of Baroda, Account No. 05860200001696, IFSC Code: BARB0PARLIA
Note: Micro & Small Enterprise (MSE) are exempted from the payment of EMD as per MSEs
Order, 2012 and policy Circular No. 1(2)(1)/2016-MA, Ministry of MS & ME dated 10th March
2016 if valid registration certificate from NSIC/MSME is uploaded and submitted self-attested copy
with Technical Bid for the product for which bidder has submitted quotation.
B) Documentary evidence of the constitution of the company/firm/Proprietorship such as Memorandum

and Articles of Association, Partnership Deed etc. should be submitted with details of the Name,
Address, Telephone Number, Fax Number, e-mail address of the firm and of the Managing Director /
Partners / Proprietor should be submitted.
C) Power of Attorney or Resolution of the Board by which the authorized signatory has been authorized
by the bidding firm to sign the documents should be submitted.
D) Bidders must have: -
a) Minimum three years old valid Manufacturing License of the product quoted with latest license
renewal certificate.
b) Approved product list as per the license issued for quoted drugs for minimum three years.
c) Manufacturing License along with approved product list must be valid till the last date of the
submission of tender.
d) In Case of those drugs which are notified first time in IP 2018 & IP Addendum 2019 then
Manufacturing and Marketing license should be in any official compendium (USP/BP/IP) along
with current valid License in IP in continuation.
e) Market standing certificate & Manufacturing certificate issued by the Licensing Authority as a
Manufacturer for each drug quoted for the last 3 years (Certificate should be enclosed with list of
items) except for the drugs falling under the category of ‘New Drug’ as defined by CDSCO
(Central Drugs Standard Control Organisation). If permission in Form 46 from DCGI has been
obtained, then the 3 years Manufacturing & Market standing clause will be relaxed. The provisions
of Rule 122 E of Drugs and Cosmetics Act rule 1945 shall be applicable.
f) FFS (Flow Fill & Seal Process) Technology will be accepted wherever applicable.
Note: If Manufacturing License for the quoted product is issued under “for export only” category
will not be accepted.
Bidders shall submit dully attested copies of required manufacturing license and approved product list
in support of above-mentioned condition and they are required to specify the quoted product in their
approved product list by highlighting it.
E) Bidder must have Market Standing Certificate (in India) of minimum two batches of quoted product in
last three years issued by the concerned Licensing Authority from Drugs Control Department for the
quoted product. Self-attested copies are to be submitted.
F) Non-Conviction Certificate (NCC) issued by the concerned Licensing of the state certifying that the
firm/company has not been convicted in last three years should be submitted. It should be not more
than 12 months old. Self-attested copies are to be submitted.
G) WHO-GMP (WHO-Good Manufacturing Practice) as per revised Schedule- ‘M’/COPP Certificate of
the manufacturing unit issued by the Licensing Authority/ Drugs Control Department. The WHO-
GMP certificate must be valid as on the last date of submission of tender. Self-attested copies are to be
submitted in hard copy.
H) Maximum Production Capacity Certificate (section wise) issued by concerned Licensing Authority
Form Drugs Control Department highlighting the quoted product section. Self-attested copies are to be
submitted.
I) Copies of the Audited Balance Sheet, Profit and Loss statement showing details of their annual
average turnover for any three of the last four consecutive financial years not less than 25 Crores
(Twenty-Five crore). In case of loan licensee average annual turnover of manufacturing unit/ Host
Company for any three of the last four consecutive financial years not less than 25 Crores (Twenty-
Five crore). Details shall be provided in per Annexure IV. Self-attested copies are to be submitted.
J) Declaration On nonjudicial Stamp Paper for eligibility in participating the tender for quoted drugs in
prescribed format as per Annexure-II
K) Tenderer shall furnish Company’s bank details as per Annexure V (Mandate Form).
L) Tenderers are required to submit Annexure-VI indicating details of manufacturing License and three
years Market Standing Certificate (MSC) as mentioned there in.
M) Tenderer are required to submit declaration duly signed to supply the drugs as per the design in
enclosure 1 and enclosure 2 in Annexure VII as well as other instructions given in this regard.
N) Duly attested Checklist as per (ANNEXURE- I) shall be submitted.
O) Copy of PAN Card of the bidder company should be submitted (self-attested).
P) Copy of certificate of valid GST registration of the bidder company should be submitted (self-
attested).
Q) Copy of Income Tax Return for any three of last four Consecutive Assessment years should be
submitted (self-attested).
R) Duly attested Copy of valid GS-1 registration certificate from GS1 India.
S) The copies of relevant pages approved by drug authorities of concerned country for any quoted Drug/
products manufactured by manufacturing units approved by US FDA, TG Australia, Health Canada,
EU approval, MCC South Africa approval, Brazil Anvisa (if any) should be uploaded with technical
bid.
Note: -
(i) The certificates/ reports / annexure submitted with the bid document should be self-attested by the
authorized signatory of the firm with official seal, wherever required.
ii) Technical evaluation of the Bid will be done on the basis of the above mentioned criteria and
documents mentioned in Clause no. 3 (TECHNICAL BID- COVER ‘A’) Mandatory Documents
shall be submitted online only at CPPP portal: https://eprocure.gov.in Failing which the bid will
not be considered for technical evaluation.
iii) Hard copy of required documents uploaded shall be submitted along with EMD and other required
documents on or before the last day of submission of tender for purely evaluation purposes.
However, the submission of hard copy of uploaded tender document submitted shall not
substitute/modify the provisions of e-tendering system.
iv) The technical evaluation shall be done only on the basis of documents/papers submitted by the
bidder on https://eprocure.gov.in
v) Clear copy of valid drug license highlighting the drug code should be uploaded. In case scanned
copy of license uploaded is not visible or tempered, BPPI shall not considered the license for such
drug.
4. GENERAL CONDITIONS:
A) Tender bid is invited directly from Manufacturers in India. Loan licensee is also eligible.
Distributors/agents/contract manufacturers/Importers are not eligible to participate in the tender.
B) Manufacturer has Production & financial capacity to manufacture and deliver the drugs quoted by the
firm in the tender as per quantity mentioned in tender during contract period.
C) Bidders are advised to quote only for such drugs which meets the drug specification as mentioned in
Annexure XII. Do not quote if it differs with regard to any parameter.
D) The quantities specified in the tender is for the tender purpose only and it represents the basis of unit
for ease of pricing. The actual quantity may vary from zero to the maximum required quantity during
the contract. The quantity will be drawn from successful tenderers as and when required from time to
time during the contract period.
E) STP (Standard Testing Procedure) for Non- Pharmacopoeia awarded drugs are required to submit
within 15 days from the date of Letter of Acceptance.
F) The bidder shall submit the complete stability data (long term stability studies and accelerated
stability studies) for all awarded drugs whenever required by the BPPI. For New drugs,
complete stability data of 6 months’ period shall be acceptable. (If manufacturer has licensed a
formula from another company and such licensed formula is used for the product, then the
stability data of the licensor should be submitted along with licensing agreement.)
G) The manufacturer shall declare the active API polymorphic form used in formulation for all
quoted drugs and declare that it is internationally accepted active polymorph when ask by BPPI.
H) The Tenderer should have not been blacklisted/debarred/de-registered/banned due to quality failure for
the quoted product /firm by any State Government / Central Government/ BPPI/Central or State
Government’s Drug procurement agencies at the time of submission of bid. Further, quoted drugs
have not been failed in house testing or testing by any State Government/Central Government / its
Drug procurement agencies/BPPI during last two years. If any tenderer has been
blacklisted/debarred/de-registered/banned due to quality failure, such tenderer or their
Partner/Director/Owner shall not be permitted to participate in the tender.
I) During the validity of the tender if the firm / Company is blacklisted/debarred/de-registered/banned by
any State Government/ Central Government/ BPPI/ Central or State Government’s Drug procurement
agencies / convicted by any Court of law in India, it shall be intimated to BPPI along with relevant
authentic document by the tenderer firm/ company within one month.
J) During tender or Rate Contract period, if L1 bidder is debarred/deregistered /blacklisted/ banned by
any Central Government or State Government or its procurement agencies due to quality failure, BPPI
may purchase the drugs from other bidders at L1 rate or may go for fresh tender as per discretion of
BPPI.
K) The BPPI reserves the right to purchase any drugs from PSUs as per discretion of BPPI. In case of
emergencies, BPPI may go to PSUs and price will be as per negotiation and at the discretion of BPPI.
L) The Tenderer should confirm that they have read tender document including Amendment(s) to Tender
document (if any) along with terms and condition and these terms and condition of tender document
including Amendment(s) to Tender document (if any) are acceptable unconditionally to them.
M) Validity of Rate Contract: -The rate contract will be applicable for 2(two) year from the date of
acceptance of LOA. The validity of contract may be extended with mutual consent for some specified
period to the maximum of 1(one) year by BPPI, if necessary.
N) During the contract period at any stage, if certificate submitted with their bid is found
fabricated/forged/not complying products manufactured by manufacturing units having
approval of the any agency like US FDA, TG Australia, Health Canada, EU, MCC South Africa
approval, Brazil Anvisa as declared in tender, penal action shall be taken as per the tender
terms and condition and in addition to penal action, recovery shall be made (if any).
O) If a company/firm has two or more separate manufacturing units at different sites / States, which are
not separate entities then the company will be allowed to submit only one tender for all units but
necessary document regarding separate manufacturing units will uploaded as a separate set with the
same tender. However, one bidder will be allowed to submit only one offer for one product.
P) Only authorized employee of the Company/Tenderer will be allowed to transact the business with the
Tender Inviting Authority.
5. PRICE BID – “COVER-B” (Financial Bid/BOQ)

A) Cover “B” (Financial Bid/BOQ) contains the Price Bid of the Tenderer. The Tenderer shall fill in the
rate per unit size, % age rate of GST in respective column of BOQ for the items quoted.
B) Determination of L1 Bidder:
a) In determining the lowest evaluated price, the rate quoted per unit size for the given specification,
exclusive of GST as indicated in column No. 7 of the BOQ shall be taken into consideration. The
rates quoted should be in rupees and paisa up to 2 digits. The Tenderer is not permitted to
change/alter specification or unit size given in the ANNEXURE-XII.
b) GST (Goods and Services Tax)-The Tenderers must indicate the rate of GST applicable and
payable by them. In case no information is given, it shall be presumed that rate is inclusive of
GST and no GST shall be charged by them under any circumstances.
c) The bidder is required to indicate rate of GST (%) as digit only in column 9 of BOQ without
suffixing the % sign and not to indicate amount of GST in Rs. at particular cell of excel sheet
of BOQ.
d) Purchase preference shall be given over acceptable L1 bidder to bidder offering Products
manufactured by manufacturing units approved by US FDA, TG Australia, Health Canada,
EU approval, MCC South Africa approval, Brazil Anvisa subject to matching of acceptable L1
rate.
e) (i) If the participating Micro and Small Enterprises (MSE) meets all the other eligibility criteria and
their quoting price is within price band of L1+15 (fifteen) per cent shall also be allowed to
supply a portion of requirement by bringing down their price to L1 price in a situation where L1
price is from someone other than a MSE and such MSE shall be allowed to supply up to 20
(twenty) per cent of total tendered value. The 20 (twenty) per cent quantity is to be distributed
proportionately among these bidders, in case there are more than one MSEs within such price
band.
(ii) Within this 20% (Twenty Percent) quantity, a purchase preference of four per cent (that is, 20
(twenty) per cent out of 20 (twenty) per cent) will be reserved for MSEs owned by Scheduled
Caste (SC)/Scheduled Tribe (ST) entrepreneurs (if they participate in the tender process and
match the L1 price). Provided that, in event of failure of such SC/ST MSE to participate in tender
process or meet tender requirements and L1 price, four per cent sub-target shall be met from
other MSE. MSEs would be treated as owned by SC/ ST entrepreneurs: a) In case of proprietary
MSE, proprietor(s) shall be SC /ST b) In case of partnership MSE, the SC/ST partners shall be
holding at least 51% (fifty-one percent) shares in the unit c) In case of Private Limited
Companies, at least 51% (fifty-one percent) share shall be held by SC/ST promoters.
6. EARNEST MONEY DEPOSIT:
A) The Earnest Money Deposit referred to under Clause 3.A, shall be Rs. 10 lakhs. The Earnest
Money Deposit shall be paid in the form of Bank Guarantee or National Electronic Fund
Transfer (NEFT) or Bankers Cheque/ Demand Draft in favour of BUREAU OF PHARMA
PUBLIC SECTOR UNDERTAKINGS OF INDIA, payable at Delhi. EMD in form of Bank
Guarantee, Irrevocable Bank Guarantee in favour of Bureau of Pharma Public Sector
Undertakings of India from any Nationalized/scheduled Bank should be valid for a period of 12
months from the date of tender opening. The format of Bank Guarantee is at ANNEXURE-X.
BPPI will not pay interest on any deposit held in the form of Bankers Cheque or Demand Draft or
Electronic Fund Transfer.
Account Details for National Electronic Fund Transfer (NEFT):
Bank Name: Bank of Baroda, Account No. 05860200001696, IFSC Code: BARB0PARLIA
B) Micro and Small Enterprise (MSE) are exempted from the payment of EMD, if valid registration
certificate from NSIC/MSME is uploaded for the product for which bidder has submitted
quotation.
C) PSUs are exempted from the payment of EMD.
D) The tender submitted without sufficient EMD will be summarily rejected.
E) Non-payment of EMD (except in cases where payment of EMD is specifically exempted) will result
in rejection of the bid.
F) The Earnest Money Deposit will be refunded to the successful bidders after successful completion of
first supply.
G) The Earnest Money Deposit of the Tender will be forfeited without further notice if:
a) If the tenderer withdraws his bid any time after opening of price bid.
b) On refusal to supply medicine after the award of contract/Letter of Acceptance (LOA).
c) In case of the lowest bidder (L1 bidder), fails to execute the contract or fails to complete the first
supply successfully within the stipulated time.
d) If the undertaking as Annexure II is not found correct at any stage during the contract period.
7. GUIDELINES FOR THE PREPARATION OF TENDER:

A) The bidder shall bear all costs associated with the preparation and submission of its bid and Tender
Inviting Authority will in no case be responsible or liable for these costs, regardless of the conduct or
outcome of the bidding process.
B) Language of Bid: - The Bid prepared by the bidder and all correspondence and documents relating
to the bid exchanged by the bidder and the Tender Inviting Authority, shall be in English language,
Supporting documents furnished by the bidder may be in other languages provided they are
accompanied by an authenticated (by the authority concerned) accurate translation of the relevant
passages in the English language in which case, for purposes of interpretation of the Bid, the English
translation shall alone govern. Failure to submit authentic translation of documents would result in
rejection of bids. No bid can be partly in one language and partly in another language.
C) Power of Attorney or Resolution of the Board by which the authorized signatory has been authorized
by the bidder firm should sign the documents in cases where person other than the Managing
Director/Managing Partner or sole Proprietor signs the document.
8. PERIOD OF VALIDITY OF TENDER:
a) The tender must remain valid for minimum 150 days from the date of opening of Technical Bid.
(As mentioned in Clause 1.ii)
b) Prior to the expiration of the bid validity the Tender Inviting Authority may extend the bid
validity for further period with mutual consent of the bidder.
c) The bidder who has extended the bid validity is not required or permitted to modify its bid.
d) The bidder cannot withdraw the bid within validity of Tender.
9. AMENDMENT OF TENDER DOCUMENTS:

At any time prior to the last date of submission of online bid, Tender Inviting Authority may, for any
reason, whether on own initiative or in response to a clarification requested by a prospective Tenderer,
may modify the condition in Tender documents by uploading an amendment on BPPI website:
www.janaushadhi.gov.in; and on CPP portal i.e. https://eprocure.gov.in will be binding on them. In
order to provide reasonable time to take the amendment into account in preparing their bid, Tender
Inviting Authority may at discretion, extend the date and time for submission of online bid.
A) Bidders are advised to check the website of BPPI: www.janaushadhi.gov.in; and CPP Portal i.e.,
https://eprocure.gov.in; regularly at least 3 days prior to closing date of submission of tender for any
corrigendum or amendment to the tender document.
B) BPPI will not issue separate communication for any corrigendum or amendment.
10. METHOD OF SUBMISSION OF TENDER:
A) The tender document shall be downloaded from the websites janaushadhi.gov.in; and CPP portal i.e.
https://eprocure.gov.in. Tender Document is free of cost. No tender cost is to be deposited
B) Bids shall be submitted online only at CPP Portal i.e., https://eprocure.gov.in. Manual bids shall not
be accepted except for the original documents/instruments as mentioned in Clause 3 of tender
document.
C) Bidders are advised to follow the ‘Special Instructions to the Contractors/Bidders for the e‐
submission of the bids online’ available through the link ‘Help for Contractors’ at the e‐
Procurement Portal https://eprocure.gov.in.
D) If a particular document/Certificate to be uploaded as specified in bid, is not applicable for a bidder,
the bidder shall attach a scanned copy of declaration in the letter head stating that the specific
document is not applicable/exempted for the bidder in connection to this tender.
E) Bidder shall not modify the downloaded tender form including downloaded price Bid template in
any manner. In case any tender form/Price bid template is found to be tampered with/modified in any
manner, such bid will be summarily rejected, Bid Security would be forfeited, and bidder is liable to
be banned from doing business with BPPI.
F) Interested eligible Tenderer may obtain further information in this regard from the office of the
Tender Inviting Authority on all working days between 10:00 AM and 5:00 PM.
G) Once the bid have been uploaded in the CPP Portal https://eprocure.gov.in the bidder has to make
sure that he has uploaded the files in the correct format and the bidder has to download the uploaded
files from their own end and has to check whether the files uploaded is in proper format or not, no
corrupted files have to be uploaded.
11. MODIFICATION AND WITHDRAWAL OF BIDS:
A) The bidder may modify or withdraw its bid after the bid submission before last time and date of
submission of online Technical Bid.
B) No bid will be allowed to be withdrawn after the last date & time of submission of online Technical
Bids.
12. OPENING OF TENDER:

A) The opening of the Technical Bid and the Price Bid will be done online as specified. The date of
technical bid opening is published in advance. The date of opening of price bid will be announced
only after the opening and evaluation of Technical bid. The bidder who are found eligible and on
satisfying the criteria for technical evaluation/based on undertakings & Declaration, will only be
informed the time and date of opening of Price Bid - Cover “B” of the tender.
B) Only authorized employee of tenderer is entitled to be present at the time of opening of Technical
Bid - Cover “A” of the tender submitted by them.
C) In case, the date for opening of technical bid is declared holiday, the technical bid shall be opened on
next working day at 11.30 A.M.
D) The original/attested hard copies (as mentioned in Clause no. 3, eligibility criteria) must reach the
BPPI Head office on or before stipulated time, failing which the bid shall be summarily rejected.
13. EVALUATION OF TENDER:
A) Technical evaluation of the Bid will be done on the basis of criteria and documents mentioned in
S.N. 3 (TECHNICAL BID-COVER A) & Annexure I (Chek List) which are present in the CPP
Portal i.e. https://eprocure.gov.in.
B) Bids of firms who have furnished all the required documents for each of the product quoted will be
considered.
C) If at any stage, it is found that the contract has been successfully obtained by the bidder by
submitting forged/fabricated certificates/documents/licenses and/or by concealing the fact about
blacklisting/debarring/de-registration of the firm by Govt. of India/Suspension/Cancellation/non-
renewal of the manufacturing license of the bidder firm, the tender bid/rate contract may be
rejected/terminated and suitable punitive action may be taken against the firm.
D) In event of financial bid opening, due to provisions/compulsion of e-tendering system if
complete quoted product list of financial bids of a bidder is opened then only those financial
bids of quoted product shall be considered of whose technical bid has been found eligible by
the Technical Evaluation Committee.
E) After evaluation of technical bid of tenderer/bidder, BPPI may ask the objection/clarification
from tenderer/ bidder.
14. INSPECTION OF MANUFACTURING FACILITIES:
A) BPPI or its authorized representative(s) has/have the right to inspect the manufacturing premises of
Tenderers, before accepting the rate quoted by them or before releasing any purchase order(s) or at
any point of time during the continuance of tender and also has the right to reject the tender or
terminate/cancel the purchase orders issued and/or not to place further order, based on adverse
reports brought out during such inspections. Copy of one full set of the documents submitted for the
bid should be made available at the time of inspection.
B) Originals of all the documents uploaded/submitted in the Technical Bids should be produced for
verification during Site inspection and Physical Verification.
15. ACCEPTANCE /REJECTION OF BIDS:
A) BPPI reserves the right to accept or reject the tender for the supply of all or any one or more items
of the drugs tendered for in a tender without assigning any reason.
B) Evaluation of the tender and determination of the L1 rate (Lowest rate) will be done based on rate
per unit size exclusive of GST as mentioned in column 7 of BOQ. BPPI shall have the right to call
other eligible bidders those are willing to match L1 rates. If such firms are found, then the order
quantity may be dispersed in ratio of: -
“Minimum 30% quantity to L1 bidder and remaining among the bidder’s subject to the matching
of L1 price for quoted drugs at the discretion of BPPI”.
Purchase preference shall be given to the bidders having manufacturing units approved by
foreign accredation i.e., US FDA. TG Australia, Health Canada, EU approval, MCC South Africa
approval, Brazil Anvisa.
C) However, in case the price quoted by the lowest responsive tenderer (L1) is not reasonable and un-
acceptable, the price may be negotiated with L1 only as per CVC guidelines and, if it reduces the
price to the desirable level, rate contract may be concluded with L1. To meet the demand, BPPI
shall conclude parallel rate contract by counter offering the L1 rate to higher eligible bidders as per
above provision.
D) Negotiation if required will be done strictly as per Central Vigilance Commission guidelines.
E) Letter of acceptance of tenders for Rate Contract will be communicated to the Tenderers in writing
as per ANNEXURE XI.
16. AWARD OF CONTRACT:

A) The contract will be awarded to the lowest evaluated responsive bidder qualifying to the final round
after Technical and Price Bid evaluation as per the clause 5. B) Determination of L1 bidder and
clause 16. B. Acceptance /Rejection of BID, subject to the reservations and preferences to BPPI.
“Minimum 30% quantity to L1 bidder and remaining among the bidder’s subject to the matching
of L1 price for quoted drugs at the discretion of BPPI”.
Purchase preference shall be given to the bidders having manufacturing units approved by
foreign accredation i.e., US FDA. TG Australia, Health Canada, EU approval, MCC South Africa
approval, Brazil Anvisa.
B) Letter of Acceptance:
The Tender Inviting Authority shall issue Letter of Acceptance (LOA) as per Annexure-XI to the
lowest responsive bidder in respect of the drugs selected. Communication by e-mail / fax / letter will
be deemed as valid communication.
C) The successful bidder, upon receipt of the Letter of Acceptance (LOA), shall communicate the
acceptance of the same to the BPPI and shall furnish the documents, asked if any.
D) The bidder shall not, at any time, assign, sub-let or make over the contract or the benefit thereof or
any part thereof to any person or persons whatsoever. Such practices will be deemed as fraudulent
practices and also as breach of terms of contract and shall invite punitive action.
17. PERFORMANCE SECURITY DEPOSIT:
A) On being informed about the acceptance of the tender for Rate Contract, the Performance Security
Deposit @5% will be deducted from each running bills and accumulated security deposit will be
refunded without any interest by BPPI to the tenderer within 60 days following the date of completion
of tenderers performance obligations under the contract including the shelf life obligation.
B) The Security deposit of supplier will be returned by BPPI only after the supplier has given
undertaking to replace such medicines and indemnify BPPI against any losses on account of quality
parameters duly notarized.
18. METHODOLOGY FOR PLACING ORDERS:
For the above purpose the following procedures will be adopted

A) After the conclusion of Price Bid opening (Cover B), the rates offered by tenderers for each product
are evaluated and lowest acceptable rate (L1 Rate) arrived at is declared and that tenderer is informed.
B) BPPI reserves right to issue purchase order for any drug on any one rate contract holder or
more than one rate contract holder for same drugs.
C) If two or more than two Tenderer’s are declared as lowest suppliers for the same item(s), such
Tenderers are eligible for Rate Contract and the placement of Purchase Orders for such item(s) for
which they are declared as lowest.
D) The supplier shall start supply of the Drugs/Medicines to any or all the Warehouse
(Address/Location) as mentioned in clause 19 (A) or any other place decided by BPPI and supply
shall confirm to the conditions mentioned in the provision of tender documents, viz, logo,
nomenclature, specification etc. within the stipulated period.
E) Once The supplier shall supply the Drugs/Medicines at any of the BPPI Warehouse as mentioned in
purchase order (or any other place decided by BPPI) along with copy of Purchase order, copy of test
reports and 3 original copies of Invoice. No payment will be processed without test reports.
F) A purchase order is placed on supplier for supply of definite quantity in terms of Rate Contract during
validity period of Rate Contract that purchase order is valid and binding contract.
G) No Minimum drawl is in the Rate Contract. The actual quantity may vary from nil to maximum
required quantity during validity of Rate Contract.
H) The Drugs/Medicines supplied in excess of the ordered quantity shall not be accepted and the supplier
shall take back the excess at their cost. BPPI will not be responsible for the loss to the supplier and
will not entertain any demand/claim.
I) The purchaser reserves the right to conclude one or more than one rate contract for the same item.
J) The purchaser has the option to renegotiate the price with the rate contract holders. In case of
emergency, the purchaser may purchase the same item through Ad hoc contract with a new supplier.
K) Purchase orders, incorporating definite quantity of drugs/products to be supplied along with all other
required conditions following the rate contract terms, shall be issued for obtaining supplies through
the rate contract.
L) The purchaser is entitled to place purchase orders up to the last day of the validity of the rate contract
and, though supplies against such purchase orders will be affected beyond the validity period of the
rate contract, all such supplies will be guided by the terms & conditions of the rate contract.
M) The details of the required drugs, medicines, etc. are shown in ANNEXURE -XII. The tender
quantity mentioned herein is not a fixed procurement quantity and it is only a tentative
requirement and may be increased or decreased by the BPPI, at its discretion, depending on it is
actual need. Though the tentative quantity is indicated in the Rate Contract, the BPPI, will confirm
the actual requirement through purchase order/orders from time to time. The tenderers shall supply
the drugs only on the basis of the purchase order issued time to time within validity of Rate contract
period by the BPPI. Any supply without a valid purchase order will not be acceptable by BPPI and
the BPPI shall not be responsible for any loss on this account.
N) However, once the purchase order/orders is/are issued by the BPPI, the tenderer shall not renege from
the commitment of supplying the quantity mentioned in the acceptance of tender for Rate Contract.
O) The rates quoted shall not be varied with the Purchase order quantity during the full contract period.
P) The rates quoted and accepted will be binding on the Tenderer for the full contract period of
two years and any increase in the price will not be entertained till the completion of this
contract period. Accordingly, this clause will be applicable for all orders placed during the contract
period. However, Rate Contract validity period may be extended for period up to further one
year at same rate, terms & conditions with the consent of the supplier.
Q)No Tenderer shall be allowed at any time and on any ground, whatsoever it may be, to claim revision
or modification in the rates quoted by them. Representation to make correction in the tender
documents on the ground of Clerical error, typographical error, etc., committed by the Tenderers in
the Bids shall not be entertained after submission of the tenders. Cross Conditions such as “SUBJECT
TO AVAILABILITY”, “SUPPLIES WILL BE MADE AS AND WHEN SUPPLIES ARE
RECEIVED” etc., will not be entertained under any circumstances and the tenders of those who have
mentioned such conditions shall be treated as incomplete and accordingly the Tender will be
summarily rejected.
R) Supplies should be made directly by the tenderer and not through any other Agency / Dealer /
Distributors.
S) The supplier shall take utmost care in supplying the quality Drugs/Medicines and ensure that the
batch number mentioned in the packages of the Drugs/Medicines tally with the batch number
mentioned in the Invoice produced to BPPI for payment. Also, the supplier shall ensure the quantity
relevant to the Batch Number of the Drugs/Medicines is mentioned in the invoice. Drugs to be
supplied of any batch shall not be accepted with different MRP.
T) “MRP inclusive of all taxes” is to be printed on each unit/label. MRP will be intimated to successful
bidders at the time of placing purchase orders.
U) The Rate Contract (RC) awarded under the present tender enquiry will be in the nature of standing
offer. Purchase Order (PO) may be placed from time to time against Rate Contract (RC).
V) FALL CLAUSE:
If at any time during the execution of the contract, the controlled price becomes lower or the supplier
reduces the sale price or sells or offers to sell such stores, as are covered under the contract, to any
person / organization including the purchaser or any department of Central government/state Govt. or
its procurement agencies at a price lower than the price chargeable under the contract, he shall
forthwith notify such reduction or sale or offer of sale to the purchaser and the price payable under
the contract for the stores supplied after the date of coming into force of such reduction or sale or
offer of sale shall stand correspondingly reduced
NOTE: BPPI don’t give any guarantee of minimum purchase under this Rate Contract.
19. SUPPLY CONDITIONS:

A) Purchase orders will be issued to the Tenderer(s) at the discretion of the BPPI as per actual
requirements. All the supplies shall be received at any or all of the following warehouse of BPPI or
any other place decided by BPPI:
i) Central Warehouse Gurugram (Bureau of Pharma Public Sector Undertaking of India (BPPI)
Sugal Logistic Park, Warehouse No.1, Opp. GITM College, Bilaspur-Tauru Road
Village Bilaspur and Khasra No. 60//14/2, 17,24,6,15, 16, 25, 7/1, 14/1, 61//9, 10, 11,62//3/2,
4,10//17, 24, 19//3, 8/2, 9/1/1, 12/2/2/2 min 13/1/1 min.
Pin Code – 122413
Phone No. – 011-49431800
ii) Regional Warehouse Guwahati (Bureau of Pharma Public Sector Undertaking of India (BPPI)
DAG No. 884 of K P PATTA No. 04, Mughuapara, Pamohi Village, Dist. Kamrup(M) Guwahati,
Assam India 781035.
Phone No. – 011-49431800
iii) Regional Warehouse Chennai (Bureau of Pharma Public Sector Undertaking of India (BPPI)
79, KIZHMUTHALAMPEDU, PANAPAKKAM,
City Tiruvallur, State Tamil Nadu
Pin Code – 601201
Phone No. – 011-49431800
B) Within 3 days from the receipt of purchase orders the Tenderer should inform BPPI through BPPI
vendor portal the confirmation for the receipt of the purchase order.
C) The Tenderer should also fill the details of supply/delivery schedule to BPPI through BPPI vendor
portal within 7 days from the receipt of the purchase order with expected dispatch/supply date.
i. The bidder shall have to fill Advance supply notice (ASN) on BPPI vendor portal with all
other details i.e., invoice copy, Certificate of Analysis (COA), Batch no. Quantity, Date of
Manufacturing (DOM) Date of Expiry (DOE), no. of shipper boxes etc.
ii. Once the ASN is accepted by the BPPI, the bidder will be provided the date to execute the
supplies at BPPI warehouse as mentioned in purchase order.
Note:
• In case, the supply shall not be made by the date as conveyed by the supplier, supply order
shall be cancelled at their risk and cost. If no response is received through BPPI vendor
portal within 7 days from the supplier / tenderer about supply of drugs as per purchase order,
it shall be presumed that the supplier/tenderer is not interested to supply the drugs ordered as
per purchase order and BPPI shall purchase the drugs from alternative sources.
• In case of newly awarded bidder, bidder must share their permanent email ID and phone
number for BPPI vendor portal registration to it1@janaushadhi.gov.in.
D) The supplier must supply the ordered quantity as follow delivery schedule:
Sl. Nature of Product Delivery
No. Schedule (Days)
1 Delivery Schedule against first P.O. for injectable/Infusion/Vials 60 days
(Products required sterility testing)
2 Delivery Schedule against subsequent P.O. for 45 days
Injectable/Infusion/Vials (Products required sterility testing)
3 Delivery Schedule against first P.O. for all drugs except 45 days
Injectable/Infusion/Vials (Products do not required sterility testing)
4 Delivery Schedule against subsequent P.O. for all drugs except 45 days
Injectable/Infusion/Vials (Products do not required sterility testing)
5 For biological products 60 days
6 Vaccines and Blood products 120 Days
E) If the delivery date happened to be a holiday for BPPI, the supply should be completed by 5.00
PM on the next working day.
F) In case of Non- execution of the order, BPPI reserves the right to place purchase orders
(partially/fully) on alternate source at the risk and cost of the default tenderer(s) without any
notice/Information.
G) If a supplier fails to execute supply as per Purchase Order, the 5% of value of unexecuted quantity
of Purchase Order shall be recovered from pending bill or EMD/Bank Guarantee/Performance
security deposit and their bad performance shall be kept in record of BPPI for future dealing as
considered appropriate by BPPI.
H) If the Tenderer fails to execute the supply within the stipulated time, the BPPI is at liberty to make
alternative arrangement for purchase of the items for which the Purchase orders have been placed,
from any other sources or in the open market or from any other Tenderer who might have quoted
higher rates, at the risk and the cost of the defaulted supplier and in such cases the BPPI has every
right to recover the cost and impose Liquidated Damages as mentioned in Clause 25.
I) The liquidated damages as specified in clause 25. (B) of the tender conditions will be levied on the
quantity supplied after the schedule as mentions in “Clause 19. (D) from the date of issue of
purchase order. However, no supplies will be accepted after 30 days of the expiry of delivery date
i.e., completion of specified liquidated damages period as per clause 25 (B), the purchase order
shall be cancelled at the risk and cost of the supplier. However, the supplier must take prior
approval from BPPI for supply of drugs beyond stipulated delivery period in Purchase
order.
J) Supplier shall complete the earliest pending purchase order before commencing the supply of
subsequent purchase orders. Further, supplies against a purchase order are to be made in
minimum numbers of batches as far as possible and same batch should not be supplied in
repeated consignment.
K) Bidder must comply to the shelf life of each quoted drugs in accordance with “Schedule P” of
Drugs and Cosmetics Rules, 1945. In case drug/medicine not covered in “Schedule P” of
Drugs and Cosmetics Rules, 1945, the bidder must supply the drug/medicine with minimum
24 months shelf life. Bidders must declare the required shelf-life detail in Para VI of
Annexure II.
L) The Tenderer must submit an Analysis report for every batch of drug along with invoice. In case
of failure on part of the supplier to furnish such report, the batch of drugs will be returned to the
suppliers and he is bound to replenish the same with Govt. approved lab test report. The Drugs
supplied by the successful Tenderer shall be of the best quality and shall comply with IP/BP/USP
and the specifications, stipulations and conditions specified in the tender.
M) Tenderer should supply the product as follow:
(i) Within 2 months excluding month of manufacture of products having shelf life up to 2 years,
(ii) Within 3 months excluding month of manufacture of products having shelf life more than 2
years & up to 3 years and
(iii) Within 4 months excluding month of manufacture of products having shelf life more than 3
years
(iv) Within 3.5 months excluding month of manufacture of products for drug code 574 HUMAN
RABIES VACCINE INJECTION 2.5 IU.
Products supplied beyond the above-mentioned period from the date of manufacturing shall levied
a LD as Per Clause 25. (E) of tender documents. For example, product having manufacturing of
November 2020 must be supplied by 31st January 2021 in case shelf life up to 2 Years.
N) If at any time the Tenderer has, in the opinion of the BPPI delayed the supply of drugs due to one
or more reasons related to Force Majeure events such as riots, mutinies, wars, fire, storm,
tempest or other exceptional events at the manufacturing premises, the time for supplying the
drugs may be extended by the BPPI at discretion for such period as may be considered reasonable.
However, such extension shall be considered only if a specific written request is made by the
Tenderer within 10 days from the date of occurrence of such event with necessary documentary
evidence. The supplier shall not be liable to pay LD and forfeiture of Security deposit for the
delay in executing the contract on account of the extension of supply period on the ground of
force majeure events.
O) The exceptional events do not include the Scarcity of raw material, Increase in the cost of raw
material, Electricity failure, Labour disputes/Strikes, Insolvency, and Closure of the
Factory/Manufacturing unit on any grounds etc.
P) Suppliers are required to supply the drugs within the delivery period mentioned in the purchase
order. In this regard it is informed to the bidders that their performance shall be considered
unsatisfactory in case of delayed supply (beyond delivery period) or non-supply of products. BPPI
may reject their bid in future tenders considering their unsatisfactory performance of supplies.
Q) Leaked, soiled, broken containers with damaged labels shall not be accepted.
R) If BPPI observes some physical defects (like empty blisters, improper labelling) of the supplies
during sampling, the batch shall be rejected. If supplier wants to take back the batch for
rectification, they can take back at their cost, rectify and send back to BPPI within 15 days
otherwise same batch shall not be accepted. Due to rectification, if its shelf life condition as per
tender provision does not meet, it shall be discretion of BPPI depending upon requirement to
accept the goods with penalty.
S) Tenderers shall not supply the drugs declared banned by Government of India, even if Purchase
Order is placed.
20. LOGOGRAM:
Logogram means, wherever the context occurs, the design as specified in Enclosure 1 & 2 of
ANNEXURE-VII. The name of the drug shall be mentioned in English and Hindi as per
pharmacopoeia and its strength.
A) Tenders should supply for Drugs etc., as per the specifications such as name, strength, minimum
size and packed with appropriate size of the strips/blisters/bottles/tubes etc as per the design
enclosed as per Enclosure 1 to ANNEXURE –VII and Enclosure 2 to ANNEXURE –VII.
B) All dosage form has to be supplied in packing as specified in product list (ANNEXURE XII) and
shall also conform to “Schedule P1” of the Drugs & Cosmetics Act & Rules 1945, wherever it
applies. Affixing of stickers and rubber stamps shall not be accepted and supplies will be returned
back at supplier’s cost.
C) Vials, Ampoules (more or equal than 5 ml) and Bottles containing the items tendered for should
also carry the printed PMBJP logogram of proportionate size.
D) Failure to supply Drugs etc., with the printed logogram of proportionate size will be treated as
breach of the terms of Rate Contract / violation of tender conditions. The purchase order shall be
cancelled at the risk and cost of the supplier. However, if such failure continuous despite notice,
will be viewed as a serious lapse and initiate blacklisting of the supplier and levied a LD as per
clause 25 (D) of tender documents.
E) Drugs without GS-1 Standard Barcoding on Primary, Secondary and Tertiary Packaging will not
be accepted.
21. PACKING:
A) The drugs shall be supplied in the package specified in ANNEXURE -VIII and ANNEXURE -
XII and the package shall carry the logograms of proportionate size specified in 1 to
ANNEXURE –VII & 2 to ANNEXURE –VII and shall also conform to “Schedule P1” of the
Drug & Cosmetic Act & Rules, 1945, whether it applicable.
Non-affixing of logograms will be treated as violation of tender conditions and fine will be
deducted from the amount payable as per condition in Clause 25 (D) of tender documents.
B) The drugs in any dosage form to be supplied by the supplier should not be embossed indicating
any code no./logo or name of the company. Failure to comply with this shall lead to non-
acceptance of the goods besides imposition of penalties as per clause 25. (D)
C) The packing in each carton shall be strictly as per the specification mentioned in Annexure-VIII.
The outer carton/secondary packaging should be of pearl white duplex board (off white/grey is
not acceptable) with a minimum of 350 GSM with Gloss laminated packing for the strips,
blisters, ointments, creams etc. and for ampoules and vials should be with pearl white board of
350 GSM (off white/grey is not acceptable). The material to be used for carton should be
from virgin chemical pulp. Failure to comply with this shall lead to non-acceptance of the goods
besides imposition of penalties as per clause 25 (D). Storage conditions must be indicated on outer
label.
D) The cap of bottle preparations should not carry the name/logo/other details of the supplier.
However, cap may contain BPPI logogram.
E) The labels in the case of Injectable preparations should clearly indicate whether the preparations
are meant for Intravenous (IV), Intramuscular (IM), Intra Dermal (ID), Subcutaneous (SC)
administration etc.
F) It should be ensured that only virgin packaging material of uniform size, including bottle and vial,
is used for packing.
G) All primary packing containers should be strictly conforming to the specification included in the
relevant pharmacopoeia.
H) Packing should be able to prevent damage or deterioration during transit.
I) The packings/labels of two different products of a same supplier should be clearly distinct from
each other
J) In the event of items of drug supplied found to be not as per specifications in respect of their
packing and logogram, the BPPI is at liberty to make alternative purchase of the items of drugs
for which the Purchase orders have been placed from any other sources or in the open market or
from any other Tenderer who might have quoted higher rates, at the risk and the cost of the
supplier. In such cases the BPPI has every right to recover the cost and impose penalty as
mentioned in Clause 25 & 26.
K) Designs of packaging with the logograms shall be subject to approval by BPPI within 3 days of
receipt of purchase order or within 30 days of release of letter of acceptance. Text matter of all
type of label must be checked and responsibility shall be of manufacturer.
In case of failure of BPPI to do so, the supplier may go ahead with the design as per the
specification in Enclosure-1 to ANNEXURE VII and Enclosure-2 to ANNEXURE VII.
STP (Standard Testing Procedure) for Non- Pharmacopoeia awarded drugs are required to
submit within 15 days from the date of Letter of Acceptance.
L) The colour of the strength must be different from the colour of the generic name of the drug
on primary and secondary packaging and the approval for the same should be taken from
the quality/regulatory department while taking artwork approval. The printing ink used
should be of good quality (clarity, brightness, contrast) which is easily readable.
M) WHO-GMP certified, Therapeutic code & NABL lab tested shall be indicated on the
primary and secondary packaging and shall be incorporated as per the approval from the
quality/regulatory department while taking artwork approval.
N) Barcodes as per GS-1 standards are required to be printed on products at various
packaging levels (Primary, Secondary and Tertiary) as per Annexure-IX.
22. QUALITY TESTING & QUALITY CONTROL:
A. All the batches of the drugs supplied shall be supported by test/ analysis reports furnished by
independent NABL Accredited Drugs Testing Laboratory/Central Drug Testing Laboratory/In
House Quality Control Laboratory. The Tender Inviting Authority has the right to get the drugs
tested at the laboratories of his choice for further verifications, from BPPI empanelled
laboratories.
B. Random samples of each supplied batch will be chosen at the point of supply or
distribution/storage points for testing. The samples will be sent to different BPPI empanelled
laboratories including Government Drugs Testing Laboratory/NIPER/PSU labs for testing.
Handling and testing charges will be deducted by BPPI for the above purpose, as specified in
Clause 24.
C. STP (Standard Testing Procedure) for Non- Pharmacopoeia awarded drugs are required to
submit within 15 days from the date of Letter of Acceptance by mail to Quality and
Regulatory officer of BPPI with artwork approval for design of packaging with the
logogram as per Clause 21.K.
D. The Drugs shall have the active ingredients at the prescribed level as indicated in official
compendiums throughout the shelf life period of the drug. The samples will be drawn periodically
throughout the shelf life period and if found “Not of Standard Quality”, the cost of entire batch
paid will be recovered whether consumed fully/partially. Also, action will be initiated for
blacklisting as per clause 26 irrespective of the period of supply. The supplies will be deemed to
be completed only upon receipt of the quality certificates from the laboratories. Samples which do
not meet quality requirement shall render the relevant batches liable to be rejected. If the sample is
declared to be “Not of Standard Quality” or spurious or adulterated or misbranded, such
batch/batches will be deemed to be rejected goods.
E. In the event of the samples of Drugs supplied fails in quality tests or found to be not as per
specifications, the BPPI is at liberty to make alternative purchase of the items of drugs for which
the Purchase orders have been placed from any other sources or in the open market or from any
other Tenderer who might have quoted higher rates, at the risk and the cost of the supplier and in
such cases the BPPI has every right to recover the cost and impose penalty as mentioned in Clause
26(I).
F. If the product / sample fails in quality test, every failed batch shall be taken back by the supplier at
their own cost and BPPI shall not be responsible for any damage during this period.
G. The supplier shall furnish evidence of the basis for shelf life and other stability data concerning
the commercial final package on request by the BPPI. In case of any complaint in the field, the
B.M.R/ B.P.R for the particular batch of the product(s) supplied shall be produced when
demanded. For New drugs, complete stability data of 6 months’ period shall be acceptable.
H. The products should conform to the standards of IP/BP/USP/EP/JP as the case may be.However,
the drugs notified in the IP (amended up to date) shall be accepted only if supplied
conforming to the standards outlined in the IP. In case the product is not included in the any of
the said compendiums, the supplier, upon award of the contract, must provide the reference
standards and testing protocols for quality control testing.
I. The case of admixture of drugs will be treated as a violation of tender conditions and fine will be
levied as per clause 26. If such lapses happen more than twice in a tender period such cases will
be treated as “Misbranded Drugs”.
23. PAYMENT PROVISION:
A) No advance payments towards costs of drugs will be made to the supplier.
B) Payments towards the supply of drugs will be made within 60 days from the date of receipt of
goods, strictly as per the tender terms and condition. The payment will be made either by means of
a/c payee Cheque or through RTGS (Real Time Gross Settlement System)/Core Banking/NEFT.
The Tenderer shall furnish the relevant details in original (ANNEXURE -V) to make the payment
through RTGS/Core Banking/NEFT.
C) All bills/Invoices should be raised in triplicate and the bills should be drawn as per GST Rules in
the name of Bureau of Pharma Public Sector Undertakings of India. 8th Floor, Videocon Tower,
Block-E1, Jhandewalan Extension, New Delhi-110055 or in the name of any other authority as
may be designated.
D) (i) Payments for supply will be considered only after supply of minimum 50% of Drugs ordered in
the individual Purchase Order PROVIDED reports of Standard Quality on samples testing are
received from Government Analyst or Approved Laboratories of BPPI.
(ii) However, in case of cancellation of a particular purchase order due to failure in delivery,
payment for part supplies less than 50% of the purchase order quantity on the date of cancellation
of the purchase order may be considered for release of payment subject to the following:
a) If the Tenderer have supplied at least 50% of the quantity ordered in the subsequent
purchase order within delivery period stipulated in purchase order from the issue of such
purchase order.
b) If further purchase order is not placed with the supplier due to any reason, not attributable
to the supplier, the amount eligible will be paid within 60 days from the date of last supply.
c) The payment for part supply as mentioned above will subject to the deduction of liquidated
damages, penalty towards unexecuted quantity, risk and cost etc., as per the tender
conditions.
E) If at any time during the period of contract, the price of tendered items is reduced or brought down
by any law or Act of the Central or State Government or by the Tenderer himself, the Tenderer
shall be bound to inform the BPPI immediately about such reduction in the contracted prices.
Tender Inviting Authority is empowered to unilaterally effect such reduction as is necessary in
rates in case the Tenderer fails to notify or fails to agree for such reduction of rates.
F) In case of any increase of decrease in the Taxes/GST after the date of submission of tenders and
during the tender period, such variation in the taxes/GST will be to the account of the BPPI. For
claiming the additional cost on account of the increase in taxes/GST, the Tenderer should produce
the proof of having paid additional amount on this account on the goods supplied to BPPI from the
concerned authorities and also must claim the same in the invoice separately. However, the basic
price structure and the price of the Drugs approved under the tender shall not be altered. Similarly,
if there is any reduction in the taxes/GST and statutory levies as notified by the Govt., after the
date of submission of tender, the Tenderer will be paid based on the unit rate worked out on the
basis of the reduced taxes/GST/statutory levies without any change in the basic price or the price
structure of the drugs approved under the tender. Any increase or decrease in taxes/GST and
statutory levies will be considered based on the notification issued by the Government.
G) However, if the firm supplies after originally stipulated Delivery period, increase in taxes/GST due
to statutory variation in taxes/GST shall be borne by the supplier. In case of decrease in taxes/GST
due to statutory variation in taxes/GST, the same shall be passed on by the supplier to the BPPI.
24. HANDLING & TESTING CHARGES:

In all supplies, 1.5% of the supply value shall be deducted towards handling & testing charges.
25. LIQIDATED DAMAGES & OTHER PENALTIES:
A) All supply should be made within the stipulated time as per the clause 19.D of the Delivery
Schedule and quantity as mentioned in the Purchase Order.
B) If the supply reaches the Drug Warehouses beyond the stipulated time as mentioned in PO/Bid
document, liquidated damages will be levied at the rates 2% per week or part thereof, subject to
maximum of 10% irrespective of the fact that whether the BPPI has suffered any damage/loss or
not, on account of delay in effecting supply
C) If the supply is received in damaged condition it shall not be accepted. The supplier shall have to
replace the goods with damage and the penalty equal to the penalty for unexecuted supplies will be
levied for the damaged goods and payments will be withheld till proper replacement.
D) All the Tenderers are required to supply the product(s) with printed MRP as per purchase order and
logogram of appropriate size on the strips, blisters, vials, ampoules& bottles and with prescribed
packing specification. If there are any deviation in these Tender conditions, action will be taken to
blacklist the product, and/or a separate damage will be levied @ 5% of value of the defaulted
quantity irrespective of the Tender Inviting Authority having actually suffered any damage/loss or
not, without prejudice the rights of alternative purchase specified in Clause No.19F,19 H and 21.J.
E) If supplier supplied the drug time beyond the manufacturing date as mentioned in clause 19. (M) of
supply conditions, a liquidation damage will be levied @ 5% per month subject to maximum 30%
(Up to 6 months).
F) In all the above conditions, the decision of the Tender Inviting Authority shall be final and binding.
26. DEDUCTION & OTHER PENALTIES ON ACCOUNT OF QUALITY
FAILURE:
A) If the samples do not conform to statutory standards, the Tenderer will be liable for relevant action
under the existing laws and the entire stock in such batch has to be taken back by the Tenderer
within a period of 30 days of the issue of the letter from the BPPI. Such stock shall be taken back
at the expense of the Tenderer. Further, actual handling and testing charges shall be paid to BPPI
by the supplier otherwise these charges shall be recovered from their pending
bill/EMD/Performance Security Deposit.
B) The BPPI has the right to destroy such “NOT OF STANDARD QUALITY DRUGS” if the
Tenderer does not take back the goods within the stipulated time. The BPPI will arrange to
destroy the “NOT OF STANDARD QUALITY DRUGS” after the expiry of 30 days mentioned
above without further notice and shall also collect handling charges (in case the product is sent
back to supplier on freight to pay basis)/ demurrage charges calculated at the rate of 2% per week
on the value of the drugs rejected till such time stipulated. Further, the cost of disposal shall be
recovered from the supplier.
C) If any items of Drugs/Medicines supplied by the Tenderer have been partially or wholly used or
consumed after supply and are subsequently found to be in bad odour, unsound, inferior in quality
or description(Adulterated/Spurious/Misbranded) or otherwise faulty or unfit for consumption,
then the contract price or prices of total such batches supplied will be recovered from the
Tenderer, if payment had already been made to him. In other words, the Tenderer will not be
entitled to any payment whatsoever for Items of drugs found to be of “NOT OF STANDARD
QUALITY” whether consumed or not consumed and the Tender Inviting Authority is entitled to
deduct the cost of such batch of drugs from any amount payable to the Tenderer. On the basis of
the nature of failure, action will be initiated to blacklist the product/supplier.
D) For the supply of Adulterated/Spurious/Misbranded, as defined in the Drugs and Cosmetics Act,
1940, to BPPI. BPPI reserves the right to blacklist the supplier. No further supplies shall be
accepted from the firm/company.
If the tenderer is blacklisted, the tenderer shall also not be eligible to participate in tenders of
Tender Inviting Authority of BPPI for supply of Drugs for a period of 5 years from the date of
blacklisting.
In case of supply of NOT OF STANDARD QUALITY drug(s) to BPPI, the product shall be
blacklisted by BPPI and no further supplies shall be accepted for the particular drug(s). The
Tenderer shall also not be eligible to participate in tenders of BPPI for supply of such Drugs for a
period of 2 years from the date of blacklisting.
In addition, the Director of Drugs Control of concerned State will be informed for initiating
necessary action on the Tenderer in their state. Performance Security Deposit will also be forfeited
without any intimation.
E) The Tenderer shall furnish the source of procurement of raw material utilized in the formulations,
if required by the BPPI. The BPPI reserves the right to cancel the purchase orders, if the source of
supply is not furnished.
F) The decision of the BPPI or any officer authorized by him, as to the quality of the supplied drugs,
medicines etc., shall be final and binding. In such cases, the BPPI will be at liberty to terminate,
the contract either wholly or in part on 30 days’ notice. The Tenderer will not be entitled for any
compensation whatsoever in respect of such termination besides forfeiture of Performance
Security Deposit.
G) For contravention of the stipulations of the contract or for other justifiable reasons, the contract
may be terminated by the BPPI, and the Tenderer shall be liable to pay for all losses sustained by
the BPPI in consequence of the termination which may be recovered from the Tenderer, as per
rules besides forfeiture of Performance Security Deposit.
H) Non-performance of any of the contract conditions and provisions will disqualify a firm from
participating in the tender for the next 2 years/ Blacklisting the tenderer.
I) In the event of making Alternative Purchase, as specified in Clause 19.H, Clause 21.J and in
Clause 22.F penalty will be imposed on the supplier. The excess expenditure over and above
contracted prices incurred by the BPPI in making such purchases from any other sources or in the
open market or from any other Tenderer who has quoted higher rates and other losses sustained in
the process, shall be recovered from the Performance Security Deposit or from any other money
due and become due to the supplier and in the event of such amount being insufficient, the balance
will be recovered personally from the supplier as per rules.
J) In all the above conditions, the decision of the BPPI shall be final and binding.
27. BLACKLISTING IN THE EVENT OF WITHDRAWAL FROM THE TENDER,

AND NON-ADHERENCE TO THE QUALITY STANDARDS AND SUPPLY
SCHEDULE:
A) BLACKLISTING OF PRODUCT/TENDERER ON WITHDRAWAL OF TENDER
If the Tenderer fails to perform the obligations under the tender conditions / commits default in the
performance of the contract/LOA, such Tenderers will be blacklisted for a period of 2 years by
BPPI from the date of intimation besides forfeiture of EMD/ Performance Guarantee.
The Tenderers who have withdrawn after participating in the tender after the last date and time of
submission of online bid, either fully or partially, the entire firm/company will be blacklisted for
a period of 2 years from the date of intimation by BPPI apart from forfeiture of the Security
Deposit/EMD.
B) BLACKLISTING FOR QUALITY FAILURE/QUALITY TEST BY THE EMPANELLED
LABORATORIES OF BPPI.
a) Each and every batch of drugs/medicines supplied by the supplier shall be subjected to quality
test by the Empaneled laboratories as per the procedure adopted by BPPI.
BPPI shall also draw the samples of products supplied in the marketplace and get the same
tested, to make sure the products are conforming to quality requirements till Self life.
b) If the sample of any batch fails in quality test and report is received stating “Not of standard
quality “in any test the report along with the chromatograms etc. such batch of drugs shall be
rejected & no further procurement of that drug from the supplier will be taken for two years
from the date of sample being declared not of standard quality.
(i) If the supplier challenges and request for retesting, the sample shall be tested at government
testing laboratory or reputed govt. institute like NIPER. The test report of govt. lab or
NIPER will be final and will be binding to the supplier.
(ii) The cost of such Re-testing shall be recovered from the supplier.
(iii) If 2 batches of item/drug supplied by the same supplier is reported to NOT OF STANDARD
QUALITY in specification, then the firm shall be blacklisted for 2 years after observing
procedure laid down in Para 27.B.(d) besides forfeiture of Performance Security Deposit.
(iv) If a single batch of any product(s) supplied by the company/firm declared as
Adulterated/spurious/ Misbranded by the Government Authorities during the shelf life of the
product supplied irrespective of tender period, the company/firm shall be blacklisted for a
period of 2 years from the date of intimation & forfeiture of security deposit.
C) Quality Test by Statutory Authorities:
(i) If any drug is declared “NOT OF STANDARD QUALITY”, by any government agencies or
drug licensing authority, the issue of available stock of the particular item will be stopped.
Further, the available stock of the product in hospitals/JAS will be retrieved.
(ii) If any batch of any product(s) supplied by the company/firm declared, NOT OF
STANDARD QUALITY in specification as defined in the Drugs and Cosmetics Act, 1940,
by the Government Authorities during the relevant tender period or during quality check
within shelf life period, the company/firm shall be blacklisted for a period of 2 years from
the date of blacklisting after observing procedure laid down in Para 27.B(d)
D) Procedure for Blacklisting:

(i) On receipt of complaint from Distributer/retailers/customers or report from Govt.
Analyst/Drug Testing Laboratory indicating that a particular Item/Drug is “NOT OF
STANDARD QUALITY/ ADULTERATED/ SPURIOUS/MISBRANDED” (As the case
may be), a show cause notice shall be issued to the supplier calling for explanation within 7
days from the date of notice. On receipt of explanation from the supplier, the CEO, BPPI
may take appropriate action on merits of the case and impose penalty including the
blacklisting of the item of the product/company or firm as deemed fit besides forfeiture of
Performance Security Deposit.
(ii) If a particular item of the drug has been blacklisted according to the procedure stated above,
the supplier is not eligible to participate in any of the tenders for such item floated by the
BPPI until the period of blacklisting is over.
(iii) If a supplier company/firm is blacklisted according to the procedure stated above, such
supplier is not eligible to participate in any of the tenders floated by the BPPI until the
period of blacklisting is over.
E) BLACKLISTING FOR NON-SUPPLY:
Due to non-supply of item against any purchase order, 5 % value of purchase order shall be
recovered from the supplier in addition of other penal like risk purchase.
In case of repeated circumstances of non-supply of items i.e. 2 times, the supplier may be
blacklisted for 2 years in addition of forfeiture of Performance Security Deposit/ EMD and other
penal action.
28. SAVING CLAUSE:

No suit, prosecution or any legal proceedings shall lie against the Tender Inviting Authority or any
person for anything that is done in good faith or intended to be done in pursuance of the tender.
29. RESOLUTION OF DISPUTES
The BPPI and the supplier shall make every effort to resolve, amicably by direct informal
negotiation any disagreement or dispute arising between them under or in connection with the
contract.
A) ARBITRATION AND JURISDICTION;
Normally, there should not be any scope of dispute between the BPPI and the supplier after
entering into a mutually agreed valid contract/ Rate Contract.
However, due to various unforeseen reasons, problems may arise during the progress of the
contract/ Rate Contract leading to disagreement BPPI and the supplier shall first try to resolve the
same amicably by mutual Consultation. If the parties fail to resolve the dispute by such mutual
consultation within twenty-one days, then, depending on the position of the case, either the BPPI or
the supplier shall give notice to other party of its intension to commence Arbitration procedure as
per Indian Arbitration and Conciliation Act, 1996. Such disputes/differences shall be referred to
Sole Arbitrator to be appointed by the CEO of BPPI. The venue of Arbitration Shall be at New
Delhi. The award published by the Arbitrator shall be final and binding on the parties.
30. CONTACTING THE BPPI BY THE BIDDER:

A) No bidder shall contact the BPPI on any matter relating to its bid, from the time of bid opening
to the time the contract is awarded.
B) Any effort by a bidder to influence the BPPI in the Purchaser’s bid evaluation, bid comparison
or contract award decisions may result in rejection of the bidder’s bid.
C) The bidder shall not make any attempt to establish unsolicited and unauthorized contact with
the Tender Accepting Authority, Tender Inviting Authority or Tender Scrutiny Committee after
opening of the bids and prior to the notification of award and any attempt by any bidder to
bring to bear extraneous pressures on the Tender Accepting Authority, Inviting Authority or
Tender Scrutiny Committee, shall be sufficient reason to disqualify the bidder.
D) Notwithstanding anything contained in clause (C) above the Tender Inviting Authority or the
Tender Accepting Authority, may seek bonafide clarifications from bidders relating to the bids
submitted by them during the evaluation of bids.
31. FRAUDULENT AND CORRUPT PRACTICES:

A) For Bidders:
It is purchaser’s policy to ensure that suppliers and their authorized representatives/agents
observe the highest standard of ethics during the procurement and execution of such contracts. (In
this context, any action taken by a bidder, supplier, contractor, or by their authorized
representatives/agent, to influence the procurement process or contract execution for undue
advantage is improper) In pursuance of this policy, the purchaser;
a) Defines, for the purposes of this provision, the terms set forth below as follows:
(i) “corrupt practice” is the offering, giving, receiving or soliciting, directly or indirectly, of
anything of value to influence improperly the actions of another party (“another party”
refers to a public official acting in relation to the procurement process or contract
execution]. In this context, “public official” includes staff and employees of other
organizations taking or reviewing procurement decisions.
(ii) “fraudulent practice” is any act or omission, including a misrepresentation, that knowingly
or recklessly misleads, or attempts to mislead, a party to obtain a financial or other benefit
or to avoid an obligation (a “party” refers to a public official; the terms “benefit” and
“obligation” relate to the procurement process or contract execution; and the “act or
omission” is intended to influence the procurement process or contract execution).
(iii) “collusive practice” is an arrangement between two or more parties designed to achieve an
improper purpose, including to influence improperly the actions of another party [“parties”
refers to participants in the procurement process (including public officials) attempting to
establish bid prices at artificial, non-competitive level].
(iv) “coercive practice” is impairing or harming, or threatening to impair or harm, directly or
indirectly, any party or the property of the party to influence improperly the actions of a
party (a “party” refers to a participant in the procurement process or contract execution).
(v) “obstructive practice” is (a) deliberately destroying, falsifying, altering or concealing of
evidence material to the investigation or making false statements to investigators in order to
materially impede a investigation into allegations of a corrupt, fraudulent, coercive or
collusive practice; and/or threatening, harassing or intimidating any party to prevent it from
disclosing its knowledge of matters relevant to the investigation or from pursuing the
investigation; or acts intended to materially impede the exercise of the purchaser’s
inspection and audit rights provided for under sub-clause (e) below.
b) Will reject a proposal for award if it determines that the bidder considered for award has,
directly or through an agent, engaged in corrupt, fraudulent, collusive, coercive or
obstructive practices in competing for the contract in question;
c) will cancel the contract if the purchaser determines at any time that the bidder, supplier and
contractors and their sub-contractors engaged in corrupt, fraudulent, collusive, or coercive
practices
d) will sanction a firm or individual, including declaring in eligible, either indefinitely or for a
stated period of time, to be awarded a contract if it at any time determines that the firm has,
directly or through an agent, engaged in corrupt, fraudulent, collusive, coercive or
obstructive practices in competing for, or in executing, a contract; and
e) will have the right to inspect the accounts and records of the bidders, supplier, and
contractors and their subcontractors/authorized representatives and to have them audited by
auditors appointed by the purchaser.
B) For Suppliers:
If the BPPI determines that a Supplier has engaged in corrupt, fraudulent, collusive, coercive or
obstructive practices, in competing for or in executing the Contract, then the BPPI may, after
giving 7 days’ notice to the Supplier, terminate the Supplier's engagement under the Contract and
cancel the contract, and the procurement will be made at the risk and cost of the supplier besides
blacklisting the bidder for 5 years with forfeiture of Performance Security Deposit apart from
other penal actions.
a) For the purposes of this Sub-Clause:
(i) “corrupt practice” is the offering, giving, receiving or soliciting, directly or indirectly, of
anything of value to influence improperly the actions of another party;
(ii) “fraudulent practice” is any act or omission, including a misrepresentation, that
knowingly or recklessly misleads, or attempts to mislead, a party to obtain a financial or
other benefit or to avoid an obligation;
(iii)“collusive practice” is an arrangement between two or more parties designed to achieve
an improper purpose, including to influence improperly the actions of another party;
(iv) “coercive practice” is impairing or harming, or threatening to impair or harm, directly or
indirectly, any party or the property of the party to influence improperly the actions of a
party;
(v) “obstructive practice” is (aa) deliberately destroying, falsifying, altering or concealing of
evidence material to the investigation or making false statements to investigators in order
to materially impede a purchaser investigation into allegations of a corrupt, fraudulent,
coercive or collusive practice; and/or threatening, harassing or intimidating any party to
prevent it from disclosing its knowledge of matters relevant to the investigation or from
pursuing the investigation; or (bb)acts intended to materially impede the exercise of the
purchaser’s inspection and audit rights provided for.
32. JURISDICTION:
In the event of any dispute arising out of the tender such dispute would subject to the jurisdiction of
the Civil Court within the city of Delhi only.
…………………………………….
ANNEXURE – I
Ref. Clause 3 (N)
CHECK-LIST (Whether Uploaded the documents)
COVER – A
S.N. Check List YES Page Remarks
/No No.
1 Check list – ANNEXURE – I as per clause 3. N.
EMD Rs. 10,00,000/- in the form of Bank Guarantee or National
2 Electronic Fund Transfer (NEFT) or Bankers Cheque or
Demand Draft as per ANNEXURE-III (Clause 3. A & 6. A).
NSIC or MSME certificate (If claimed for EMD exemption) as per
3
Clause No. 3. A Note.
Copies of documentary evidence for the constitutions of the
company / Firm/ Proprietorship such as Memorandum and
4
Article of Association, Partnership deed with complete address
as per Clause 3. B.
Power of attorney or Resolution of board by which the
5 authorized signatory has been authorized by the Tenderer to
sign the tender documents as per clause 3. C.
Copy of Minimum three years old valid Manufacturing License
6 of the product quoted with latest license renewal certificate as
per Clause 3. D.
Copy of Market Standing Certificate issued by the Licensing
7 Authority from Drug Controller Administration of the State for
minimum 2 batches in last 3 Years as per Clause no. 3. E.
Copy of Non-Conviction Certificate issued by the concerned
8 Licensing Authority from Drug Controller Administration of the
State, not older than 12 months as per Clause no. 3.F.
Copies of WHO-GMP (WHO-Good Manufacturing Practice)
as per revised Schedule- ‘M’/COPP Certificate of the
manufacturing unit issued by the Licensing Authority/ Drugs
9
Control Department/FDA. The WHO-GMP certificate must
not be older than one year from the last date of submission of
tender as per Clause 3. G.
Copy of Maximum Production Capacity Certificate (section
wise) issued by concerned Licensing Authority Form Drugs
10
Control Department/FDA highlighting the quoted product
section as per Clause no. 3.H..
ANNEXURE –II (Declaration On non-judicial Stamp Paper for
11 eligibility in participating the tender) original Annexure II
delivered to BPPI as per clause 3. J.
ANNEXURE-V (Mandate form) to furnish company bank
12
details as per clause 3 (K) & 23(B)
ANNEXURE-VI indicating manufacturing License, validity of
13
license and market standing certificate details as per clause 3. L.
ANNEXURE-VII (Declaration to supply the drugs as per the
14 design in enclosure 1 and enclosure 2 in Annexure VII) as per
clause 3(M) , 20 & 21
Copies of approval of Manufacturing Unit of the any agency like
15 US FDA, TG Australia, Health Canada, EU, MCC South Africa
approval, Brazil Anvisa, if any as per clause 3 (S).
Copy of valid GS-1 registration certificate for bar coding as per
16
Clause 3. R.
Copy of Audited Annual Balance sheet and Profit and loss statement
showing details of their Annual average turn over not less than 25
17
crores for any three of the last four consecutive financial years as
per Clause 3. I..
T) ANNEXURE IV {certificate from the C.A. (Chartered Accountant)
18 or Company Secretary. Original Annexure IV delivered to BPPI
as per clause 3. I.
Self-attested copy of PAN Card of the Bidder Company. As per
19 Clause 3(O).
Self-attested copy of Certificate of valid GST registration of the
20 bidder company. As per Clause 3(P).
Self-attested copy of Income Tax Return for any three of last four
21
consecutive Assessment years. As per Clause 3(Q).
Authorization letter nominating an employee of the tenderer to
22 transact the business with the Tender Inviting Authority as per
clause 4. P.
NOTE: - EMD instrument, ANNEXURE II, ANNEXURE IV, ANNEXURE V and ANNEXURE
VI are to be delivered in original to BPPI, rest of the document duly authorized should be
submitted on or before stipulate date as mentioned in the tender document “technical cover A”.
Name of authorized signatory: ………………………………………………….
Signature of authorized signatory: ……………………………………………….
Company seal:
ANNEXURE –II
(On nonjudicial Stamp Paper)
Ref. Clause No. 3.(J)
DECLARATION
I/We M/s. ………… represented by its Proprietor/Managing Partner /Managing Director having its
registered office at ……………………………….........and its factory premises at
…………………………………………………………………………
………………………………………………………………do hereby declare as under: -
(I) that I/we have carefully read all the terms and conditions of tender in ref. no. BPPI/DRUG/RC-
156/2020 dated 17/07/2020 including Amendment(s) to Tender document (if any) issued by Bureau of
pharma public sector undertakings of INDIA, New Delhi,110055 and accept unconditionally all terms and
condition of tender document including Amendment(s) to Tender document (if any).
(II) A. that I/We are holding and have uploaded (a) valid drug license for quoted drugs,(b) valid WHO-
GMP certificate , (c) 3 years market standing certificate for quoted products issued by licensing authority,
(d) a certificate manufactured & marketed two batches within 3 years issued by C.A. for quoted drugs, (e )
valid non conviction certificate not older than 12 months,(f) declaration of the active API polymorphic
form used in formulation for quoted drugs and declare that it is internationally accepted active polymorph
(if any) and (h) the copies of the specifications for all quoted drugs and STP (standard testing procedure)
for Non- Pharmacopoeia quoted drugs and also enclosed all undertaking/declaration as per Annexure
mentioned in the tender document.
(II) B. that I/We shall submit the complete stability data (long term stability studies and accelerated
stability studies) for all awarded drugs within 15 days from the date of issue Letter of Acceptance. (If
manufacturer has licensed a formula from another company and such licensed formula is used for
the product, then the stability data of the licensor shall be submitted along with licensing agreement.)
(II) C. that I/we shall supply the drugs as per specification, composition, strength, design, logo and
packing given in ANNEXURE-XIII and Shape, Colour, Packing Type, etc. of drugs shall be as given
in ANNEXURE-XIV
On the basis of above undertaking/declaration, the price bid shall be opened subsequently after opening of
technical bid. However, any document uploaded with technical bid is not complying as per undertaking, the
contract/ Rate Contract shall be cancelled with forfeiture of EMD/Performance Security Deposit/Bank
guarantee against tender no. BPPI/DRUG/RC-156/2020 dated 17/07/2020 along with other action.
(III) a.) I/We declare that we possess the valid drug manufacturing license for BPPI’s tendered items as per
details below:
Description of Address of
Sr. Drug Drug Lic. Date of Validity of
Drug as per BPPI Unit Size Manufacturing
No. Code No. Issue Drug Lic.
Tender Unit
b.) I/We declare that we possess the valid WHO-GMP (World Health Organization-Good Manufacturing
Practices) Certificate issued by competent authority and complies and continue to comply with the
condition lied in schedule M of Drug & cosmetic act, 1940 the rules made there under.
I am / We are aware of the Tender inviting Authority’s right to forfeit the Earnest Money Deposit
and /or Performance Security Deposit and blacklist me/us for a period of 5 years if, any information
furnished by us proved to be false at time the of inspection and not complying the condition as per schedule
M of the said Act for a period of five years.
(IV)
(a) I do hereby declare that I have uploaded valid GS1 registration certificate for bar coding and will supply
the drug with bar code as per ANNEXURE IX and as per the design as per enclosures to ANNEXURE XII
enclosed with tender document as well as other instruction given in this regard.
(b) We have valid approval of the any agency like US FDA, TG Australia, Health Canada, EU, MCC South
Africa approval, Brazil Anvisa, (if any) only for following quoted drugs and relevant certificate & approval
indicating/highlighting drug code have been uploaded with technical bid: -
S. No. Drug Code Description of Drug as per Unit Size Whether approval of the any
BPPI Tender agency like US FDA, TG
Australia, Health Canada,
EU, MCC South Africa
approval, Brazil Anvisa
(yes/No)
(V) that in pursuant to the conditions in Clause No. 6.(A) of the tender, the Earnest Money Deposit can be
forfeited by the Tender Inviting Authority in case of violation of any of the conditions and non-performance of
the obligation under tender document.
(VI) that our company/applied items have not been blacklisted/debarred/de-registered/banned due to quality
failure for the quoted product /firm by any State Government / Central Government/ BPPI/ Central or
State Government’s Drug procurement agencies for the following products quoted in the tender at the time
of submission of bid. Further, quoted drugs have not been failed in house testing or testing by any State
Government/Central Government / its Drug procurement agencies/BPPI during last two years. We are eligible
to participate in the tender ref. No. BPPI/DRUG/RC-156/2020 dated 17/07/2020 for the following quoted
products with mentioned shelf life in Annexure XIII: -
S. Drug Code Description of Drug as per Unit Size Shelf life complying the “Schedule-
No. BPPI Tender P” of the Drugs and Cosmetics Rule,
1945.
Note: In case drugs/medicines not covered in “Schedule P” of the Drugs and Cosmetics Rules, 1945, the bidder
must quote the drug/medicine with minimum 24 months shelf life.
Signed.............................................................................
Name: ………………………………………………….
Designation…………………………………….…….
(Company Seal)
Witness: -
(1) Signed: ……………………………………….
Name: ...............................................................
Designation: ………………………………….
(2) Signed: ……………………………………….
Name: ...............................................................
Designation: ………………………………….
To be attested by the Notary

ANNEXURE-III
Ref. Clause No. 3(A), 6. (A)
DETAILS OF E.M.D SUBMITTED
UPLOAD THE SCANNED COPY OF DRAFT/ PAY ORDER/BANK GURANTEE/NEFT RECEIPT
Note: Micro & Small Enterprise (MSE) are exempted from the payment of EMD as per MSEs
Order, 2012 and policy Circular No. 1(2)(1)/2016-MA, Ministry of MS & ME dated 10th March
2016 if valid registration certificate from NSIC/MSME is uploaded and submitted self-attested
copy with Technical Bid for the product for which bidder has submitted quotation.
-------------------------------------
ANNEXURE- IV
Ref. Clause No. 3. (I)
{Format for a certificate from the C.A. (Chartered Accountant) or Company Secretary}
(I) It is certified that M/s................................………is a Private Ltd./Ltd.

/Proprietorship/Partnership company/firm and they have PAN no………..and GST
registration no……..………………………..They have filed Income tax returned and
GST returned up to date. The authorized signatory of the company/firm is
Shri…………………………….and whose signature is attested as under:……………..
(II) The annual Turnover of M/s. ............................... for any three of the last four
consecutive financial years for manufacturing of drugs are given below and certified
that the statement is true and correct.
Sl. No. Financial Year Turnover in Crore (Rs.)
1. 2016-17
2. 2017-18
3. 2018-19
4. 2019-20
TOTAL Rs........................................ Lakhs
Average Turnover per annual Rs........................................ Lakhs
It is certified that M/S …………………………….(Name of company and

address)having factory at……………………………………… (address of factory) have
required plant/plants, machinery/machineries, building/buildings & other infrastructure to
manufacture the tendered drugs. It is also certified that the statement is true and correct.
(III) It is certified that M/s ____________________________ has Production &

financial
capacity to manufacture and deliver the drugs quoted by them in the tender as per
quantity & delivery schedule mentioned in tender. This certificate is based on their
Manufacturing capacity, inventory of raw Material and financial statement.
(IV) Further, It is certified that M/S ………………………………is Micro and Small

Enterprises (MSE) and registered with Director of Industries of concerned State/UT or
appropriate authorities for quoted drugs against BPPI tender No. BPPI/DRUG/RC-
156/2020 and eligible for exemption of paying EMD. This MSEs is owned by Scheduled
Caste (SC)/Scheduled Tribe (ST) entrepreneurs.
(V) They have manufactured & marketed 2 or more commercial batches of each quoted
drugs in last three years.
Date: Name: …………………………………………
Signature: ……………………………………..
Stamp: …………………………………………
Registration No.:……………………………….
NOTE
(i) Strike which is not applicable in above certificate.
(ii) MSEs would be treated as owned by SC/ ST entrepreneurs: a) In case of
proprietary MSE, proprietor(s) shall be SC /ST b) In case of partnership MSE, the
SC/ST partners shall be holding at least 51% (fifty-one percent) shares in the unit
c) In case of Private Limited Companies, at least 51% (fifty-one percent) share
shall be held by SC/ST promoters.
ANNEXURE V
Ref. clause 3 (K) & 23. (B)
MANDATE FORM
Sl. No. Details Required

1. Company Name
2. Postal Address of the Company
GST No.
Telephone No.
Fax No.
E-mail ID
3. Name of the Managing Director /
Director / Manager
Mobile No. / Phone No
E-mail ID
4. Name:
Name and Designation of the
authorized company official Designation:
Mobile No.
E-mail ID
For Vendor Portal Registration
5. Permanent E-mail ID
Permanent Mobile No.
Bank Details
a) Name of the Bank
b) Branch Name & address
c) Branch Code No.
d) Branch Manager Mobile
No.
e) Branch Telephone no
f) Branch E-mail ID
6. g) 9-digit MICR code number
of the bank and branch
appearing on the MICR
cheque issued by the bank
h) IFSC Code of the Branch
i) Type of Account (Current /
Savings)
j) Account Number (as appear
in cheque book)
(In lieu of the bank certificate to be obtained, please attach the original cancelled cheque issued
by your bank for verification of the above particulars).
I / We hereby declare that the particulars given above are correct and complete. If the
transaction is delayed or not effected at all the reasons of incomplete or incorrect information, I
would not hold Bureau of Pharma Public Sector Undertakings of India (BPPI) responsible. I have
read the conditions of the tender / Rate contract entered and agree to discharge the responsibility
expected of me / from the company as a tenderer / successful tenderer.
Date: Signature :
Name :
Designation:
Place: Company Seal (Name of the person signing & designation)
CERTIFIED THAT THE PARTICULARS FURNISHED ABOVE BY THE COMPANY ARE

CORRECT AS PER OUR RECORDS.
Signature of the authorized official of the bank
Bank Seal with address:

----------------------------------------------------------------------------------------------------------
Annexure VI
Additional Document
Tender No. BPPI/DRUG/RC-156/2020,
Ref Clause No. 3 (L) Date:
S. Drug Code Drug Unit Marketing standing Certificate

N. (Only Specification Size Drug Manufacturing License (MSC)
Quoted (As per Drug License License License Page no. of Market Period of Page no. of
Drugs as Tender Manufacturing Issue Renewal Validity Document Standing Marketing Document
mentioned Specification) License No. date Date Date in uploaded Certificate as per in uploaded
in Scan Copy Issue Date Marketing Scan Copy
Annexure standing
II) (Do not put Certificate (Do not put
page nos. in (MSC) page nos. in
range) range)
Note:
(i) In case any details as desired above is missing/not submitted against quoted drugs, the bid for such drugs are
liable to be rejected.
(ii) It is strictly do not put page nos. in range, indicate the page nos. one by one for all respective quoted drugs
codes.
Signature:
Name:
Authorized Signatory:
Seal of the Company:
ANNEXURE -VII
Ref. Clause no 20 & 21
DECLARATION
I/We do hereby declare that I/we will supply the drug as per the design in Enclosure 1 to
Annexure VII & Enclosure 1 to Annexure VII as well as other instruction given in this regard.
Signature of the Tenderer
Name: ………………………………
Designation: ………………………..
(Company Seal)
Enclosure–1 to ANNEXURE - VII
Ref. Clause No. 20
DESIGN FOR: Foil / blister of tablet and capsule
1. Text Matter Printing on Foil /Blister should be in minimum two colour i.e. Black &
red.
However, colour and design of PMBJP (Pradhan Mantri Bhartiya Janaushadhi
Pariyojana) logogram in standard colour format & BPPI Drug code-XXXX as
given in PO as per approval at the time of ART WORK approval before supply
should be as given below.
2. PMBJP Logogram should be placed along with the address as given below.
3. BPPI helpline number 1800 180 8080 should be printed.
4. Font type should in CALIBIRI format for any type of title name of generic medicines.
5. Title name of generic medicine should be bold in minimum 12 font size & the
strength corresponding to it must be bold in minimum 14 font sizes and it may
increase respectively according to size of label & the rest text matter should be in
minimum 8 font size.
6. The stereo printing of batch no./manufacturing /expiry date & other details shouldn’t
overlap the text matter.
7. “Bureau of Pharma PSUs of India” should be running text only and should not be
prominent.
1. Pradhan Mantri Bharitya Janaushadhi Priyojana should be printed in Hindi at side

of strips.
Enclosure – 2 to ANNEXURE – VII
Ref. Clause No. 20
1. Design for injection for primary packing
a) Vial (5ml or more) should be supplied with the following PMBJP logogram & BPPI
Drug code-XXXX as given in PO as per approval at the time of ART WORK
approval before supply as under:
b) BPPI helpline number 1800 180 8080 should be printed
c) Font type should in CALIBIRI format for any type of title name of generic medicines
d) Title name of generic medicine should be minimum 12 font sizes and it may increase
respectively according to size of label.
e) “Bureau of Pharma PSUs of India” should be running text only and should not be
prominent.
Manufactured for:
Bureau of Pharma PSUs of India

8th Floor, Videocon Tower, Block-E1, Jhandewalan Extension, New Delhi-110055
BPPI helpline number 1800 180 8080 BPPI DRUG CODE—XXXX
b) Ampoules or Vials less than 5 ml for primary packing

(i) Injection in ampoule or vial (less than 5 ml) should be supplied with PMBJP
logogram & BPPI Drug code-XXXX as given in PO as per approval at the time
of ARTWORK approval before supply.
(ii) BPPI helpline number 1800 180 8080 should be printed.
(i) Font type should in CALIBIRI format for any type of title name of generic
medicines.
(ii) Title name of generic medicine should be minimum 12 font sizes and it may
increase respectively according to size of label.
(iii)“Bureau of Pharma PSUs of India” should be running text only and should not be
prominent.
Manufactured for :

(ii) LIQUID:
a) Liquid preparation should be supply with pilfer proof ROPP cap.
b) Bottle cap should not bear the manufacturer’s logogram
c) Bottle label should bear PMBJP logogram & BPPI Drug code-XXXX as given in
PO as per approval at the time of ARTWORK approval before supply as
below:
d) BPPI helpline number 1800 180 8080 should be printed
e) “Bureau of Pharma PSUs of India” should be running text only and should not be
prominent
f) Font type should in CALIBIRI format for any type of title name of generic
medicines
g) Title name of generic medicine should be minimum 12 font sizes and it may
increase respectively according to size of label.
Manufactured for :

BPPI helpline number 1800 180 8080 BPPI DRUG CODE--XXXX
OINTMENTS / CREAMS
a) Ointment / Cream /Gel /Glass Jar should bear PMBJP logogram & BPPI Drug
code-XXXX as given in PO as per approval at the time of ART WORK
approval before supply as below:
Manufactured for :

b) BPPI helpline number 1800 180 8080 should be printed

c) Ointment / cream tube should be packed in mono carton (secondary packing) with
PMBJP logogram & BPPI Drug code-XXXX as given in PO as per approval at the
time of ART WORK approval before supply as given below.
d) “Bureau of Pharma PSUs of India” should be running text only and should not be
prominent
e) Font type should in CALIBIRI format for any type of title name of generic medicines
f) Title name of generic medicine should be minimum 12 font sizes and it may increase
respectively according to size of label.
ANNEXURE-VIII
Ref. Clause No. 21
SCHEDULE FOR PACKAGING OF DRUGS
GENERAL SPECIFICATIONS
1. Strips of Aluminium foils should be 0.07 mm thickness and grammage of foil minimum 80
g/m2, LDPE minimum 35 g/m2 and total GSM not less than 110 g/m2.
2. Aluminium foils back material for blisters should be minimum 0.025 mm thickness,
grammage of foil minimum 75 g/m2 and tensile strength minimum 400 Kg/cm2.
3. The rigid PVC used in blister packing should be of not less than 250 microns (thickness) and
grammage minimum 350 g/m2.
4. ALU-ALU blisters, total grammage minimum 250 g/m2, total minimum thickness 130
microns, and bursting strength minimum 15 Kg/cm2.
5. Pin hole should be nil and toxicity should be comply as per USP in all foil and PVC.
6. All glass bottles should be new neutral glass, Type-1, free from visual defects.
7. Pet bottles used for syrups/solution should be clean, standard for market and so accepted as
per drug laws stipulation.
8. Ointments should be packed in lacquer zed Aluminium Tubes or Lami tubes and properly
sealed.
9. Small Tablets packed in blisters should be packed to facilitate easy removal of the tablet
without breaking / crushing.
10. Specification of outer cartons should be as per given in their Schedule.
11. In case of any conflict between Carton specifications and packets per carton specification the
specification of the packets / carton shall prevail.
12. All plastic containers should be made of virgin grade plastics
13. Injection in vials should have a flip-off seals.
14. Container used for infusions should be as per market standard and must not leak during use.
15. The strips shall be aluminium strip / blisters with aluminium foil back.
16. The outer carton/secondary packaging should be of pearl white duplex board (off white/grey
is not acceptable) with a minimum of 350 GSM with Gloss laminated packing for the strips,
blisters, ointments, creams etc. and for ampoules and vials should be with pearl white board of
350 GSM (off white/grey is not acceptable). The material to be used for carton should be
from virgin chemical pulp.
17. All liquid oral preparations to be provided with a measuring plastic cup, fitted over the cap of
the bottle in a mono carton. In case of Paediatric Preparation, all liquid oral has to be provided
with a measuring plastic cup, dropper fitted over the cap of the bottle in a mono carton.
18. All primary/secondary/tertiary packaging should have PMBJP logo and drug code mentioned
as per purchase order.
16. Two Horizontal/vertical/standing lines in two different colour will be there on Primary and
secondary packaging, to differentiate therapy groups. The colours of lines will be intimated
during Artwork approval.
The primary packing should be decided by the party depending on the drug category as per Drug
& Cosmetic act. For e.g if drug is hygroscopic then tablet should be packed in Alu/Alu blister or
if it is light sensitive then to be packed in Amber colour PVC e.t.c.
Shipper size or corrugated box specification with weights
S. N Particulars Weight Ply Grammage Bursting

strength
1 Tablets Not more than 7 Outer box Not less
12.0 Kg should be than 10
2 Capsules (Hard gel and Not more than 7 150 GSM Kg/cm2.
soft gel) 12.0 Kg and inside
3 Syrups Not more than 12 7 partition/
to14.0 Kg lining should
4 Ointment/gel/cream Not more than 7 be 120 GSM.
12.0 Kg
5 Injection (vial, respules Not more than 8- 7
and ampules) 12.0 Kg
6 IV fluids Not more than 7
12.0 Kg
7 Bottles/Jars Not more than 7
12.0 Kg
(4) In the case of 10 ml Ampoules, 20 or 25 ampoules may be packed in a mono carton. Multiples
of mono carton boxes should be packed in CB.
(5) If the vial is packed in individual carton, there is no necessity for grey board box packing. The
individual carton may be packed as such in the CB with center pad.
(6) In case of ampoules less than 10 ml, every 10 or 5 ampules should be inside the tray with printed
white board box.
(7) Vials of eye, ear drops, and nasal drops should be packed in an individual mono carton with a
dispensing device. If the vial is of FFS/BFS technology, they should be packed as per approved
artwork and market standard.
ANNEXURE IX
(BARCODE REQUIREMENTS}
Reference clause 3(R)
GS1 barcode requirements on Drugs procured by Bureau of Pharma Public

Sector undertakings of India (BPPI)
These requirements cover medicines/drugs procured by Bureau of Pharma Public Sector

Undertakings of India (BPPI), New Delhi meant for supply and distribution through BPPI regulated
distribution channel.
Barcode based on GS1 identification standards are provided below at various levels of product
packaging which includes primary, secondary and shipper/carton levels and need to be complied
with while supplying medicines/drugs to BPPI.
GS1 India is unique identification & barcoding standards body setup by Ministry of Commerce &
Industry, Govt. of India along with APEDA, BIS, Spices board, IIP and apex industry chambers
like CII, FICCI, ASSOCHAM to assist India industry and govt. bodies on adoption of global
standards.
Suppliers are also required to provide GS1 subscription validity certificate at the time of supply of
medicines/drugs issued by GS1 India. For validity certificate suppliers can contact GS1 India at
011-42890-846.
Barcodes based on GS1 global standards are required to be printed on product packaging at
primary, secondary and tertiary packaging levels in addition to other, existing statutory labelling &
marking requirements.
Technical Specification for GS1 Standards
Tertiary Level Pack:
Is defined as a level of packaging that shall contain one or more secondary/primary levels of packaging and is also
considered as the final logistics unit like shippers/pallets.
The Tertiary label will carry two barcodes in GS1-128 format
First Barcode
a) Unique product identification code (GTIN - Global Trade Identification Number)
b) Manufacturing Date
c) Expiry date
d) Batch no.
e) Quantity
Second Barcode
f) Serial Shipping Container Code (SSCC) –
Note-
1) While encoding Manufacturing and expiry date in the barcode, if a specific Manufacturing or
expiry date is not printed on the finished pack/drug then Supplier should select first day of the
month as the Manufacturing date and Last day of the month as expiry date.
Example- If Shelf life is 24 months, April 2019 manufacturing date should be encoded as
190401 and March 2021 expiry date as 210331.
2) SSCC number of the Tertiary pack should never be reused on another Tertiary pack
irrespective the Item, Batch or expiry is different.
3) For converting, GTIN-13 into GTIN-14, kindly use “0” as a prefix for all levels of packaging.
Attribute Description Length Nature Data Type

Application Identifier
to indicate GTIN-14
(02) 2 Fixed Numeric
Brackets not encoded
in the barcode
Unique Product
0 8901072 00253 3 14 Fixed Numeric
Number-GTIN-14
to indicate
(11) Manufacturing date 2 Fixed Numeric
in the barcode
Expiry Date in
180101 6 Fixed Date
YYMMDD format
to indicate Expiry
(17) date Brackets not 2 Fixed Numeric
encoded in the
barcode
Expiry Date in
220131 6 Fixed Date
YYMMDD format
Application identifier
to indicate Lot/batch
(10) number 2 Fixed Numeric
in the barcode
BATCH123 Batch No / Lot No 20 Variable Alphanumeric
(37) to indicate Quantity 2 Fixed Numeric
in Outer Carton
No of Primary packs like
500 number of strips/Bottles in Upto 8 Variable Numeric
the tertiary.
to indicate the SSCC
in the barcode
Unique number of
the tertiary pack. It
1 8901072 000000000 6 18 Fixed Numeric
should never be
reused.
Recommended Barcode – GS-

128
Secondary Level Pack:
Is defined as a level of packaging that may contain one or more primary packages usually termed as Mono-
carton/carton
Secondary level barcode can be generated using 2D- GS1 Datamatrix or 1D- GS1-128 format.
Note-
1) Shrink wrap packaging will not be considered as Secondary level packaging.
Data Attributes Captured in GS1 Datamatrix format
1) Unique product identification code (GTIN)

2) Batch No.
3) Qty- No of strips/bottle

to indicate GTIN-14.
in the barcode
GTIN-14- Unique
product code with
14 Fixed Numeric
0 8901072 00253 3 first digit being the
packaging indicator
in the barcode
BATCH123 Batch No / Lot No Upto 20 Variable Alphanumeric
to indicate serial
(37) number 2 Fixed Numeric
in the barcode
Quantity/Units in
5 Upto 8 Variable Alphanumeric
Secondary pack
Recommended Barcode
depending upon the space
available – GS1 Data matrix or
Or
GS1-128
Primary Level Pack:
Is defined as the first level of packaging in direct contact with the product like Strip, Vial, Bottle etc
Scenario-I Primary pack with a Mono-carton/Carton/Secondary level pack
For primary packaging packed in a Mono-carton/Secondary pack carton
a. Unique product identification code (GTIN)
Note-

Application Identifier to
indicate GTIN-14
Brackets not encoded in
the barcode
GTIN-14 with first digit
0 8901072 00253 3 being the packaging 14 Fixed Numeric
indicator
Recommended Barcode –
GS1 Datamatrix,
Scenario-II Primary pack without Mono-carton/Secondary level pack
For Primary packaging going directly into Tertiary pack without a Carton/Mono-carton/Secondary
pack
1) Unique product identification code (GTIN)
2) Batch No.
Note-
(01)08901072002533
(10)BATCH123
to indicate GTIN-14.
in the barcode
GTIN-14- Unique
product code with
14 Fixed Numeric
0 8901072 00253 3 first digit being the
packaging indicator
in the barcode
BATCH123 Batch No / Lot No Upto 20 Variable Alphanumeric
Mapping of Manufacturer GTIN with BPPI Drug code-
• GS1 has facilitated an online application to link Manufacturer GTIN code with BPPI Drug code. The
manufacturer must update the same before sending the physical consignment to BPPI.
• Kindly contact Mr. Ankit Arora or Mr. Amrit Garg for the same at 011-42890846/42890818 or write
email at ankit@gs1india.org or amrit@gs1india.org
Barcode Design and Printing-

• For BPPI suppliers, GS1 India has facilitated an online application to generate the barcode designs for each
level of packaging.
• Using the same, the supplier will be able to generate Primary, secondary and Tertiary barcodes as per BPPI
format.
• Kindly contact Mr. Ankit Arora or Mr. Amrit Garg for the same at 011-42890846/42890818 or write
email at ankit@gs1india.org or amrit@gs1india.org
Please contact GS1 India office for any further assistance –

GS1 India
(Under Min. of Commerce, Govt. of India)
330, 2nd Floor, ‘C’ Wing, August Kranti Bhawan,
Bhikaji Cama Place, New Delhi - 110066
T +91-11-42890890, (D) +91-11-42890846
F +91-11-26168730
E ankit@gs1india.org
W http://www.gs1india.org
ANNEXURE –X
(Ref: -Clause 6.A)
MODEL BANK GUARANTEE FORMAT FOR FURNISHING EMD
Whereas …………………………………………………………………………………
(hereinafter called the
“tenderer”) has submitted their offer dated………………………………….………………………
for the supply
Of Drugs (hereinafter called the “tender”) against the purchaser’s tender enquiry No.
BPPI/DRUG/RC-156/2020 know all men by these presents that we …………………
……………………….of …………………………… having our registered office
at……………………………………………. are bound unto Bureau of Pharma Public
Sector Undertakings of India New Delhi(hereinafter called the “Purchaser) in the sum of Rs.
Ten lakh only for which payment will and truly to be made to the said Purchaser, the Bank
binds itself, its successors and assigns by these presents. Sealed with the Common Seal of
the said Bank this…………… day of …………….202..
THE CONDITIONS OF THIS OBLIGATION ARE:
(1) If the tenderer withdraws or amends, impairs or derogates from the tender in any
respect within the period of validity of this tender.
(2) If the tenderer having been notified of the acceptance of his tender by the
Purchaser during the period of its validity: -
(a) Fails or refuses to accept/execute the contract.
WE undertake to pay the Purchaser up to the above amount upon receipt of its first written
demand, without the Purchaser having to substantiate its demand, provided that in its
demand the Purchaser will note that the amount claimed by it is due to it owing to the
occurrence of one or both the two conditions, specifying the occurred condition or
conditions.
This guarantee will remain in force up to 12 months from the due date of tender i.e. ........and
any
demand in respect thereof should reach the Bank not later than the above date.
(Signature of the authorized officer of the Bank) ……………………………………….
Name of the officer………………………………………………………………………
Designation of the officer………………………………………………………………..
Seal, name & address of the Bank and address of the Branch…………………………...
ANNEXURE-XI
Ref: Clause No. 15.E
Letter of acceptance of tender for Rate Contract
Speed post/e-mail
Ref. No. BPPI/DRUG/RC-156/2020 Date: ………….
To,
M/S_______________________________
_______________________________
Sub: Tender for the Supply of Drugs and Medicines to BPPI for two years: Acceptance
tender for Rate Contract.
Ref: Your quotation against BPPI e-Tender No. BPPI/DRUG/RC-156/2020 dated:
17/07/2020 opened on ………. (Technical Bid) & on …… (Price bid).
Please refer to your quotation i.e. technical and price bid (BOQ) along with
enclosures/Annexure against subject tender read with your subsequent clarification/confirmation
for the supply of Drugs to BPPI, the rate offered/accepted by your firm has been approved for
Rate Contract for two years from the date of issue of this letter.
Rate of GST Rates in Rs.

Drug Drug Unit Rates in Rs. Per unit (%) Per unit
S. N.
Code Name Size exclusive of GST inclusive of
GST
2. The contract will be with financial limit and BPPI can place the Purchase Order with
unlimited variation in quantities indicated in the tender.
3. The estimated value of the contract awarded to you is Rs........(in word).
4. Performance Security Deposit @5% will be deducted from each bills and accumulated
security deposit will be refunded by BPPI to the tenderer within 60 days following the date of
completion of tenderers performance obligations under the contract including the shelf life
obligation.
5. Approval for Artwork should be obtained from our Quality Control department by you within
30 days of release of this letter. (e-mail id: regulatory@janaushadhi.gov.in)
6. STP (Standard Testing Procedure) for Non- Pharmacopoeia awarded drugs are required to
submit to Quality Control department (e-mail id: regulatory@janaushadhi.gov.in)within 15
days from the date of Letter of Acceptance
7. As per clause 4. M of Tender document, the Rate Contract validity period may be extended
for period up to further one year at same rate, terms & conditions with the consent of the
supplier.
8. The terms and conditions of Rate Contract shall be applicable as mentioned in tender
document. By issue of this acceptance letter, the Rate Contract is hereby concluded.
Please acknowledge receipt.
Authorized Signatory,
For and on behalf of BPPI
Annexure -XII
Clause 18 (M)
Bureau of Pharma Public Sector Undertakings of India, New Delhi
Tender for supply of drugs (Tender No. BPPI/DRUG/RC-156/2020 dated 17/07/2020)
(1) (2) (3) (4) (5) (6) (7)

Sl. Drug Generic Name of the Composition of the Drug Unit Size Pack Size Indicative
No. Code Drug Requirem
ent in
Unit Size
1 3 Pregabalin Capsules IP 75 Each Capsule contains 10's 10's X 10 860000
mg Pregabalin 75 mg
Excipients q.s
2 6 Chlorzoxazone, Diclofenac Each uncoated tablet contains: 10's 10's X 10 1640000
and Paracetamol Tablets Chlorzoxazone 500 mg
(500 mg + 325 mg + 50 Diclofenac Potassium 50 mg
mg) Paracetamol 325 mg
3 9 Diclofenac Sodium Each sustained release film-coated 10's 10's X 10 2300000
Sustained Release Tablets tablet contains:
IP 100 mg Diclofenac Sodium IP 100 mg
4 10 Diclofenac Sodium Each ml contains: 3ml 3ml 12000000
Injection IP 25mg/ml Diclofenac Sodium IP 25mg Ampoule Ampoule X
10
5 11 Diclofenac Gastro- Each Gastro resistant tablet contains: 10's 10's X 10 570000
Resistant Tablets IP 50 mg Diclofenac Sodium I.P 50 mg
6 14 Ibuprofen and Paracetamol Each uncoated tablet contains: 10's 10's X 10 580000
Tablets IP (400 mg + 325 Ibuprofen IP 400mg
mg) Paracetamol IP 325 mg
7 15 Ibuprofen Tablets IP 200 Each Film Coated Tablet contains: 10's 10's X 10 120000
mg Ibuprofen 200 mg
8 16 Ibuprofen Tablets IP 400 Each film-coated tablet contains: 15's 15's X 10 200000
mg Ibuprofen IP 400mg
9 17 Indomethacin Capsules IP Each capsule contains: 10's 10's X 10 160000
25 mg Indomethacin IP 25mg
10 18 Azithromycin Tablets IP Each Film Coated Tablet contains: 6's 6's X 10 2600000
250 mg Azithromycin (anhydrous) 250 mg
(as Azithromycin Dihydrate IP)
11 22 Paracetamol Paediatric Each 5 ml Suspension contains: 60ml 60ml X 10 3500000
Oral Suspension IP 125 Paracetamol I.P 125mg Bottle
mg/5 ml
12 24 Pentazocine Injection IP 30 Each ml contains: 1ml 1 ml x 10 580000
mg/ml Pentazocine 30mg Ampoule
13 26 Tramadol Hydrochloride Each ml contains: 2ml 2ml X 10 730000
Injection 100 mg/2 ml Tramadol Hcl 50mg Ampoule
14 28 Tramadol Tablets 50mg Each Film-coated tablet contains: 10's 10's X 10 770000
Tramadol Hydrochloride 50mg
15 29 Acyclovir Tablets IP 400 Each uncoated tablet contains: 10's 10's X 10 270000
mg Acyclovir 400mg
16 30 Amikacin Injection IP 100 Each ml contains: 2ml Vial 2ml X 10 380000
mg/2 ml Amikacin Sulphate IP equivalent to
Amikacin 50 mg
Methyl Paraben IP 0.08% w/v
Propyl Paraben IP 0.02% w/v
mg/2 ml Amikacin sulphate IP equivalent to
Amikacin 125mg
mg/2 ml Amikacin sulphate IP equivalent to
Amikacin 250 mg
19 36 Amoxycillin and Potassium Each 5ml suspension contains: 30ml 30ml X 10 800000
Clavulanate Oral Amoxycillin Trihydrate equivalent to
Suspension (200 mg + 28.5 Amoxycillin 200mg
mg)/5 ml Potassium Clavulanate diluted
equivalent to Clavulanic acid 28.5mg
20 37 Amoxycillin and Potassium Each vial contains: Vial with 1's X 10 110000
Clavulanate Injection 300 Amoxycillin Sodium IP equivalent to WFI
mg Amoxycillin 250 mg
Potassium Clavulanate IP equivalent
to Clavulanic Acid 50mg
21 38 Amoxycillin and Potassium Each vial contains: Vial with 1's X 10 110000
Clavulanate Injection Amoxycillin Sodium IP equivalent to WFI
600mg Amoxycillin 500 mg
Potassium Clavulanate IP equivalent
to Clavulanic Acid 100mg
22 40 Amoxycillin and Each hard gelatin capsule contains: 10's 10's X 10 370000
Cloxacillin Capsules (250 Amoxycillin Trihydrate IP equivalent
mg + 250 mg) to Amoxycillin 250mg
Cloxacillin Sodium IP equivalent to
Cloxacillin 250mg
23 42 Amoxycillin Trihydrate Each uncoated dispersible tablet 10's 10's X 10 290000
Dispersible Tablets IP 125 contains:
mg Amoxycillin Trihydrate IP equivalent
to Amoxycillin 125mg
24 47 Azithromycin Oral Each 5 ml contains: 15ml 1's X 10 680000
Suspension (100mg/ 5ml) Azithromycin (as dihydrate)
equivalent to Azithromycin
(anhydrous) 100mg
Flavoured Syrupy base q.s
25 48 Azithromycin 100mg Each uncoated dispersible tablet 10's 10's X 10 170000
Dispersible Tablets contains: Azithromycin 100mg
26 52 Cefadroxil Tablets IP Each uncoated tablet contains: 10's 10's X 10 690000
500mg Cefadroxil Monohydrate equivalent
to Anhydrous Cefadroxil 500 mg
Excipients q.s.
27 58 Cefoperazone Injection IP Each Vial Contains: Vial with 1's X 10 250000
1g Sterile Cefoperazone Sodium IP WFI
equivalent to Cefoperazone 1gm
28 62 Cefotaxime Sodium Each Vial contains: Vial with 1's X 10 4700000
Injection IP 1000 mg Cefotaxime Sodium IP equivalent to WFI
Cefotaxime 1g
29 64 Cefotaxime Sodium Each Vial contains: Vial with 1's X 10 700000
Injection IP 500 mg Cefotaxime Sodium 500 mg WFI
30 65 Cefpodoxime Proxetil Each uncoated dispersible tablet 10's 10's X 10 200000
Dispersible Tablets 100 mg contains:
Cefpodoxime Proxetil IP equivalent
to Cefpodoxime 100mg
31 66 Cefpodoxime Tablets IP Each film coated tablet contains: 10's 10's X 10 120000
200mg Cefpodoxime Proxetil IP equivalent
to Cefpodoxime 200 mg
32 73 Cefotaxime Sodium and Each Vial contains: Vial with 1's X 10 110000
Sulbactam Sodium Ceftriaxone Sodium IP equivalent to WFI
Injection (250mg + 125mg) Ceftriaxone 250mg
Sulbactam Sodium equivalent to
Sulbactam 125mg
33 78 Cefuroxime Axetil Tablets Each film coated tablet contains: 10's 10's X 10 530000
IP 500mg Cefuroxime Axetil I.P eq. to
Cefuroxime: 250mg
34 79 Cefuroxime Axetil Tablets Each film coated tablet contains: 10's 10's X 10 690000
IP 250mg Cefuroxime Axetil IP equivalent to
Cefuroxime 500mg
35 82 Cephalexin Capsules IP Each Hard Gelatin capsule contains: 10's 10's X 10 300000
500mg Cephalexin IP equivalent to
Anhydrous Cephalexin 500 mg
36 83 Ciprofloxacin and Each film-coated tablet contains: 10's 10's X 10 190000
Tinidazole Tablets Ciprofloxacin Hydrochloride IP
(250mg+300mg) equivalent to Ciprofloxacin 250mg
Tinidazole IP 300mg
37 88 Co-trimoxazole Each 5 ml contains: 50ml 50ml X 10 1100000
(Sulphamethoxazole Trimethoprim 40mg
200mg and Trimethoprim Sulphamethoxazole 200mg
40mg per 5ml) Oral
Suspension IP
38 89 Co-trimoxazole Each uncoated tablet contains: 10's 10's X 10 210000
(Sulphamethoxazole Trimethorim IP 160 mg
800mg and Trimethoprim Sulphamethoxazole IP 800mg
160mg) Tablets IP
39 90 Co-trimoxazole Each uncoated tablet contains: 10's 10's X 10 110000
(Sulphamethoxazole Trimethoprin 20mg
100mg and Trimethoprim Sulphamethoxazole 100mg
20mg) Tablets IP
40 92 Doxycycline Capsules IP Each hard gelatin capsule contains: 10's 10's X 10 120000
100mg Doxycycline Hydrochloride IP
equivalent to Doxycycline 100mg
41 93 Erythromycin Stearate Each uncoated tablet contains: 10's 10's X 10 180000
Tablets IP 250mg Erythromycin Estolate equivalent to
250mg of Erythromycin Base
42 94 Gentamicin Sulphate Each ampoule contains: 2ml 2ml X 10 180000
Injection IP 80 mg/ 2ml Gentamicin Sulphate 80mg
43 95 Levofloxacin Tablets IP Each film coated tablet contains: 10's 10's X 10 300000
250mg Levofloxacin Hemihydrate IP
equivalent to Levofloxacin 250mg
Excipients q.s
44 99 Norfloxacin Tablets IP 400 Each film coated tablet contains: 10's 10's X 10 520000
mg Norfloxacin 400mg
45 100 Ofloxacin and Ornidazole Each film coated tablet contains: 10's 10's X 10 290000
Tablets (200mg + 500mg) Ofloxacin 200mg
Ornidazole 500mg
46 104 Roxithromycin Oral Each 5ml contains: 30ml 30ml X 10 110000
Suspension (50 mg/ 5ml) Roxithromycin 50mg
Flavoured Syrupy Base q.s.
47 106 Roxithromycin Tablets IP Each film-coated tablet contains: 10's 10's X 10 110000
300mg Roxithromycin IP 300mg
48 110 Adapalene 0.1%w/w Gel Contains: 15g tube 1's X 20 120000
Adapalene 0.1 % w/w
in gel base q.s.
49 112 Beclomethasone Contains: 15g tube 1's X 20 270000
Dipropionate 0.025 % w/w, Beclomethasone Dipropionate IP
Clotrimazole 1 % w/w and 0.025% w/w
Gentamicin Sulphate 0.1 % Clotrimazole 1% w/w
w/w Cream Gentamycin Sulphate 0.1% w/w
50 115 Calamine Lotion Composition: 100ml 100ml X 10 210000
Calamine 15% w/v
Zinc Oxide 5% w/v
Bentonite 3% w/v
Sodium Citrate 0.5% w/v
Glycerol 5% v/v
51 120 Fusidic Acid Cream 2 % Each g contains: 5g tube 5g tube X 20 1200000
w/w Fusidic Acid 20 mg
Potassium Sorbate 2.7 mg
52 126 Povidone-Iodine Solution Povidone-Iodine Solution IP 10 % 500ml 1's X 6 370000
IP 10 % w/v w/v
53 127 Povidone-Iodine Solution Povidone-Iodine Solution IP 5 % w/v 100ml 100ml X 10 790000
IP 5 % w/v
54 131 Silver Sulphadiazine Contains: 20g 20g tube X 190000
Cream IP 1% w/w 20g Silver Sulfadiazine 1% w/w 20
in cream base q.s.
55 132 Silver Sulphadiazine Contains: 500g 1's X 6 110000
Cream IP 1% w/w 500g Silver Sulfadiazine 1% w/w
in cream base q.s.
56 133 Glibenclamide Tablets IP Each uncoated tablet contains: 10's 10's X 10 610000
2.5mg Glibenclamide IP 2.5mg
57 136 Gliclazide Tablets IP 80 Each uncoated tablet contains: 10's 10's X 10 1500000
mg Gliclazide I.P 80 mg
58 158 Etoposide Injection IP 100 Each ml contains: Vial 1's X 10 110000
mg/5 ml Etoposide IP 20mg
59 163 Tamoxifen Citrate Tablets Each uncoated tablet contains: 10's 10's X 10 140000
IP 10 mg Tamoxifen Citrate I.P equivalent to
Tamoxifen 10mg
60 164 Tamoxifen Citrate Tablets Each uncoated tablet contains: 10's 10's X 10 350000
IP 20 mg Tamoxifen Citrate I.P equivalent to
Tamoxifen 20mg
61 178 Albendazole and Each uncoated chewable label 1's 1's x 10 1400000
Ivermectin Tablets (400mg contains:
+ 6mg) Ivermectin 6 mg
Albendazole q.s
62 184 Paracetamol and Each uncoated tablet contains: 10's 10's X 10 2000000
Dicyclomine Dicyclomine hydrochloride 20mg
Hydrochloride Tablets Paracetamol 325mg
(325mg + 20mg)
63 186 Domperidone Tablets IP 10 Each film-coated tablet contains: 10's 10's X 10 1400000
mg Domperidone Maleate IP equivalent
to Domperidone 10mg
64 192 Famotidine Tablets IP Each film coated tablet contains: 14's 14's x 10 870000
40mg Famotidine: 40mg
65 194 Hyoscine Butylbromide Each sugar-coated tablet contains: 10's 10's X 10 220000
Tablets IP 10mg Hyoscine Butylbromide IP 10 mg
66 195 Isapgol Husk IP 200 gm Each 100 gm contains: 200g 200g 1400000
Ispaghula Husk IP 100 g Tetrapack Tetrapack X
10
67 197 Lactulose Solution (10g Each 15ml contains: 100ml 100ml X 10 1100000
per 15ml) Lactulose solution equivalent to
Lactulose 10g
68 199 Metoclopramide Tablets IP Each uncoated tablet contains: 10's 10's X 10 300000
10 mg Metoclopramide Hydrochloride IP
equivalent to Anhydrous
Metoclopramide Hydrochloride: 10
mg
69 200 Metoclopramide Injection Each ml contains: 2ml 2ml X 10 1200000
IP 5mg/ml Metoclopramide 5mg
70 206 Omeprazole and Each Hard Gelatin capsule contains: 10's 10's X 10 1100000
Domperidone Capsules IP Omeprazole IP: 20 mg (As enteric
(20mg + 10mg) coated pellets)
Domperidone IP: 10 mg (As coated
pellets)
71 207 Omeprazole Capsules IP Each capsule contains: 10's 10's X 10 11000000
20 mg Omeprazole IP: 20 mg (As enteric
coated pellets)
72 210 Ornidazole Tablets IP Each film coated tablet contains: 10's 10's X 10 710000
500mg Ornidazole IP: 500 mg
73 214 Rabeprazole and Each capsule contains: 10's 10's X 10 18000000
Domperidone Sustained Rabeprazole Sodium: 20 mg (as
Release Capsules (20mg + Enteric coated pallets) Domperidone:
30mg) 30 mg (as sustained release pallets)
74 215 Rabeprazole Gastro Each gastro-resistant tablet contains: 10's 10's X 10 14000000
Resistant Tablets IP 20 mg Rabeprazole Sodium IP 20mg
75 217 Ranitidine Tablets IP Each film-coated tablet contains: 10's 10's X 10 16000000
150mg Ranitidine Hydrochloride IP
167.4mg
equivalent to Ranitidine 150mg
76 218 Ranitidine Tablets IP Each film coated tablet contains: 10's 10's X 10 320000
300mg Ranitidine Hydrochloride 334.8 mg
equivalent to
Ranitidine: 300mg
77 220 Calcium with Vitamin D3 Each film-coated tablet contains: 10's 10's X 10 13000000
Tablets IP (500mg+250IU) 1250mg Calcium Carbonate
equivalent to Elemental Calcium IP
500mg
Vitamin D3 IP 250IU
78 227 Polyvitamin Tablets NFI Each film-coated tablet contains: 10's 10's X 10 5500000
(Prophylactic) Vitamin A 2500 IU
Vitamin D3 200IU
Vitamin B1 2mg
Vitamin B6 0.5mg
Vitamin B12 2mg
Niacinamide 25mg
Calcium Pantothenate 1mg
Vitamin C 50mg
Folic Acid 0.2mg
79 231 Vitamin B-Complex Each film coated tablet contains: 10's 10's X 10 4500000
Tablets (B1 100mg, B2 Vitamin B1 10mg
10mg, B3 45mg, B5 50mg, Vitamin B2 10mg
B6 3mg, B12 15mcg) Vitamin B3 45mg
Vitamin B5 50mg
Vitamin B6 3mg
Vitamin B12 15mcg
80 232 Vitamin B-Complex Syrup Each 5ml contains: 200 ml 1's X 6 730000
Pyridoxine Hydrochloride IP 0.75 mg
Thiamine Hydrochloride IP 2.5 mg
Riboflavin Sodium Phosphate IP 2.5 mg
Cynocobalamine IP 2.5 mcg
Nicotinamide IP 22.5 mg
D-Panthenol IP 3.0 mg
81 233 Vitamin-C Chewable Vitamin-C Chewable 100mg Tablet 10's 10's X 10 5300000
Tablets 100mg
82 235 Budesonide Respules Each 2 ml respules contains: 2ml 2ml X 10 3600000
0.5mg/ml Budesonide: 0.5mg
83 236 Budesonide Inhaler Each activation delivers 200 MDI 1's X 10 110000
100mcg Budesonide IP 100mcg
84 238 Budesonide Inhaler Each activation delivers 200 MD 1's X 10 110000
200mcg Budesonide IP 200mcg
85 244 Etophyllin and Each 2 ml contains: 2ml 2ml X 10 1700000
Theophylline Injection Etophylline 84.7 mg
(84.7mg+25.3 mg) Theophylline anhydrous equivalent
to Theophylline hydrate 25.3 mg
86 251 Montelukast Sodium Each film coated tablet contains: 10's 10's X 10 1300000
Tablets IP 10mg Montelukast Sodium IP
equivalent to Montelukast 10mg
87 252 Montelukast Sodium and Each film coated tablet contains: 10's 10's X 10 9600000
Levocetrizine Tablets IP Montelukast Sodium IP equivalent to
(10mg + 5mg) Montelukast: 10 mg Levocetrizine
Dihydrochloride :5 mg
Excipients: q.s
88 255 Salbutamol Inhalation IP Each activation delivers: 200 MD 1's X 10 1300000
100 mcg/puff Salbutamol sulphate IP equivalent to
Salbutamol 100mcg
89 256 Salbutamol Tablets IP 2mg Each uncoated tablet contains: 10's 10's X 10 810000
Salbutamol Sulphate IP
equivalent to Salbutamol 2mg
90 259 Salbutamol Syrup IP 2mg Each 5 ml contains: Salbutamol 100ml 100ml X 10 1600000
/5ml Sulphate equivalent to Salbutamol: 2
mg
Flavoured Syrup base: q.s.
91 261 Adenosine Injection IP 6 Each ml contains: 2ml 2ml X 10 110000
mg/ 2ml Adenosine IP 3 mg
water for injection IP q.s.
92 266 Atorvastatin Tablets IP Each Film Coated tablets Contains: 10's 10's X 10 2800000
10mg Atorvastatin Calcium IP equivalent
to Atorvastatin 10mg
93 269 Clopidogrel Tablets IP Each Film Coated tablets Contains: 10's 10's X 10 16000000
75mg Clopidogrel Bisulphate IP equivalent
to Clopidogrel 75mg
94 272 Diltiazem Tablets IP 60 mg Each Film Coated tablets Contains: 10's 10's X 10 1200000
Diltiazem Hydrochloride IP 60mg
95 273 Dobutamine Injection Each vial (20ml) contains: Vial 1's X 10 110000
250mg/20ml Dobutamine 250 mg
96 274 Dopamine Hydrochloride Each ml contains: Dopamine 5ml Vial 1's X 10 110000
Injection 200 mg/5ml Hydrochloride 40mg
97 275 Enalapril Tablets IP 5 mg Each uncoated tablet contains: 10's 10's X 10 3800000
Enalapril Maleate IP 5 mg
98 276 Enoxaparin Injection IP 40 Each prefilled syringe contains: 0.4ml 1's X 10 210000
mg/0.4 ml Enoxaparin sodium IP 40mg PFS
water for injection IP q.s. to 0.4 ml
99 277 Enoxaparin Injection IP 60 Each pre-filled syringe contains: 0.6ml 1's X 10 140000
mg/0.6 ml Enoxaparin sodium IP 60 mg PFS
equivalent to 6,000 IU anti-Xa
activity.
100 278 Frusemide Injection IP 10 Each ml Contains: 2ml 2ml X 10 1100000
mg/ml Frusemide IP 10mg
Water for injection qs
101 279 Frusemide Tablets IP 40 Each Uncoated tablets Contains: 10's 10's X 10 3200000
mg Frusemide IP 60mg
102 281 Heparin Sodium Injection Each ml contains: 5ml Vial 1's X 10 110000
IP 5000 IU/ml Heparin Sodium 5000 IU
103 286 Lisinopril Tablets IP 5mg Each Uncoated tablets Contains: 10's 10's X 10 350000
Lisinopril IP
Equivelent to anhydrous
Lisinopril 5 mg
104 287 Losartan and Each Film Coated tablets Contains: 10's 10's X 10 20000000
Hydrochlorothaizide Losartan Potassium IP 50mg
Tablets IP (50mg + 12.5mg) Hydrochlorothiazide IP 12.5 mg
105 288 Losartan Tablets IP 25mg Each Film Coated tablets Contains: 10's 10's X 10 5700000
Losartan Potassium IP 25mg
106 295 Simvastatin Tablets IP Each film-coated tablet contains: 10's 10's X 10 160000
10mg Simvastatin IP 10mg
107 296 Simvastatin Tablets IP Each film-coated tablet contains: 10's 10's X 10 120000
20mg Simvastatin IP 20mg
108 298 Telmisartan and Each uncoated bilayer tablet 10's 10's X 10 36000000
Hydrochlorothiazide contains:
Tablets IP (40mg+12.5 Telmisartan IP 40mg
mg) Hydrochlorthiazide IP 12.5mg
109 301 Tranexamic Acid Tablets Each Film Coated tablets Contains: 10's 10's X 10 580000
IP 500 mg Tranexamic Acid IP 500mg
110 305 Chloroquine Phosphate Each film-coated tablet contains: 10's 10's X 10 750000
Tablets IP 250mg Chloroquine Phosphate IP 250mg
111 312 Oral Rehydration Salts Each pack contains: 1's 1's x 10 4900000
20.5 g Sachet (WHO Sodium Chloride IP 2.6 mg
Formula) Potassium Chloride IP 1.5 mg
Sodium Citrate IP 2.9 mg
Dextrose IP (anhydrous) 13.5 mg
Excipients q.s.
112 329 Prednisolone Tablets IP 5 Each uncoated dispersible tablets 15's 15's X 10 2100000
mg Contains:
Prednisolone IP 5mg
113 330 Prednisolone Tablets IP 10 Each uncoated tablet contains: 10's 10's X 10 2700000
mg Prednisolone IP 10 mg
114 332 Thyroxine Sodium Tablets Each Uncoated tablets Contains: 100's 1's X 10 580000
IP 100 mcg Thyroxine Sodium IP Bottle
Equivalent to anhydrous
Thyroxine Sodium 100mcg
115 334 Dexamethasone Injection Each ml contains: 2ml 2ml X 10 1900000
4mg/ml Dexamethasone Sodium Phosphate
IP equivalent to
Dexamethasone Phosphate 4mg
116 338 Atropine Sulphate Injection Composition: 1ml 1 ml x 10 670000
IP 0.6mg/ml Each ml contains: Ampoule
Atropine Sulphate IP 0.6mg
117 344 Ciprofloxacin Eye Drops Composition: 5ml 1's X 10 2200000
IP 0.3% w/v Ciprofloxacin Hydrochloride IP eq.
To Ciprofloxacin 0.3 % w/v
Benzalkonium Chloride Solution IP
0.025% W/V
Purified water IP q.s.
118 345 Gentamicin Eye Drops IP Composition: 10ml 1's X 10 390000
0.3% w/v Gentamicin Sulphate IP eqv. To
Gentamicin 0.3 % w/v
Benzalkonium Chloride Solution IP
0.02% W/V (As preservative)
Purified water IP q.s.
119 352 Bupivacaine Hydrochloride Each ml contains: 20ml Vial 1's X 10 110000
Injection IP 5 mg/ml Bupivacaine Hydrochloride 5 mg
120 357 Lignocaine and Adrenaline Each ml contains: 30ml Vial 1's X 10 110000
Injection IP (2%w/v and Lignocaine Hydrochloride IP 21.33mg
1:80000) Adrenaline Bitartrate IP 0.0225 mg
equivalent to
(Adrenaline 0.0125 mg)
121 358 Propofol Injection Each ml contains: 10ml Vial 1's X 10 120000
10mg/ml Propofol 10 mg
122 359 Tetanus Vaccine Each 0.5 ml contains: 0.5ml 0.5ml 360000
Tetanus Toxoid ≥ 5 LF Ampoule Ampoule X
10
123 368 Gliclazide Extended Each Uncoated Sustained Release 10's 10's X 10 2300000
release Tablets 60mg tablets contains:
Gliclazide IP 60mg
124 372 Metformin Hydrochloride Each film coated sustained release 10's 10's X 10 17000000
Prolonged release Tablets tablet contains:
IP 500mg Metformin Hydrochloride IP 500mg
125 384 Itraconazole Capsules Each hard gelatin capsule contains: 4's 4's x 10 14000000
100mg Itraconazole 100mg
126 386 Diethylcarbamazine Each uncoated tablet contains: 30's 30's x 10 120000
Tablets IP 50mg Diethylcarbamazine Citrate IP 50mg
Excipients q.s.
127 392 Griseofulvin Tablets IP Each uncoated tablet contains: 10's 10's X 10 560000
250 mg Griseofulvin IP 250 MG
128 396 Amphotericin B Injection Each Vial contains: 20ml Vial 1's X 10 110000
IP 50 mg/Vial AMPHOTERICIN B 50 mg
129 403 CLINDAMYCIN INJ IP Each ml contains: 2ml 2ml X 10 110000
300 MG/2 ML Clindamycin Phosphate IP eq. to
Clindamycin 150 mg
Benzyl alcohol IP 9.0 mg
As preservative
130 404 LINEZOLID INFUSION Each 100 ml contains: 300g 1's X 10 110000
600MG/300 ML Linezolid IP 200mg
Dextrose (Anhydrous) IP 5% W/V
Water for injection q.s.
131 410 Trastuzumab Injection Each vial Contains: 1's 1's x 10 110000
440mg With Wfi Transtuzumab 440mg
132 418 Rosuvastatin Tablets IP 20 Each Film Coated tablets Contains: 10's 10's X 10 4500000
mg Rosuvastatin Calcium IP
Equivelent to Rosuvastatin 20 mg
133 419 Ointment Of Heparin Each gram contains: 20g 1's X 20 110000
Sodium and Benzyl Heparin Sodium 50 IU
Nicotinate Benzyl Nicotinate 2mg
134 424 Carvedilol Tablets IP 3.125 Each Film Coated tablets Contains: 10's 10's X 10 4500000
mg Carvedilol IP 3.125 mg
135 425 Diltiazem Sustained Each uncoated sustained release 10's 10's X 10 1900000
Release Tablets 90 mg tablet contains:
Diltiazem Hydrochloride IP 90mg
136 426 Acenocoumarol Tablets 2 Each Uncoated tablets contains: 30's 30's x 10 260000
mg Acenocoumarol IP 2 mg
137 427 S(-)Amlodipine Tablets IP Each uncoated tablet contains: 10's 10's X 10 3400000
2.5 mg S(-)AMLODIPINE Besylate IP
equivalent to S(-)AMLODIPINE 2.5
mg
138 430 Amiodarone Tablets IP 200 Each uncoated tablet contains: 10's 10's X 10 400000
mg Amiodarone Hydrochloride IP
200mg
139 431 Ramipril and Each uncoated tablet contains: 10's 10's X 10 480000
Hydrochlorothiazide Ramipril IP 5mg
Tablets IP (5mg+12.5 mg) Hydrochlorothiazide IP 12.5mg
140 434 Propranolol Tablets IP 40 Each uncoated tablet contains: 10's 10's X 10 1500000
mg Propranolol Hydrochloride IP 40mg
141 438 Indapamide Tablets IP 1.5 Each film-coated tablet contains: 10's 10's X 10 340000
mg Indapamide IP 1.5mg
142 442 Fenofibrate Tablets IP 160 Each film-coated tablet contains: 10's 10's X 10 780000
mg FENOFIBRATE IP 160 MG
143 443 Isosorbide Dinitrate Each Uncoated Sublingual tablets 50's 50's X 10 720000
Tablets IP 5 mg contains:
Isosorbide Dinitrate IP 5mg
(from equivelent amount of Diluted
Isosorbide Dinitrate IP)
144 444 Enalapril and Each uncoated tablet contains: 30's 30's x 10 110000
Hydrochlorothiazide Enalapril Maleate IP 10 mg
Tablets IP (10mg + 25mg) Hydrochlorothiazide IP 25 mg
145 446 Amlodipine and Each uncoated tablet contains: 10's 10's X 10 1100000
Hydrochlorothiazide Amlodipine Besilate IP
Tablets (5mg + 12.5mg) equivalent to Amlodipine 5mg
Hydrochlorthizide IP 12.5mg
146 447 MOXONIDINE Each Film Coated tablets Contains: 10's 10's X 10 590000
TABLETS 0.3 MG Moxonidine 0.3 mg
147 448 Ramipril and Amlodipine Each uncoated tablet contains: 10's 10's X 10 130000
Tablets (5mg + 5mg) Ramipril IP 5mg
Amlodipine Besilate IP
equivalent to Amlodipine 5mg
148 449 Spironolactone Tablets IP Each uncoated tablet contains: 15's 15's X 10 2400000
25 mg Spirinolactone IP 25mg
149 451 Streptokinase Injection IP Each vial contains: 10ml Vial 1's X 10 110000
15,00,000 IU STREPTOKINASE IP 15,00,000 IU with
Diluent
150 452 Warfarin Tablets IP 5 mg Each uncoated tablet contains: 10's 10's X 10 610000
Warfarin Sodium Clathrate IP
equivalent to Warfarin sodium
(anhydrous) 5mg
151 453 Bisoprolol and Each film-coated tablet contains: 10's 10's X 10 160000
Hydrochlorothiazide Bisoprolol Fumarate IP 5mg
Tablets IP (5mg + 6.25mg) Hydrochlorthizide IP 6.25mg
152 454 Valsartan Tablets IP 80 mg Each film-coated tablet contains: 10's 10's X 10 760000
Valsartan IP 80 mg
153 455 Verapamil Tablets IP 80 Each film-coated tablet contains: 10's 10's X 10 110000
mg Verapamil Hydrochloride IP 80 mg
154 458 Labetalol Injection IP 5 Each ml contains: 4ml 1's X 10 130000
mg/ml Labetalol 5 mg Ampoule
155 459 Hydroquinone, Composition: 20g Tube 1's X 20 1300000
Mometasone and Tretinoin Hydroquinone 2%W/W
Cream (2% + 0.1% + Mometasone furoate IP 0.1 % W/W
0.025%) Tretinoin 0.025% W/W
Cream base q.s.
156 461 Betamethasone Valerate Contains: 20g Tube 1's X 20 1200000
and Neomycin Sulfate BETAMETHASONE VALERAT
Cream (0.1% W/W and 0.1 % w/w
0.5% W/W) NEOMYCIN SULFATE 0.5 % w/w
157 462 Betamethasone Valerate Contains: 30g Tube 1's X 20 110000
and Clioquinol Cream BP BETAMETHASONE VALERATE
(0.12% W/W+ 3% W/W) 0.12% w/w
CLIOQUINOL CREAM BP 3%w/w
158 466 Ursodeoxycholic Acid Each Film Coated tablets Contains: 10's 10's X 10 2100000
Tablets IP 300 mg Ursodeoxycholic Acid IP 300 mg
159 467 Dicyclomine and Each Uncoated Sublingual tablets 10's 10's X 10 1300000
Mefenamic Acid Tablets contains:
(10mg + 250mg) Mefenamic Acid IP 250mg
Dicyclomine Hydrochloride IP 10 mg
160 468 Bacillus Clausii Spores Each 5ml oral suspension contains: 5ml 1's X 10 120000
Suspension 2 Billion/5ml Spores of polyantibiotic resistant
Bacillus Clausii 2 billion
(Strains: O/C, N/R, SIN and T)
161 470 Diastase and Pepsin Liquid Each 5ml contains: 200 ML 1's X 6 400000
Diastase IP (1:1200) 50mg
Pepsin IP (1:3000) 10mg
162 477 Chlordiazepoxide and Each sugar-coated tablet contains: 10's 10's X 10 510000
Clidinium Bromide Tablets Chlordiazepoxide 5mg
(5mg+2.5mg) Clidinium Bromide 2.5mg
163 480 Enteric-Coated Each hard gelatin capsule contains: 10's 10's X 10 740000
Esomeprazole and Esomeprazole Magnesium Trihydrate
Sustained Release IP equivalent to Esomeprazole (as
Levosulpiride Capsules enteric coated) 40mg
(40mg+75mg) Levosulpiride (as sustained release)
75mg
164 481 Rifaximin Tablets 400 mg Each film-coated tablet contains: 10's 10's X 10 240000
Rifaximin 400mg
165 483 Loperamide Capsules IP 2 Each hard gelatin calsule contains: 10's 10's X 10 800000
mg LOPERAMIDE
HYDROCHLORIDE IP 2 mg
166 485 Promethazine Tablets IP 25 Each Film Coated tablets Contains: 10's 10's X 10 120000
mg Promethazine Hydrochloride IP 25
mg
167 486 Pancreatin and Activated Each enteric-coated tablet contains: 10's 10's X 10 110000
Dimethicone Tablets PANCREATIN IP 170mg
(170mg+80mg) Activated DIMETHICONE
TABLETS IP 80mg
168 487 Dicyclomine Each 5ml contains: 30g 30g X 10 110000
Hydrochloride and Dicyclomine Hydrochloride IP 10mg
Dimethicone Suspension Simethicone IP 40mg
(10mg+40mg)
169 489 Sulfasalazine Delayed Each enteric-coated tablet contains: 10's 10's X 10 350000
Release Tablets 1000mg Sulfasalazine 1000mg
170 491 Itopride Tablets 50 mg Each Film Coated tablets Contains: 10's 10's X 10 270000
Itopride Hydrochloride 50 mg
171 494 ISPAGHULA HUSK IP Each 100 gm contains: 100g 100g Tetra 430000
100 GM Ispaghula Husk IP 100 g Tetra pack X 20
pack
172 496 Dydrogesterone Tablets IP Each film-coated tablet contains: 10's 10's X 10 110000
10 mg DYDROGESTERONE IP 10 MG
173 499 Norethisterone Tablets IP 5 Each Uncoated Sublingual tablets 10's 10's X 10 730000
mg contains:
Norethisterone IP 5mg
174 501 Betamethasone Sodium Each film-coated tablet contains: 20's 20's X 10 810000
Phosphate Tablets IP 0.5 BETAMETHASONE SODIUM
mg PHOSPHATE TABLETS IP
equivalent to Betamethasone 0.5 MG
175 503 METHYLPREDNISOLON Each vial contains: Vial with 1's X 10 110000
E SODIUM SUCCINATE Methylprednisolone Sodium WFI
INJECTION 1000 MG Succinate equivalent to
PER VIAL Methylprednisolone 1g
176 505 Carbimazole Tablets 10 mg Each uncoated tablet contains: 100's 1's X 10 150000
CARBIMAZOLE 10 MG Bottle
177 507 Carbimazole Tablets IP 5 Each uncoated tablet contains: 10's 10's X 10 1200000
mg CARBIMAZOLE IP 5 MG
178 509 Hydroxychloroquine Each Film Coated tablets Contains: 10's 10's X 10 6500000
Tablets IP 200 mg Hydroxychloroquine sulphate IP 200
mg
179 513 Piroxicam Capsules IP 20 Each hard gelatin capsule contains: 10's 10's X 10 310000
mg Piroxicam IP 20mg
180 522 Alfacalcidol Soft Gelatin Each soft gelatin capsule contains: 10's 10's X 10 430000
Capsules 0.25 mcg Alfacalcidol 0.25mcg
181 523 Naproxen Tablets IP 500 Each uncoated tablet contains: 15's 15's X 10 220000
mg NAPROXEN IP 500 MG
182 528 Paracetamol, Each uncoated tablet contains: 10's 10's X 10 2200000
Phenylephrine and PARACETAMOL IP 325 mg
Chlorpheniramine Tablets PHENYLEPHRINE
(325mg+10mg+2mg) HYDROCHLORIDE IP 10 mg
CHLORPHENIRAMINE
MALEATE IP 2 mg
183 529 Levosalbutamol and Each 2.5ml respule contains: 2.5ml 2.5ml X 5 230000
Ipratropium Respules Ipratropium Bromide IP equivalent to
(1.25mcg+500mcg) Ipratropium Bromide (anhydrous)
500mcg
Levosalbutamol Tartrate equivalent
to Levosalbutamol 1.25mcg
184 530 Formoteral and Budesonide Each capsule contains: 30's 30's x 10 120000
Rotacaps (6mcg+200mcg) Formoterol Fumarate (as Formoterol
Fumarate dihydrate IP) 6mcg
Budesonide IP 200mcg
185 532 Salmeterol and Fluticasone Each capsule contains: 30's 30's x 10 110000
Rotacaps (50mcg+250mcg) Salmeterol Fumarate (as Formoterol
Xinafoate IP) 50mcg
Fluticasone Propionate IP 250mcg
186 534 Salbutamol and Each hard gelatin capsule for dry 30's 30's x 10 110000
Beclomethasone Respicaps powder inhalation contains:
(400mcg + 200mcg) Beclomethasone Dipropionate
200mcg
Salbutamol sulphate equivalent to
Salbutamol 400mcg
187 537 Ambroxol Hydrochloride Each 5ml contains: 100ml 100ml X 10 280000
and Levosalbutamol Ambroxol Hydrochloride 15 mg
Sulphate Syrup Salbutamol Sulphate equivalent to
Salbutamol 1 mg
188 538 Theophylline Tablets 400 Each Uncoated Sublingual tablets 10's 10's X 10 130000
mg contains:
Theophylline Anhydrous IP 400mg
(In beta cyclodextrin)
In a controlled release system
189 539 Acetylcysteine Tablets 600 Each film coated tablet contains: 10's 10's X 10 430000
mg Acetylcysteine 600mg
190 540 Levosalbutamol and Each 2ml respule contains: 2ml 2ml X 10 110000
Budesonide Respules Levosalbutamol Tartrate equivalent
(1.25mg+1mg) to Levosalbutamol 1.25 mg
Budesonide 1 mg
191 541 Acebrophylline Capsules Each hard gelatin capsule contains: 10's 10's X 10 1800000
100 mg Acebrophylline IP 100mg
192 542 Saline Nasal Drops Composition: 20 ml 20ml X 10 370000
(Sodium Chloride 0.65% Sodium Chloride IP 0.65% W/V (In
w/v) purified water made hypertonic &
buffered)
Added Benzalkonium chloride
solution IP Eqv. To Benzalkonium
Chloride 0.01% w/v as preservation
193 543 Menthol (55 mg ± 5.) MENTHOL (55 mg ± 5.) 10's 10's X 10 110000
Cinnamon (12.5 mg ± 2) CINNAMON (12.5 mg ± 2) and
and Pine Oil (112.5 mg ± PINE OIL (112.5 mg ± 1) SOFT
1) Soft Capsules CAPSULES
194 544 FLUTICASONE Each 2 ml contains: 2ml 2ml X 10 140000
PROPIONATE RESPULE Fluticasone Propionate IP 0.5 mg
0.5 MG/2ML in normal saline solution q.s.
195 555 Doxofylline Tablets IP 400 Each Uncoated tablets contains: 10's 10's X 10 1300000
mg Doxofylline IP 400mg
196 556 Montelukast and Each Film Coated tablets Contains: 10's 10's X 10 2000000
Fexofenadine Fexofenadine Hydrochloride IP 500
Hydrochloride Tablets mg
(10mg + 120mg) Montelukast Sodium IP equivelant to
Montelukast 10mg
197 558 Fluticasone and Azelastine Each Spray delivers: 120 MD 1's X 10 110000
Nasal Spray (27.5mcg + Fluticasone Furoate 27.5 mcg
140mcg) Azelastine Hydrochloride 140 mcg
198 559 Salbutamol and Each uncoated tablet contains: 30's 30's x 10 110000
Theophylline Tablets Salbutamol Sulphate IP
(2mg+100mg) equivalent to Salbutamol 2mg
Theophylline (anhyd.) IP 100mg
199 560 Fluticasone Propionate Each spray delivers: 120 MD 1's X 10 110000
Nasal Spray 50 mcg Fluticasone Propionate IP 50 mcg
200 561 Levosalbutamol Syrup Each 5ml contains: 100ml 100ml X 10 220000
(1mg/5Ml) Levosalbutamol Sulphate IP
equivalent to Salbutamol 1mg
Flavoured syrup base q.s.
201 563 Oxymetazoline Nasal Each ml contains: 10ml 1's X 10 870000
Drops (0.5 mg /ml) Oxymetazoline Hydrochloride IP
0.5mg
in a buffered aqueous solution.
202 564 Tiotropium Bromide and Each capsule contains: 15's 15's X 10 110000
Formoterol Fumarate Tiotropium bromide monohydrate Ip
Dihydrate Rotacaps equivalent to Tiotropium 18mcg
(18mcg+12mcg) Formoterol Fumarate Dihydrate IP
12mcg
203 565 Tiotropium Bromide, Each capsule contains: 15's 15's X 10 110000
Formoterol Fumarate Tiotropium bromide monohydrate Ip
Dihydrate and Ciclesonide equivalent to Tiotropium 18mcg
Rotacaps Formoterol Fumarate Dihydrate IP
(18mcg+12mcg+400mcg) 12mcg
Ciclesonide IP 400mcg
204 566 Ipratropium Bromide Each ml contains: 15ml 1's X 10 110000
Respirator Solution Ipratropium bromide IP 250mcg
250mcg
205 567 Salbutamol and Each activation delivers: 200 MDI 1's X 10 120000
Ipratropium Inhaler Salbutamol sulphate IP equivalent to
(100mcg+20mcg) Salbutamol 100mcg
Ipratropium bromide IP 20mcg
206 568 Salmeterol and Fluticasone Each activation delivers: 100 MD 1's X 10 110000
Propionate Inhaler IP Salmeterol (as Salmeterol Xinofoate)
(25mcg+250mcg) 50mcg
Fluticasone Propionate 250mcg
207 574 Rabies Vaccine, Human IP Anti Rabies Vaccine (Purified Chick 1ml with 1 ml x 10 110000
embryo cell) 2.5 IU, 1ml vial Diluent
208 582 Vitamins A,C,D,E,And B Each 15ml contains: 200 ML 1's X 6 560000
Complex and Minerals Vitamin A 2500 IU
Syrup Thiamine Hydrochloride 1.5 mg
Riboflavin Sodium Phosphate 1.7 mg
Pyridoxine Hydrochloride 1.5 mg
Cyanocobalamine 1 mcg
Vitamin C 25 mg
Vitamin D3 200 IU
Vitamin E 10 IU
Nicotinamide 20 mg
D-Panthenol 5 mg
Biotin 10 mcg
Zinc 3 mg
Iodine 50 mcg
Iron 5 mg
Manganese 0.8 mg
Chromium 8 mcg
Molybdenum 8 mcg
in a flavoured base q.s.
209 583 Cyproheptadine Tablets IP Each uncoated tablet contains: 10's 10's X 10 420000
4 mg Cyproheptadine Hydrochloride IP
4mg
210 586 Methylcobalamin, L- Each film-coated tablet contains: 10's 10's X 10 600000
Cartinine L- Tartrate and L- CARTININE L- TARTRATE
Folic Acid Tablets equivalent to L-carnitine 500 mg
(1500mcg+500mg+1.5mg) Methylcobalamine 1500 mcg
Folic acid 1.5 mg
211 592 L-Lysine + Multivitamins Each 5ml contains: 200 ML 1's X 6 840000
(Vit-B1,B2,B3,B5,B6 ) Thiamine Hydrochloride 2.25 mg
Syrup Riboflavin Sodium Phosphate 2.5 mg
Nicotinamide 22.5 mg
D-panthenol 3.0 mg
Pyridoxine Hydrochloride 0.75 mg
Lysine Hydrochloride 375 mg
212 593 Folic Acid, Each ml contains: 10ml 1's X 10 110000
Cyanocobalamine and Folic Acid 15 mg
Nicotinamide Injection Cyanocobalamine 500 mcg
(15mg+500mcg+200mg) Nicotinamide 200 mg
Benzyl Alcohol 2.5% v/v
Phenol 0.5% w/v
(As preservative)
213 594 Glucose Powder Each pack contains: 75g Tetra 100g Tetra 250000
Dextrose Monohydrate IP 75 g Pack pack X 24
214 595 Thiamine, Pyridoxine Hcl Each 2 ml ampoule contains: 2ml 2ml X 10 110000
and Cyanocobalamin Mecobalamin IP 1000 mcg
Injection Pyridoxine HCl IP 50 mg
(100mg+50mg+1000mcg) Thiamine 100 mg
215 599 Pregabalin Tablets 75 mg Each film coated tablet contains: 10's 10's X 10 2400000
Pregabalin IP 75 mg
216 608 Betamethasone Contains: 20g Tube 1's X 20 690000
Dipropionate and Salicylic Betamethasone Dipropionate 0.05%
Acid Ointment w/w
Salicylic acid 3% w/w
217 609 Silver Nitrate and Contains: 15g tube 1's X 20 110000
Chlorhexidine Gluconate Silver Nitrate 0.20% w/w
Cream Chlorhexidine Gluconate Solution
0.20%w/w
Preservative: Chlorocresol
0.12%w/w
218 610 Paracetamol, Each 5ml contains: 60ml 60ml Bottle 580000
Phenylephrine Paracetamol IP 125mg Bottle X 10
Hydrochloride and Phenylephrine Hydrochloride IP 5mg
Cetirizine Dihydrochloride Cetirizine Dihydrochloride 2mg
Suspension
(125mg+5mg+2mg)
219 612 Povidone-Iodine Powder Povidone-Iodine Powder 5% w/w 10gm 1 X 20 580000
5% W/W Container
220 625 Bromhexine Hydrochloride Each uncoated tablets contains: 15's 15's X 10 300000
and Phenylephrine Bromhexine Hydrochloride IP 8mg
Hydrochloride Tablets Phenylephrine Hydrochloride 5mg
(8mg + 5mg)
221 628 Etophylline and Each film-coated prolonged release 10's 10's X 10 1100000
Theophylline Prolonged tablet contains:
Release Tablets Etophylline 231mg
(231mg+69mg) Theophylline IP Anhydrous
equivalent to Theophylline IP
Hydrate 69mg
222 629 Inhalent Softgel Each Soft Gelatin Capsule Contains: 10's 10's X 10 210000
Caps(Camphor25mg+Clor Camphor 25 mg
othymol 5 Chlorothymol 5mg
mg+Eucalyptus130mg+Me Eucalyptus (Oil) 130mg
nthol 55mg+Turpentine Menthol 55mg
oil110mg Turpentine Oil 110mg
223 631 Etamsylate Tablets 500 mg Each Uncoated tablets contains: 10's 10's X 10 210000
Etamsylate 500mg
224 632 Etamsylate Tablets 250 mg Each uncoated tablet contains: 10's 10's X 10 130000
Etamsylate 250 mg
225 640 Nimesulide Gel 1% W/W Nimesulide Gel 1% w/w 20g Tube 1's X 20 310000
226 643 Paracetamol 125mg+ Each 5 ml contains: 60ml 60ml Bottle 110000
CPM 1 mg + Sodium Paracetamol IP 125mg Bottle X 10
Citrate 60mg in a flavour Chlorpheniramine maleate IP 1mg
syrup base Sodium Citrate IP 60mg
In a flavoured syrup base
227 644 Phenylephrine Each ml contains: 15ml 1's X 10 150000
Hydrochloride 5.00mg Phenylephrine Hydrochloride IP 5mg Bottle
Chlorpheniranmine Chlorpheniramine Maleate IP 2mg
Maleate 2.00mg Drops Flavoured syrup base q.s.
228 645 Nimesulid, Paracetamol Each uncoated tablet contains: 10's 10's X 10 350000
and Chlorzoxazone Tablets Nimesulide 100mg
(100mg+325mg+375mg) Paracetamol 325mg
Chlorzoxazone 375mg
229 648 Diclofenac dethylamine Composition: 35g Tin 35g Tin X 3400000
BP1.16%Linseed Oil Diclofenac Diethylamine IP 1.16% 20
BP3% Eq. to Diclofenac Sodium 1% w/w
w/wMethylsalicylate Linseed oil BP(Oleum Lini) 3%ww
IP10%w/wMenthol IP5% Methyle Salicylate IP 10%W/W
w/wSpray Menthol IP 5% W/W
Excipients & propellant q.s. to 100%
w/w
230 655 Pepsin and Fungal Diastase Each 5 ml contains: Fungal Diastase : 200 ml 1's X 6 630000
Enyme Syrup Mix Fruit 12.5 mg (Fungal Diastase derived
Flavour (7.5mg + 12.5mg from Aspergillus oryzae, digests not
per 5ml) less than 10 gm of cooked starch)
Pepsin : 7.5 mg (Digests not less than
225 gm of coagulated egg albumin)
Sorbital Solution (70%) (Non-
crystalising) & Flavoured Syrupy
base - q.s
231 656 Diastase and Pepsin Each ml contains: 15ml 1's X 10 110000
Enzyme Drops Diastase (1:1200) 33.33 mg
Pepsin (1:3000) 5mg
Vit B1 1 mg
Vit B2 1 mg
Vit B6 1 mg
Vit B12 1 mcg
Niacinamide 10 mg
232 664 Mouth Ulcer Gel (Choline Contains: 10g 1 X 20 560000
Salicylate Sodium 9% Choline Salicylate sodium 9% w/v
W/V, Benzalkonium Benzalkonium Chloride 0.01% w/w
Chloride 0.01% W/W)
233 665 Vitamin B Complex and Each hard gelatin capsule contains: 10's 10's X 10 4500000
Ascorbic Acid Capsules Thiamine 10mg
Riboflavin 10mg
Niacinamide 50mg
Pyridoxine Hydrochloride 3mg
Cynocobalamine 50mcg
Calcium Pantothenate 12.5mg
Folic acid 1mg
Ascorbic acid 150mg
234 666 Pheniramine Maleate Each ml contains: 2ml 2ml X 10 200000
Injection IP 22.75 mg Pheniramine Maleate IP 22.75 mg
235 668 Multivitamin Drops Each ml contains: 15ml 1's X 10 350000
Vitamin A (as Palmitate) 2500 IU
Vitamin E acetate 25 IU
Vitamin D3 200 IU
Ascorbic Acid 40 mg
Thiamine Hydrochloride 1 mg
Riboflavin Sodium Phosphate 1.5 mg
Niacinamide 10 mg
D-Panthenol 3 mg
D-Biotin 50mcg
Lysine Hydrochloride 18 mcg
236 676 Triamcinolone Acetonide Composition: 10g 1 X 20 110000
0.1 % w/w buccal paste Triamcinolone Acetonide IP 0.1%
w/w
237 677 Flupentixol Tablets 0.5 mg Each film-coated tablet contains: 10's 10's X 10 180000
Flupentixol Hydrochloride equivalent
to Flupentixol 0.5 mg
238 679 Nalidixic Acid Tablets IP Each tablet contains: 10's 10's X 10 110000
500 mg Nalidixic Acid Tablets IP 500 mg
239 680 Finasteride Tablets IP 5mg Each film coated tablet contains: 10's 10's X 10 370000
Finasteride IP 5mg
240 681 Phenazopyridine Each sugar coated tablet contains: 10's 10's X 10 110000
Hydrochloride Tablet Phenazopyridine Hydrochloride
100mg 100mg
241 686 Magaldrate 400mg + Each 5 ml contains: 170ml 1's X 6 500000
Simethicone 20mg/5ml Magaldrate 400 mg
Oral Suspension IP Simethicone 20 mg
242 687 Lactulose 10 gm per15 ml Each 15ml contains: 200 ml 1's X 6 550000
Lactulose solution equivalent to
Lactulose 10gm
palatable base q.s
243 689 Clotrimazole Vaginal Each extended release vaginal tablet 10's 10's X 10 420000
Tablets IP 100mg contains: Clotrimazole IP 100mg
244 691 Ofloxacin Eye Drops Ofloxacin Eye Drops 0.3%w/v 10ml 1's X 10 440000
0.3%W/V
245 692 Olopatadine Hydrochloride Contains: 10ml 1's X 10 190000
Ophthalmic Solution 0.1% Olopatadine Hydrochloride
W/V equivalent to
Olopatadine 0.1% w/v
Benzalkonium Chloride 0.01% w/v
(as preservative)
246 693 Tropicamide Eye Drops IP Contains: 5ml 5ml Drops X 110000
1% W/V Tropicamide IP 1% w/v Drops 10
Chlorbutol IP 0.5% w/v (as
preservative)
247 696 Polymyxin B Sulphate, Each ml contains: 5ml 5ml Drops X 110000
Chloramphenicol and Polymyxin B Sulphate 5000 IU Drops 10
Dexamethsone Eye/Ear Chloramphenicol 4 mg
Drops (5000 IU + 4mg + Dexamethasone Sodium Phosphate 1
1mg) mg
Phenylmercuric Nitrate 0.001% w/v
(as preservative) in a sterile base
248 697 Sulphacetamide Eye Drop Contains: 10ml 1's X 10 110000
10 % W/V Sulphacetamide Sodium 10 % w/v
Phenylethyl Alcohol 0.5% v/v
(as preservative)
249 699 Acyclovir Eye Ointment IP Contains: 5g Tube 5g tube X 20 130000
3% W/W Aciclovir IP 3% w/w
Benzalkonium chloride IP 0.01%
w/w
250 701 Pilocarpine Eye Drops IP Contains: 10ml 1's X 10 110000
2% W/V Pilocarpine Nitrate IP 2% w/v
Hydroxypropylmethylcellulose IP
0.35% w/v
Chlorbutol IP 0.5% w/v (As
preservative)
251 705 Levofloxacin Infusion IP Each ml contains: 100ml 100ml X 10 110000
500 mg/100 ml Levofloxacin 5 mg
252 707 Piroxicam Dispersible Each dispersible uncoated tablet 10's 10's X 10 110000
Tablets 10 mg contains:
Piroxicam 10mg
253 709 Piroxicam Injection 20 mg Each ml contains: 1ml 1 ml x 10 110000
Piroxicam 20 mg Ampoule
Benzyl Alcohol 20 mg
(as preservative)
254 710 Piroxicam Injection 40 mg Each ml contains: 2ml 2ml X 10 110000
Piroxicam 20 mg
Benzyl Alcohol 20 mg
(as preservative)
255 715 Glycerin IP 98%W/W Contains: 50g in 1's X 10 490000
Glycerin IP 98%w/w Bottle
256 720 Ringer Lactate Infusion Sodium chloride (600mg), Sodium 500ml in 1's X 24 1800000
Lactate (320mg), Potassium Chloride FFS
(40mg), Calcium Chloride (27mg) bottle
257 725 Dextrose IV Fluid IP 5% Dextrose IV fluid IP 5% w/v 500ml in 1's X 24 1500000
W/V FFS
bottle
258 726 Dextrose IV Fluid 10% Dextrose IV fluid IP 10% w/v 500ml 1's X 24 830000
W/V FFS
Bottle
259 734 Dehydroepiandrosterone Each hard gelatin capsule contains: 10's 10's X 10 110000
(Micronized) 25 mg Dehydroepiandrosterone
Capsule (Micronized) 25 mg
260 736 Megestrol Acetate Tablets Each uncoated tablet contains: 10's 10's X 10 110000
IP 40mg Megestrol Acetate IP 40mg
261 739 Cefuroxime Tablets IP Each film coated tablet contains: 6's 6's X 10 100000
125mg Cefuroxime Axetil IP equivalent to
Cefuroxime 125mg
262 746 Valganciclovir Each film coated tablet contains: 10's 10's X 10 100000
Hydrochloride USP 450 Valganciclovir Hydrochloride
mg tablet equivalent to Valganciclovir 450mg
263 757 Cefuroxime Injection IP Each vial contains: Cefuroxime Vial with 1's X 10 1000000
1500mg Sodium IP equivalent to Cefuroxime WFI
1.5g
264 762 Nortriptyline Tablets IP Each film coated tablet contains: 10's 10's X 10 350000
25mg Nortriptyline Hydrochloride IP
equivalent to Nortriptylin 25mg
265 768 Acetazolamide Tablets IP Each uncoated tablet contains: 10's 10's X 10 1500000
250mg Acetazolamide IP 250mg
266 769 Acetyl Salicylic Acid Each gastro-resistant tablet contains: 14's 14's x 10 1000000
(Aspirin)Tablet 325mg Aspirin 325mg
267 779 Alpha Lipoic acid 100mg Each film coated tablet contains: 10's 10's X 10 8000000
Vit. D3 1000 IU Folic acid Alpha Lipoic acid 100mg Vitamin
1.5mg Pyridoxine 3mg D3 1000 IU
Methylcobalamin 1500mcg Pyridoxine Hydrochloride 3mg
Folic acid 1.5mg
Methylcobalmine 1500mcg
268 781 Alprazolam and Fluoxetine Each Film Coated tablet contains: 10's 10's X 10 300000
Tablets (0.25mg+20mg) Fluoxetine Hydrochloride IP eq. to
Fluoxetine 20mg
Alprazolam IP 0.25 mg
269 786 Amitriptyline Each film coated tablet contains: 10's 10's X 10 1650000
Hydrochloride Tablets IP Amitriptyline hydrochloride IP 10mg
10mg
270 791 Atenolol and Amlodipine Each uncoated tablet contains: 14's 14's x 10 1500000
Tablets (25mg+5mg) Amlodipine Besilate IP equivalent to
Amlodipine 5mg
Atenolol IP 25mg
271 793 Atenolol Tablets 25 mg Each uncoated tablet contains: 14's 14's x 10 3500000
Atenolol 25mg
272 796 Atorvastatin 10mg, Aspirin Each hard gelatin capsule contains: 10's 10's X 10 9000000
(Ec) 75mg Capsules Atorvastatin Calcium IP equivalent
to
Atorvastatin 10mg
Aspirin IP 75mg (as gastro-resistant
tablet IP 75mg)
273 800 Bacitracin-Neomycin Each gram contains: 10gm 10gm 500000
Sulphacetamide Dusting Neomycin Sulphate 5 mg Powder Powder X 10
Powder Bacitracin 250 units
Sulphacetamide 60mg
274 804 Betamethasone Injection IP Each ml contains: 1ml 1 ml x 10 500000
4 mg/Ml Betamethasone Sodium Phosphate 4 Ampoule
mg
275 806 Bicalutamide Tablets IP Each film-coated tablet contains: 10's 10's X 10 250000
50mg Bicalutamide IP 50mg
276 811 Bromfenac Sodium Eye Each ml contains: 5ml 1's X 10 500000
Drops 0.09% w/v Bromfenac Sodium equivalent to Drops
Bromfenac 0.9 mg
Benzalkonium chloride solution
0.01% w/v
(as preservative)
277 815 Calcitriol Capsules IP Each soft gelatin capsule contains: 10's 10's X 10 650000
0.25mcg Calcitriol IP 0.25 mcg
278 816 Calcium Acetate Tablets Each uncoated tablet contains: 10's 10's X 10 350000
667mg Calcium Acetate 667mg
279 817 Calcium Carbonate 1250 Each Film Coated tablet contains: 10's 10's X 10 7000000
Mg Vitamin D3 250 Iu 1250 mg Calcium Carbonate
Magnesium Oxide 40 Mg from and organic source (Oyster
Manganese Sulphate 1.8 Shell)
Mg Zinc Eq. to elemental calcium 500mg
Vitamin D3 IP (Stabilised) 250 IU
Magenesium Hydroxide IP
Eq. to elemental Magnesium 40mg
Magnesium sulphate USP
Eq. to elemental Manganese 1.8 mg
Zinc sulphate monohydrateUSP
Eq. to elemental zinc 7.5mg
Sodium Borate BP
Eq. to elemental Boron 250mg
Copper sulphate pentahydrate BP
Eq. to Elemental cooper 1mg
280 818 Calcium Gluconate Contains: 10ml 1's X 10 300000
Injection IP 10 % Calcium Gluconate IP 10 % w/v
281 829 Chloramphenicol Eye Contains: 5g Tube 1's X 10 300000
Ointment IP 1%W/W Chloramphenicol IP 1%w/w
282 835 Glucosamine Sulphate and Each film-coated tablet contains: 10's 10's X 10 300000
Chondroitin Tablets Chondroitin Sulphate 400mg
(500mg+400mg) Glucosamine Sulphate 500mg
283 838 Cilostazol Tablets IP 50mg Each uncoated tablet contains: 10's 10's X 10 1200000
Cilostazol IP 50mg
284 860 Dextromethorphan Each 5 ml contains: 50ml 1's X 10 550000
Hydrobromide Syrup IP Dextromethorphan Hydrobromide IP Bottle
13.5mg
Flavoured base syrup q.s.
285 866 Diazepam Injection IP Each ml contains: 2ml 2ml X 10 300000
5mg/ml Diazepam IP 5mg
Benzyl Alcohol IP 1.5 % V/V
(As preservative)
Propylene Glycol IP q.s.
286 868 Dicyclomine Hcl Each ml contains: 2ml 2ml X 10 1000000
(Dicycloverine) Injection Dicyclomine Hydrochloride IP 10mg
IP 10mg/ml
287 875 Donepezil Hydrochloride Each film-coated tablet contains: 10's 10's X 10 200000
Tablets IP 10mg Donepezil Hydrochloride IP 10mg
288 881 Ebastine Tablets IP 10mg Each film-coated tablet contains: 10's 10's X 10 250000
Ebastine IP 10mg
289 884 Erythromycin Estolate Each 5ml contains : Erythromycin 60ml 1's X 10 300000
Suspension 125 Mg/5ml Estolate equivalent to erythromycin Bottle
125mg
290 897 Fluticasone Propionate and Each activation delivers: 120 MDI 1's X 10 500000
Formoterol Fumarate Fluticasone Propionate 250 mcg
Inhaler (250mcg + 6mcg) Formoterol Fumarate Dihydrate
6mcg
Suspended in propellant HFA 134a
291 910 Human Chorionic Each vial of sterial frize dried Vial with 1's X 10 500000
Gonadotrophin 5000 IU product contains: solvent
Powder For Inj. With Human Chorionic Gonadotrophin
solvent 5000 IU
Manitol q.s. Potassium dihydrogen
phosphate q.s.
Dipotassium hydrogen phosphate q.s.
Each ampoule of solvent contain:
1 ml sodium chloride solution for
injection 0.9% w/v
292 912 Hydrochlorothiazide Each uncoated tablet contains: 10's 10's X 10 3000000
Tablets 12.5mg Hydroclorthiazide 12.5mg
293 916 Imatinib Mesylate Tablets Each film coated tablet contains: 10's 10's X 10 300000
IP 400mg Imatinib mesylate equivalent to
imatinib IP 400mg
294 922 Isopropyl Alcohol (70%) Isopropyl Alcohol (70% Conc.) 100ml 100ml X 10 1500000
(Spirit) bottle
295 923 Isosorbidemononitrate Each uncoated tablet contains : 10's 10's X 10 2000000
Tablets IP 20mg Diluted Isosorbidemononitrate IP
equivalent to Isosorbide Mononitrate
20mg
296 924 Isoxsuprine Hydrochloride Each uncoated tablet contains : 50's 50's X 10 200000
Tablets 10mg Isoxsuprine Hydrochloride 10mg
297 932 Latanoprost Eye Drops IP Each ml contains: 2.5ml 2.5ml X 10 300000
0.005%W/V (50mcg/ml) Latanoprost IP 50 mcg
298 933 Leflunomide Tablets IP Each film-coated tablet contains: 10's 10's X 10 300000
20mg Leflunomide IP 20mg
299 934 Lenalidomide Capsules Each capsule contains: Lenalidomide 10's 10's X 10 300000
10mg 10mg
300 935 Letrozole Tablets 2.5mg Each film coated tablet contains: 10's 10's X 10 300000
Letrozole 2.5mg
301 938 Levocarnitine Injections Each 5 ml ampoule contain: 5ml Vial 1's X 10 300000
1gm Levocarnitine Injection 1 g
Hydrochloric acid q.s.
Water for injection q.s.
302 939 Levocarnitine Tablets Each film-coated tablet contains: 10's 10's X 10 500000
500mg Levocarnitine 500mg
303 944 Levosalbutamol Each activation delivers: 120 MDI 1's X 10 300000
Hydrochloride Inhaler Levosalbutamol tartrate equivalent to
50mcg Levosalbutamol 50mcg
304 947 Lithium Carbonate Each uncoated prolonged release 10's 10's X 10 300000
Prolonged Release Tablets tablet conatins:
IP 450mg Lithium Carbonate IP 450 mg
305 948 Lorazepam Tablets IP 1mg Each uncoated tablet conatins: 10's 10's X 10 1200000
Lorazepam IP 1mg
306 951 Lycopene 1000 mcg, Each 5 ml contains: 200 ml 1's X 6 900000
Vitamin A 2500 IU, Levocarnitine 5% 1000 mcg
Vitamin E 10 IU, Selenium Vitamin A 2500 IU
35 mcg and Vitamin C Vitamin E 10 IU
50mg Vitamin C 50 mg
Zinc (as Zinc Gluconate) 3 mg
Manganese 2 mg
Iodine 100 mcg
Copper 500 mcg
Thiamine HCl 2 mg
Riboflavin Sodium Phosphate 3 mg
Pyridoxine HCl 1.5 mg
307 957 Memantine Hydrochloride Each film-coated tablet conatins: 10's 10's X 10 200000
Tablets IP 10mg Memantine Hydrochloride IP 10mg
308 968 Mirtazapine Tablets IP 15 Each Film Coated tablet contains: 10's 10's X 10 350000
mg Mirtazapine IP 15 mg
309 972 Mycophenolate Mofetil Each film coated tablet contains: 10's 10's X 10 500000
Tablets IP 500mg Mycophenolate Mofetil IP 500mg
310 975 Nebivolol and Each uncoated tablet contains : 10's 10's X 10 300000
Hydrochlorothiazide Nebivolol Hydrochloride IP
Tablets (5mg + 12.5mg) equivalent to Nebivolol 5mg
Hydrochlorothiazide 12.5mg
311 976 Nebivolol Tablets IP 2.5mg Each uncoated tablet conatins: 10's 10's X 10 2500000
Nebivolol Hydrochloride IP 2.5 mg
312 978 Nepafenac Eye Drop 0.1% Each ml contains: 5ml 1's X 10 250000
W/V Nepafenac 1mg Drops
Benzalkonium Chloride IP (as
preservative) 0.005% w/v
313 986 Nitrazepam Tablets I.P Each uncoated tablet contains: 10's 10's X 10 200000
10mg Nitrazepam IP 10 mg
314 987 Nitrofurantoin Tablets I.P Each uncoated tablet contains: 10's 10's X 10 600000
100mg Nitrofurantoin IP 100 mg
315 992 Olmesartan Tablets 20mg Each film coated tablet contains: 10's 10's X 10 7000000
Olmesartan midoxomil 20mg
316 996 Oxcarbazepine Tablets IP Each film coated tablet contains: 10's 10's X 10 2100000
300mg Oxcarbazepine I P 300mg
317 1005 Phenobarbitone Tablets IP Each uncoated tablet contains : 30's 30's x 10 500000
30mg Phenobarbitone IP 30mg
318 1008 Phytomenadione (Vitamin Each ml contains: 0.5ml 0.5ml 300000
K1) Injection 1 mg/0.5Ml Phytomenadione 2 mg Ampoule Ampoule X
Polyoxyethylated fatty acid 10
derivative 70 mg, dextrose, hydrous
37.5 mg, benzyl alcohol 9 mg added
as preservative. May contain
hydrochloric acid for pH adjustment.
319 1009 Pioglitazone Tablets IP 15 Each uncoated tablet contains: 10's 10's X 10 2700000
mg Pioglitazone Hydrochloride IP
equivalent to Pioglitazone 15 mg
320 1011 Piracetam Syrup Each 5ml contains : Piracetam IP 100ml 100ml X 10 200000
500mg/5ml 500mg
321 1024 Promethazine Injection IP Each ml contains: 2ml 2ml X 10 200000
25 mg/ml Promethazine Hydrochloride 25 mg
322 1031 Quetiapine Fumarate Each film coated tablet contains: 10's 10's X 10 200000
Tablets IP 200mg Quetiapine Fumarate IP equivalent to
Quetiapine 200mg
323 1038 Recombinant Human Each Lyophilized vial contains: r-Hu Vial 1's X 10 200000
Erythropoietin Injection Erythropoietin(r-HuEPO) IP 2000 IU
2000 IU
324 1041 Risperidone and Each uncoated tablet contains: 10's 10's X 10 450000
Trihexiphenidyl Tablets Resperidone 4 mg
(4mg+2mg) Trihexyphenidyl hydrochloride IP 2
mg
325 1042 Risperidone Tablets 4mg Each uncoated tablet contains: 10's 10's X 10 500000
Risperidone 4mg
326 1060 Sodium Valproate Gastro- Each gastro-resistant tablet contains: 10's 10's X 10 1000000
Resistant Tablets IP 300mg Sodium Valproate IP 300mg
327 1068 Sucralfate and Oxetacain Each 10ml contains: Sucralfate 1gm 100ml 100ml X 10 300000
Suspension (1g + 10mg per Oxetacain 10mg
10ml)
328 1069 Sulphacetamide Sodium Each ml contains: 10ml 1's X 10 100000
Eye Drop I.P 20% W/V Sulfacetamide Sodium IP 20 % w/v
Phenylethyl alcohol IP 0.5 % v/v
(as preservative)
329 1072 Tamsulosine Prolonged- Each hard gelatin capsule contains: 10's 10's X 10 4800000
Release Capsule IP 0.4 mg Tamsulosine Hydrochloride IP
400mcg
(As prolonged release pellets)
Hydrochlorothiazide contains:
Tablets (80mg+12.5mg) Telmisartan IP 80 mg
Hydrochlorthiazide IP 12.5 mg
331 1081 Tizanidine Tablets IP 2 mg Each uncoated tablet contains: 10's 10's X 10 200000
Tizanidine Hydrochloride IP
equivalent to Tizanidine 2 mg
332 1087 Trihexyphenidyl Each uncoated tablet contains: 10's 10's X 10 1500000
Hydrochloride Tablets 2mg Trihexyphenidyl Hydrochloride IP 2
(Benzhexol Hcl Tablets IP mg
2mg)
333 1088 Trimetazidine Each film-coated modified release 10's 10's X 10 1750000
Hydrochloride Modified tablet contains:
Release Tablets 35 mg Trimetazidine Hydrochloride IP 35
mg
334 1097 Vitamin A Capsule 25000 Each soft gelatin capsule contains: 30's 30's x 10 300000
IU Vitamin A IP (as Palmitate) 25000
IU
(equivalent to Retinol 7.5 mg)
in water soluble form.
335 1106 Metoprolol Succinate Each film coated bilayered tablet 10's 10's X 10 4800000
Extended Release and contains:
Telmisartan Tablets (50mg Metoprolol Succinate IP
+ 40mg) equivalent to Metoprolol Tartarate 50
mg
(as extended release form)
Telmisartan IP 40 mg
336 1108 Sildenafil Tablets 100 mg Each Film coated tablet contains: 4's 4's X 10 1050000
Sildenafil citrate equivalent to
Sildenafil 100 mg
337 1110 Clobazam Tablet IP 5mg Each uncoated tablet contains: 10's 10's X 10 1800000
Clobazam IP 5 mg
338 1123 Clomipramine Each film coated sustained release 10's 10's X 10 100000
Hydrochloride Sr Tablets tablet contains:
75mg Clomipramine Hydrochloride 75 mg
339 1124 Fluvoxamine Maleate Each film coated sustained release 10's 10's X 10 100000
Tablets IP 100mg tablet contains:
Fluvoxamine Maleate IP 100 mg
340 1149 Lisinopril Tablets IP 10mg Each uncoated tablet contains: 15's 15's X 10 200000
Lisinopril IP equivalent to
anhydrous Lisinopril 2 mg
341 1152 Carbamazepine Sustained Each film coated prolonged release 10's 10's X 10 1500000
Release Tablets IP 200mg tablet contains:
Carbamazepine IP 200 mg
342 1154 Diethylcarbamazine Citrate Each uncoated tablet contains: 30's 30's x 10 200000
Tablets IP 100mg Diethylcarbamazine Citrate IP
100mg
Excipients q.s.
343 1156 Metoprolol Succinate Each film coated bilayered tablet 7's 7's X 10 1500000
Extended Release and contains:
Amlodipine Besilate Metoprolol Succinate IP
Tablets (25mg + 5mg) equivalent to Metoprolol Tartarate 25
mg
(as extended release form)
Amlodipine besylate IP
equivalent to Amlodipine 5 mg
344 1162 Betamethasone Cream 0.1 Contains: 20g Tube 1's X 20 300000
% w/w Betamethasone Valerate equivalent
to
Betamethasone 0.1% w/w
345 1166 Mefenamic Acid Tablets Each uncoated tablet contains: 10's 10's X 10 200000
250 mg Mefenamic Acid 250 mg
346 1167 Mefenamic Acid Tablets Each uncoated tablet contains: 10's 10's X 10 300000
500 mg Mefenamic Acid 500 mg
347 1168 Ketorolac Injection IP Each vial contins: 1ml Vial 1 ml x 10 200000
30mg/ml Ketorolac tromethamine 30 mg
348 1170 Acetylcysteine Injection Each ml contains: 2ml 2ml X 10 100000
200 mg/ml Acetylcystein 200 mg Ampoule
s
349 1186 Cyclosporin Capulses IP Each soft gelatin capsule contains: 5's 5's X 10 100000
25mg Cyclosporine IP 25 mg
350 1187 Cyclosporine Capsules IP Each soft gelatin capsule contains: 5's 5's X 10 100000
100 mg Cyclosporine IP 100 mg
351 1191 Glycopyrrolate Injection IP Each ml contains: 1ml 1 ml x 10 200000
0.2mg Glycopyrrolate 0.2 mg Ampoule
Benzyl alcohol 0.9 %
WFI q.s.
352 1203 Protamine Injection Each ml contains: 5ml 1's X 10 200000
10mg/ml Protamine Sulphate 10 mg Vial/Amp
oule
353 1219 Amino Acid Solution For Nutritive infusion of Pure Crystalline 200ml 1's X 6 200000
IV 200 ml Bottle Amino Acids Glass
Bottle
354 1220 Oseltamivir Capsules 75mg Each hard gelatin capsule contains: 10's 10's X 10 200000
Oseltamivir Phosphate IP 98.5 mg
equivalent to Oseltamivir 75mg
355 1221 Thyroxine Sodium Tablets Each uncoated tablet contains: 100's 1's X 10 1000000
50mcg Thyroxine Sodium equivalent to Bottle
Anhydrous Throxine Sodium 50 mcg
356 1225 Orlistat Capsules 120 mg Each hard gelatin capsule contains: 10's 10's X 10 200000
Orlistat 120 mg
(as pellets 50 % w/w)
357 1226 Triamcinolone Injection Each ml contains: Vial with 1's X 10 200000
40mg/ml Triamcinolone Acetonide IP 40 mg Diluent
Benzyl Alcohol IP 0.9%w/v
(as preservative)
358 1227 Triamcinolone Tablets IP 4 Each uncoated tablet contains: 10's 10's X 10 200000
mg Triamcinolone IP 4 mg
359 1228 Gabapentin and Each uncoated bilayer tablet 10's 10's X 10 350000
Amitriptyline Tablets contains:
(300mg + 10mg) Gabapentin 300 mg
Amitriptyline Hydrochloride 10 mg
360 1231 Vitamin E Acetate and Each film coated tablet contains: 10's 10's X 10 250000
Levocarnitine Tablets (200 Tocopheryl Acetate IP 200 mg
mg + 150 mg) (as 50% powder)
L-Carnitine-L-Tartarate
equivalent to Levocarnitine USP 150
mg
361 1237 Methyldopa Tablets IP 500 Each film coated tablet contains: 10's 10's X 10 100000
mg Methyldopa IP equivalent to
anhydous Methyldopa 500 mg
362 1238 Prazosin Hydrochloride Each film coated sustained release 30's 30's x 10 350000
Sustained Release Tablets tablet contains:
2.5 mg Prazosin Hydrochloride IP
equivalent to Prazosin 2.5 mg
363 1240 Gliclazide and Metformin Each uncoated tablet contains: 10's 10's X 10 10000000
Hydrochloride Tablets Gliclazid 80 mg
(80mg + 500mg) Metformin Hydrochloride 500 mg
364 1241 Cefaclor Dispersible Each dispersible tablet contains: 10's 10's X 10 200000
Tablets 250 mg Cefaclor IP equivalent to
anhydous Cefaclor 250 mg
365 1248 Haematinic Syrup Of Each 15 ml contains: 200ml 1's X 6 400000
Iron,Folic Acid and Ferric Ammonium Citrate bottle
Vitamin equivalent to Elemental Iron 32 mg
B12(32mg+0.5mg+7.5mcg Folic Acid IP 0.5 mg
) 200 ml Cyanocobalamin IP 7.5 mg
366 1251 Vitamin B6 (Pyridoxine Each tablet contains: 10's 10's X 10 200000
Hydrochloride) Tablets IP Pyridoxine Hydrochloride 100 mg
100mg
367 1252 Suspension of Calcium Each 5ml contains: 200 ml 1's X 6 300000
Phosphate With Vitamin Vitamin D3 (Cholecalciferol IP) 200
D3 and Viatmin B12 (82 IU
mg + 200 Iu + 2.5 mcg) Vitamin B12 IP 2.5 mcg
Calcium Phosphate equivalent to
elemental Calcium 82 mg
368 1254 Diphenhydramine 13-15 Each 5 ml Contains: 100ml 100ml X 10 3100000
mg. + Diphenhydramine Hcl IP 14.08 mg Bottle
Ammonium Chloride 135- Ammonium Chloride IP 138 mg
150 mg + Sodium Sodium citrate IP 57.03 mg
Citrate 57-85mg. + Menthol IP 1.14 mg
Menthol 0.9-2.6mg IP
Cough Syrup
369 1257 Allylestrenol Tablets 5 mg Each Film coated tablet contains: 10's 10's X 10 100000
Allylestrenol 5 mg
370 1283 Chlorthalidone Tablets Each uncoated tablet contains: 10's 10's X 10 400000
6.25 mg Chlorthalidone 6.25 mg
371 1284 Cilnidipine and Each film coated tablet contains: 10's 10's X 10 4000000
Telmisartan Tablets (10 mg Cilnidipine 10 mg
+ 40 mg) Telmisartan IP 40 mg
372 1298 Donepezil Tablets 5 mg Each film coated tablet contains: 10's 10's X 10 300000
Donepezil Hydrochloride 5 mg
373 1306 Escitalopram and Each film coated tablet contains: 10's 10's X 10 950000
Clonazepam Tablets (5mg Escitalopram Oxalate
+0.5mg) equivalent to Escitalopram 5 mg
Clonazepam 0.5 mg
374 1310 Faropenem Tablets 200 mg Each Film Coated tablet contains: 6's 6's X 10 200000
Faropenem Sodium equivalent
to Faropenem 200 mg
375 1311 Fenofibrate Tablets 145 mg Each film coated tablet contains: 10's 10's X 10 300000
Fenofibrate 145 mg
376 1315 Fluticasone Furoate Nasal Each spray delivers: 120 MDI 1's X 10 200000
Spray 27.5 mcg Fluticasone Furoate 27.5 mcg
377 1328 Isoxsuprine Injection IP 5 Each ml contains: 2ml Vial 2ml X 10 100000
mg Isoxsuprine Hydrochloride IP 5 mg
WFI IP q.s
378 1341 Mebendazole Tablets 100 Each uncoated tablet contains: 6's 6's X 10 100000
mg Mebendazole 100 mg
379 1342 Mebeverine Hydrochloride Each sugar coated tablet contains: 10's 10's X 10 100000
Tablets 200mg Mebeverine Hydrochloride IP 200
mg
380 1344 Meropenem and Sulbactam Each vial contains: Vial with 1's X 10 500000
Injection 1.5g Meropenem Trihydrate (Sterile) WFI
(1000mg+500mg) eq. to anhydrous Meropenem 1000
mg
Sterile Sodium Bicarbonate added as
buffering agent 90.2 mg
Sulbactum Sodium (sterile) eq. to
anhydrous Sulbactam 500 mg
381 1345 Meropenem Injection 500 Each Vial contains: Vial with 1's X 10 500000
mg Meropenem (Sterile) WFI
equivalent to
Meropenem (Anhydrous) 0.5 g
Sodium (as Sodium Carbonate) 45.1
mg
Directions: The powder to be

reconstitued with 10 ml of sterile
water for injections for IV use.
382 1353 Mirtazepine Tablets 7.5 mg Each film coated tablet contains: 10's 10's X 10 300000
Mirtazepine 7.5 mg
383 1359 Naproxen Tablets 250 mg Each uncoated tablet contains: 15's 15's X 10 200000
Naproxen 250 mg
384 1367 Olmisartan, Amlodipine Each film coated tablet contains: 10's 10's X 10 1200000
and Hydroclorthiazide Olmesartan Medoximil 20 mg
Tablets Amlodipine Besilate equivalent to
(20mg+5mg+12.5mg) Amlodipine 5 mg
Hydrochlorthiazide 12.5 mg
385 1375 Phenobarbitone Tablets 60 Each uncoated tablet contains: 30's 30's x 10 600000
mg Phenobarbitone 60 mg
386 1382 Prasugrel Tablets 10 mg Each film coated tablet contains: 10's 10's X 10 500000
Prasugrel Hydrochloride
equivalent to Prasugrel 10 mg
387 1383 Pregabalin and Each film coated tablet contains: 10's 10's X 10 1500000
Nortriptyline Tablets Pregabalin 75 mg
(75mg+10 mg) Nortriptyline Hydrochloride
equivalent to
Nortriptyline 10 mg
388 1384 Quetiapine Tablets 25 mg Each film coated tablet contains: 10's 10's X 10 650000
Quetiapine Fumarate
equivalent to Quetiapine 10 mg
389 1392 Rosuvastatin and Aspirin Each hard gelatin capsule contains: 10's 10's X 10 1500000
Capsules (10mg + 75mg) Rosuvastatin Calcium equivalent to
Rosuvastatin 10 mg
(as granules)
Aspirin 75 mg
(as Gastro-resistant tablet)
390 1396 Sertaconazole Cream Contains: 15g 1's X 20 300000
2%w/w Sertaconazole Nitrate 2.0 % w/w
391 1408 Tamsulosin and Finasteride Each film coated tablet contains: 15's 15's X 10 750000
Tablets (0.4mg+5mg) Tamsulosin Hydrochloride 0.4 mg
(as sustained release)
Finasteride 5 mg
392 1409 Teicoplanin Injection 400 Each ml contains (as lyophilisate) 1ml Vial 1 ml x 10 200000
mg Teicoplanin 400 mg
Sterile powder for preparation of
intramuscular or intravenous
injection.
393 1410 Telmisartan, Amlodipine Each uncoated bilayer tablet 10's 10's X 10 2600000
and Hydroclorthiazide contains:
Tablets Telmisartan 40 mg
(40mg+5mg+12.5mg) Amlodipine Besilate equivalent to
Amlodipine 5 mg
Hydrochlorthiazide 12.5 mg
Chlorthalidone Tablets contains:
(40mg + 6.25mg) Telmisartan 40 mg
Chlorthalidone 6.5 mg
395 1414 Terlipressin Injection 1000 Each 10ml contains: 10ml Vial 1's X 10 100000
mcg (1 mg)/10ml Terlipressin 1 mg
396 1431 Valethamate Injection 8 Each ml contains: 1ml 1 ml x 10 100000
mg/ml (For IM/IV use) Valethamate Bromide 8 mg Ampoule
Sodium Chloride IP 8 mg
WFI q.s.
397 1432 Tobramycin Eye Drops Each ml contains: 5ml Vial 1's X 10 150000
0.3% Tobramycin Sulfate equivalent to
Tobramycin 3mg
Benzalkonium Chloride 0.0001 ml
(as preservative)
398 1448 Lamotrigine Dispersible Each uncoated dispersible tablet 10's 10's X 10 200000
Tablets IP 100mg contains:
Lamotrigine IP 100 mg
399 1449 Enzyme syrup mixed fruit Each 5ml contains: 200 ml 1's X 6 200000
flavour Diastase (1:1200) 50mg
Pepsin (1:3000) 10mg
400 1450 Pyrantel Pamoate oral Each 5ml contains: 10ml 1's X 10 200000
Suspension IP 250mg/5ml Pyrantel Pamoate 250 mg
401 1451 Theophylline Controlled Each uncoated tablet contains: 10's 10's X 10 100000
release tablets 400 mg Theophylline Anhydrous IP 400mg
(in controlled release form)
402 1452 Pyridoxine Hydrochloride Each Sustained release tablet 10's 10's X 10 150000
Sustained release tablets contains:
100mg Pyridoxine Hydrochloride IP 100 mg
403 1453 Levetiracetam Syrup 100 Each ml contains: 100ml 100ml X 10 100000
mg Levetiracetam 100mg
404 1454 Terbutaline Sulphate and Each 5ml contains: Terbutaline 100ml 100ml X 10 200000
Bromhexine Hydrochloride Sulphate 1.25MG, Ambroxol 30mg,
Syrup Guaifenesin 50mg and Menthol 2.5
mg
405 1455 L-Arginine Granules 3g Each sachet of 5 g contains: 5g sachet 5g sachet X 150000
L-Arginine 3 g 10
Excipients q.s
406 1456 Itraconazole Capsules 200 Each hard gelatin capsule contains: 4's 4's X 10 2200000
mg Itraconazole BP 200 mg
(As pellets)
407 1458 Sodium Chloride Injection Sodium Chloride Injection IP 500ml IV 1 X 24 500000
IP 0.9%w/v 0.9%w/v fluid
plastic
container
408 1461 Vildagliptin Tablets 50mg Each uncoated tablet contains: 15's 15's X 10 2500000
Vildagliptin 50 mg
409 1462 Vildagliptin and Metformin Each film coated tablet contains: 15's 15's X 10 3000000
Tablets (50mg+500mg) Vildagliptin 50 mg
Metformin Hcl 500 mg
410 1463 Vildagliptin and Metformin Each film coated tablet contains: 15's 15's X 10 1500000
Tablets (50mg+1000mg) Vildagliptin 50 mg
Metformin Hcl 1000 mg
411 1473 Hand Sanitizer 100 ml Each pack contains: 70% v/v Ethanol 1’s with 1's X 50 10000000
Each pack contains: 70% and 0.5% w/v Chlorhexidine Flip top
v/v Ethanol and 0.5% w/v Gluconate cap
Chlorhexidine Gluconate
Each pack contains: 70% and 0.5% w/v Chlorhexidine Dispenser
v/v Ethanol and 0.5% w/v Gluconate Pump cap
Each pack contains: 70% and 0.5% w/v Chlorhexidine Dispenser
v/v Ethanol and 0.5% w/v Gluconate Pump cap
416 1479 Canagliflozin Tablets 100 Each film coated tablet contains: 10's 10's X 10 5000000
mg Canagliflozin hemihydrate
equivalent to Canagliflozin 100 mg
417 1480 Glimepiride 0.5 mg and Each film-coated tablet contains: 10's 10's X 10 10000000
Metformin SR 500 mg Glimepiride 0.5 mg Metformin 500
mg
(Sustained Release)
418 1481 Glimepiride 1 mg and Each film-coated tablet contains: 10's 10's X 10 10000000
Metformin PR 1000 mg Glimepiride 1 mg Metformin 1000
Tablet mg
(Prolonged Release)
Tablet mg
(Prolonged Release)
Tablet mg
(Prolonged Release)
421 1484 Lactitol Syrup 10gm/15ml Each 15ml of Lactitol contains: 200ml 1's X 6 400000
Lactitol 10 gm
422 1485 Mesalazine PR Tablet IP Each gastro-resistant prolonged 10's 10's X 10 5000000
1200mg release tablet contains:
Mesalazine 1200 mg
(Prolonged Release )
423 1486 Propranolol ER 40 mg Each Extended release capsule 10's 10's X 10 10000000
Capsule contains:
Propranolol 40 mg
424 1487 Selenium Sulphide Contains: 120ml 1's X 6 450000
Shampoo 2.5% w/v Selenium Sulphide 2.5% w/v
425 1488 Acarbose Tablets IP 25 mg Each uncoated tablet contains: 10's 10's X 10 1500000
Acarbose IP 25 mg
426 1489 Acebrophylline 100mg and Each film coated bilayer tablet 10's 10's X 10 10000000
Acetylcysteine 600mg contains:
Tablets Acebrofylline 100 mg
Acetylcystein 600mg
427 1490 Acebrophylline Sustained Each uncoated sustained release 10's 10's X 10 10000000
Release Tablets 200 mg tablet contains:
Acebrophylline 200 mg
428 1491 Aceclofenac and Each film coated tablet contains: 10's 10's X 10 10000000
Paracetamol Tablets Aceclofenac 100 mg
(100mg / 325mg) Paracetamol 325mg
429 1492 Aceclofenac Sustained Each hard gelatin capsule contains: 10's 10's X 10 10000000
release and Enteric coated Aceclofenac 200mg
Rabeprazole Sodium (as sustained release pellets)
Capsules (200mg / 20mg) Rabeprazole Sodium 20mg
(as enteric coated pellets)
430 1493 Aceclofenac, Paracetamol Each Film coated tablets contains: 10's 10's X 10 5000000
& Thiocolchicoside Tablets Thiocolchicoside 4mg
(4/100/500mg) Aceclofenac 100mg
Paracetamol 500mg
431 1494 Aceclofenac, Paracetamol Each film coated tablet contains: 10's 10's X 10 2500000
and Rabeprazole Tablets Aceclofenac 100 mg
(100mg / 325mg / 10mg) Paracetamol 325mg
Rabeprazole Sodium 10mg
(as enteric coated form)
432 1495 Aceclofenac, Paracetamol Each film coated tablet contains: 10's 10's X 10 5000000
and Tizanidine Tablets Aceclofenac 100 mg
(100mg / 325mg / 10mg) Paracetamol 325mg
Tizanidine Hydrochloride
equivalent to Tizanidine 2mg
433 1496 Aciclovir Dispersible Each dispersible uncoated tablet 5's 5's X 10 1200000
Tablets IP 400 mg contains:
Aciclovir IP 400 mg
434 1497 Acitretin Capsules IP 25 Each hard gelatin capsule contains: 10's 10's X 10 200000
mg Acitretin IP 25mg
435 1498 Acotiamide Tablets 100mg Each Film Coated tablet contains: 10's 10's X 10 500000
Acotiamide Hydrochloride hydrate
100mg
436 1499 Adalimumab 40mg/0.8 ml Each sterile single-use prefilled pen 0.8ml 0.8ml 200000
(For subcutaneous use contains: prefilled prefilled
only) Adalimumab syringe syringe X 10
WFI
437 1500 Aflibercept Injection Each ml contains: 1ml 1 ml x 10 200000
(2mg/0.05ml) Aflibercept 40 mg Ampoule
438 1501 Amantadine Hydrochloride Each hard gelatin capsule contains: 15's 15's X 10 1200000
Capsules IP 100 mg Amantadine Hydrochloride IP 100
mg
439 1502 Amiodarone Tablets IP 100 Each uncoated tablet contains: 10's 10's X 10 5000000
mg Amiodarone IP 100 mg
440 1503 Amlodipine Besilate and Each film coated tablet contains: 10's 10's X 10 5000000
Bisoprolol Fumarate Amlodipine Besilate equivalent to
Tablets (5mg / 5mg) Amlodipine 5mg
Bisoprolol Fumarate 5mg
441 1504 Amorolfine Cream 0.25% Each 5g conatins: 30g Tube 30g Tube X 2500000
w/w Amorolfine Hcl equivalent to 20
Amorolfine 0.25% w/w
442 1505 Amoxycillin and Potassium Each 5ml contains: 30ml 1's X 10 5000000
Clavulanate Oral Amoxycillin Trihydrate IP Bottle
Suspension IP (400mg / equivalent to Amoxycillin 400mg
57mg) Potassium clavulanate diluted IP
equivalent to Clavulanic Acid 57mg
443 1506 Amoxycillin and Potassium Each ml contains: 10ml 1's X 10 2500000
Clavulanate Oral Amoxycillin Trihydrate IP
Suspension IP (80mg / equivalent to Amoxycillin 80mg
11.4mg) Potassium clavulanate diluted IP
equivalent to Clavulanic Acid
11.4mg
444 1507 Amoxycillin, Dicloxacillin Each hard gelatin capsule contains: 10's 10's X 10 5000000
with Lactic Acid Bacillus Amoxycillin Trihydrate equivalent to
Capsules (250mg/ 250mg/ Amoxycillin 250 mg
2.5 billion) Dicloxacillin Sodium equivalent to
Dicloxacillin 250 mg
Lactic acid Bacillus 2.5 billion spores
445 1508 Ampicillin and Cloxacillin Each Hard gelatin capsule contains: 10's 10's X 10 2500000
Capsules (250mg / 250mg) Ampicillin Trihydrate
equivalent to Ampicillin 250 mg
Cloxacillin Sodium IP
equivalent to Cloxacillin 250 mg
446 1509 Ampicillin and Di- Each Hard gelatin capsule contains: 10's 10's X 10 5000000
Cloxacillin Capsules Ampicillin Trihydrate
(250mg / 250mg) equivalent to Ampicillin 250 mg
Dicloxacillin Sodium IP
equivalent to Dicloxacillin 250 mg
447 1510 Anti-D (Rho) Each ml contains: 1ml Vial 1 ml x 10 200000
Immunoglobulin Monoclonal Anti-D I.H 300 mcg
(Monoclonal) 300 mcg
448 1511 Antioxidant Capsules Each soft gelatin capsule contains: 30's 30's x 10 10000000
Beta Carotene 30 mg
Zinc Sulphate Monohydrate 27.5 mg
Selenium Dioxide 200 mcg
(as Selenious Acid)
Manganese 2 mg
(as Manganese Sulphate
Monohydrate)
Copper 1 mg
(as Copper Sulphate Pentahydrate)
449 1512 Apremilast Tablets 10mg Each Film coated tablets contains: 10's 10's X 10 200000
Apremilast 10mg
450 1513 Apremilast Tablets 20mg Each Film coated tablets contains: 10's 10's X 10 200000
Apremilast 20mg
451 1514 Apremilast Tablets 30 mg Each film coated tablet contains: 10's 10's X 10 200000
Apremilast 30 mg
452 1515 Atorvastatin and Aspirin Each hard gelatin capsule contains: 15's 15's X 10 10000000
Capsules (10mg / 150mg) Atorvastatin Calcium IP equivalent
to
Atorvastatin 10mg
Aspirin IP 150mg
(as gastro-resistant)
453 1516 Atorvastatin and Each hard gelatin capsule contains: 10's 10's X 10 10000000
Clopidogrel Capsules Atorvastatin Calcium IP equivalent
(20mg / 75mg) to
Atorvastatin 20mg
Clopidrogrel Bisulphate
equivalent to Clopidrogrel 75mg
454 1517 Atorvastatin, Clopidogrel Each hard gelatin capsule contains: 10's 10's X 10 10000000
and Aspirin Capsules Atorvastatin Calcium IP equivalent
(20mg / 75mg / 75mg) to
Atorvastatin 20mg (as film coated)
Clopidrogrel Bisulphate
Aspirin IP 75mg (as gastro-resistant)
455 1518 AZILSARTAN & Each film coated tablet contains : 10's 10's X 10 2500000
+CHLORTHALIDONE Azilsartan Medoxomil Potassium
Tablet 40/6.25MG equivalent to
Azilsartan Medoxomil 40mg
Chlorthalidone 6.25mg
456 1519 Azilsartan Medoxomil 40 Each film coated tablet contains : 10's 10's X 10 2500000
mg and Chlorthlidone12.5 Azilsartan Medoxomil Potassium
mg Tablets equivalent to
Azilsartan Medoxomil 40mg
Chlorthalidone 12.5mg
457 1520 Azilsartan Medoxomil Each Uncoated Tablet contains: 10's 10's X 10 5000000
Tablets 40mg Azilsartan kamedoxomil eq. to
Azilsartan medoxomil 40mg
458 1521 Azithromycin Oral Each ml contains: 15ml 1's X 10 500000
Suspension IP 200 mg Azithromycin IP (as dihydrate)
equivalent to Azithromycin
(anhydrous) 40 mg
459 1522 Beclomethasone and Beclomethasone 0.025%w/w 20g Tube 1's X 20 5000000
Clotrimazole Cream Clotrimazole 1% w/w
(0.025%w/w / 1% w/w)
460 1523 Beclomethasone and Beclomethasone 0.025%w/v 30ml 1's X 10 2500000
Clotrimazole Lotion Clotrimazole 1% w/v
(0.025%w/v / 1% w/v)
461 1524 Bepotastine Besilate Each Film coated tablet contains: 10's 10's X 10 2500000
Tablets 10mg Bepotastine Besilate 10mg
462 1525 Betahistine Tablets IP 16 Each uncoated tablet contains: 15's 15's X 10 10000000
mg Betahistine IP 16mg
463 1526 Betahistine Tablets IP 24 Each uncoated tablet contains: 15's 15's X 10 5000000
mg Betahistine IP 24mg
464 1527 Betamethasone Valerate, Betamethasone Valerate 0.12% w/w 20g Tube 1's X 20 2500000
Gentamicin and Gentamicin 0.1% w/w
Miconazole Nitrate Cream Miconazole Nitrate 2% w/w
(0.12%w/w / 0.1%w/w /
2%w/w)
465 1528 Bilastine Tablet 20mg Each uncoated table tcontains: 10's 10's X 10 5000000
Bilastine 20 mg
466 1529 Bimatoprost Ophthalmic Each ml contains: 3ml 1's X 10 2500000
Solution 0.01% w/v Bimatoprost 0.1 mg
467 1530 Bimatoprost Ophthalmic Each ml contains: 3ml 1's X 10 1200000
Solution 0.03% w/v Bimatoprost 0.3 mg
468 1531 Bisoprolol Fumarate Each film coated tablet contains: 10's 10's X 10 10000000
Tablets 2.5 mg Bisoprolol Fumarate 2.5 mg
469 1532 Botulinum Toxin Type A Each vial contains: Vial 1's X 10 200000
100 IU Botulinum Toxin Type A 100 IU
(from Clostridium botulinum)
470 1533 Brimonidine Tartrate and Composition: 5ml 1's X 10 1200000
Timolol maleate Brimonidine Tartrate 0.2%w/v
ophthalmic Solution Timolol Maleate equivalent to
(0.2/0.5% W/V) Timolol 0.5%w/v
benzakonium chloride 0.005%w/v
471 1534 Brimonidine Tartrate Eye Brimonidine Tartrate IP 0.1% w/v 5ml 1's X 10 1200000
drops IP 0.1% w/v Drops
472 1535 Budesonide Respules 0.5 Each 2 ml respule contains: 2ml 2ml X 10 10000000
mg Budesonide 0.5 mg
473 1536 Calcitriol and Calcium Each Soft Gelatin capsule Contains: 15's 15's X 10 2500000
Capsules (0.25 mcg/ Calcitriol 0.25 mcg
200mg) Elemental Calcium 200 mg
(Derived from calcium carbonate)
474 1537 Calcium and Vitamin D3 Each soft gelatin capsule contains: 10's 10's X 10 10000000
Capsules Calcium Carbonate 1250 mg
(equivalent to elemental Calcium 500
mg)
Cholecalciferol
(Vitamin D3) 500 IU
475 1538 Calcium citrate Malate, Each film coated tablet contains: 10's 10's X 10 2500000
Calcitriol and Vitamin K2- Calcium citrate Malate
7 Tablets equivalent to Elemental Calcium 250
(250mg/0.25mcg/50mcg) mg
Calcitriol 0.25
mcg
Vitamin K2-7 50 mcg
476 1539 Calcium Gluconate and Each ml Contains: 10ml 1's X 10 200000
calcium Lactobionate Calcium Gluconate 50mg
Injection 50mg/87.5mg Calcium Lactobionate 87.5mg
equivalent to
elemental calcium 9mg
477 1540 Calcium(from Coral Each film coated tablet contains: 10's 10's X 10 10000000
Grains) and Vitamin D-3 Calcium carbonate (from Coral
Tablets (500mg/ 500IU) Grains)
equivalent to Elemental Calcium 500
mg
Vitamin D3 (as stabilized granules)
500 IU
478 1541 Calcium, Calcitriol and Each soft gelatin capsule contains: 10's 10's X 10 10000000
Vitamin K2-7 Capsules Calcium Carbonate 1250 mg
(1250mg/ 0.25mcg/ (equivalent to Elemental Calcium
45mcg) 500 mg)
Calcitriol 0.25 mcg
Vitamin K2-7 45 mcg
479 1542 Calcium, Magnesium, zinc Each 5ml contains: 200ml 1's X 6 500000
and Vitamin D-3 Oral Calcium Carbonate 625 mg
Suspension equivalent to Elemental Calcium 250
mg
Magnesium Hydroxide 180 mg
equivalent to Elemental Magnesium
75 mg
Zinc Gluconate 14 mg
equivalent to elemental Zinc 2 mg
Vitamin D-3 200 IU
480 1543 Camylofin Each film caoted tablet contains: 15's 15's X 10 1200000
Dihydrochloride and Camylofin Dihydrochloride 25 mg
Paracetamol Tablets (25mg Paracetamol 300 mg
/ 300 mg)
481 1544 Capsules of Coenzyme Each soft gelatin capsule contains: 10's 10's X 10 10000000
Q10 with Lycopene, Coenzyme Q10
Selenium and Omega-3 (Ubidocarenone) 100 mg
Fatty Acids Ecosapentanoic Acid (EPA) 90 mg
Docosahexaenoic Acid (DHA) 60 mg
Lycopene (as 100%) 4000mcg
Selenium (as Selenium Dioxide
Monohydrate) 70mcg
482 1545 Carboxymethlycellulose Each ml contains: 10ml 1's X 10 5000000
Eye drops 1% w/v Sodium Carboxymethlycellulose 10
mg
483 1546 Cefixime and Each film coated tablet contains: 10's 10's X 10 1200000
Azithromycin Tablets Cefixime IP (as Trihydrate)
(200mg / 250mg) equivalent to
Anhydrous Cefixime 200 mg
Azithromycin IP (as dihydrate)
equivalent to
Anhydrous Azithromycin 250 mg
484 1547 Cefixime and Ornidazole Each film coated tablet contains: 10's 10's X 10 1200000
Tablets (200mg / 500mg) Cefixime IP (as Trihydrate)
equivalent to
Anhydrous Cefixime 200 mg
Ornidazole 500 mg
485 1548 Cefixime Oral Suspension Each 5 ml of constitued suspension 30ml 1's X 10 2500000
IP 100 mg/ 5ml contains:
Cefixime IP (as Trihydrate)
equivalent to anhydrous
Cefixime 100 mg
486 1549 Cefixime Oral Suspension Each ml of constitued suspension 10ml 1's X 10 200000
IP 25 mg/ ml contains:
Cefixime 25 mg
487 1550 Cefixime Oral Suspension Each 5 ml of constitued suspension 30ml 1's X 10 500000
IP 50 mg/ 5ml contains:
Cefixime 50 mg
488 1551 Cefoperazone and Each vial contains: Vial with 1's X 10 1200000
Sulbactum Injection Sterile sulbactum Sodium equivalent WFI
(1000mg / 500mg) to Sulbactum 0.5 g
Sterile Cefoperazone Sodium
equivalent to Cefoperazone 1 g
489 1552 Cefoperazone and Each vial contains: Vial with 1's X 10 200000
Sulbactum Injection Sterile sulbactum Sodium equivalent WFI
(2000mg / 1000mg) to Sulbactum 1 g
Sterile Cefoperazone Sodium
equivalent to Cefoperazone 2 g
490 1553 Cefpodoxime Oral Each 5 ml of reconstituted 30ml 1's X 10 200000
Suspension IP 100mg suspension contains:
Cefpodoxime Proxetil IP equivalent
to Cefpodoxime 100 mg
491 1554 Ceftriaxone and Each Vial contains: Vial with 1's X 10 200000
Tazobactum Injection Ceftriaxone Sodium IP equivalent to WFI
(250mg / 31.25mg) Ceftriaxone 250 mg
Tazobactam sodium equivalent to
Tazobactam 31.25 mg
492 1555 Ceftriaxone Injection IP 2 Each Vial contains: Vial with 1's X 10 200000
g Ceftriaxone Sodium IP equivalent to WFI
Ceftriaxone 2 g
493 1556 Cephalexin Extended Each extended release film coated 10's 10's X 10 200000
Release Tablets 750mg tablet contains:
Cephalexin equivalent to anhydrous
Cephalexin 750 mg
494 1557 Cerebroprotein Each lyophilized vial contains: Vial with 1's X 10 200000
Hydrolysate Injection Cerebroprotein Hydrolysate 1050mg WFI
30mg (approx)
equivalent to Nitrogen 30 mg
495 1558 Cerebroprotein Each Vial contains: Vial with 1's X 10 200000
Hydrolysate Injection Cerebroprotein Hydrolysate 60mg WFI
60mg
496 1559 Chloramphenicol Capsules Each capsule contains: 10's 10's X 10 200000
IP 250 mg Chloramphenicol IP 250 mg
497 1560 Chloramphenicol Capsules Each capsule contains: 10's 10's X 10 200000
IP 500 mg Chloramphenicol IP 500 mg
498 1561 Chloramphenicol, Contains: 5ml 1's X 10 2500000
Beclomethasone Chloramphenicol 5% w/v Drops
Dipropionate, Clotrimazole Beclomethasone Dipropionate
and Lidocaine Ear Drops 0.025% w/v
Clotrimazole 1% w/v
Lidocaine 1.5-2% w/v
499 1562 Chlordiazepoxide and Each film coated tablet contains: 10's 10's X 10 5000000
Amitriptyline Amitriptyline Hydrochloride
Hydrochloride Tablets equivalent to Amitriptyline 12.5mg
(5mg / 12.5mg) Chlordiazepoxide 5mg
500 1563 Chlorhexidine Contains : 100ml 100ml X 10 1200000
Gluconate Solution IP 2. Chlorhexidine
5% v/v Handrub Gluconate Solution IP 2.5% v/v
(Eq. to 0.5% w/v Chlorhexidine
Gluconate)
Ethanol IP 70% v/v
501 1564 Cholecalciferol Each Uncoated Chewable Tablets 4'S 4's X 10 10000000
ChewableTablets Contains:
(60000 IU) Cholecalciferol (as Stabilized) 60000
IU
502 1565 Cilnidipine Tablets IP 10 Each film coated tablet contains: 10's 10's X 10 10000000
mg Cilnidipine IP 10 mg
503 1566 Cilnidipine Tablets IP 5 mg Each film coated tablet contains: 10's 10's X 10 10000000
Cilnidipine IP 5 mg
504 1567 Cinitapride and Each hard gelatin capsule contains: 10's 10's X 10 200000
Pantoprazole Capsules Cinitapride Hydrogen Tartrate
(3mg / 40mg) equivalent to Cinitapride 3 mg
(as extended release pellets)
Pantoprazole Sodium equivalent to
Pantoprazole 40 mg
(as enteric coated tablet)
505 1568 Cinnarizine Tablets IP Each uncoated tablet contains: 20's 20's X 10 5000000
75mg Cinnarizine IP 75mg
506 1569 Ciprofloxacin and Contains: 10ml 1's X 10 5000000
Dexamethasone Eye/Ear Ciprofloxacin Hydrochloride
Drops (0.3% w/v / 0.01% equivalent to Ciprofloxacin 0.3% w/v
w/v) Dexamethasone 0.1% w/v
507 1570 Citicoline and Piracetam Each film coated tablet contains: 10's 10's X 10 2500000
Tablets (500mg /800mg) Citicoline sodium IP equivalent to
Citicoline 500mg
Piracetam 800mg
508 1571 Clidinium Bromide, Each film coated tablet contains: 10's 10's X 10 10000000
Chlordiazepoxide and Clidinium Bromide 2.5 mg
Dicyclomine Chlordiazepoxide 5 mg
Hydrochloride Tablets Dicyclomine Hydrochloride 10 mg
(2.5mg / 5mg / 10mg)
509 1572 Clindamycin and Contains: 15g 1's X 20 1200000
Nicotinamide Gel (1%w/w Clindamycin 1% w/w
/ 4%w/w) Nicotinamide 4% w/w
510 1573 Clindamycin Injcetion IP Each ml contains: 4ml 4ml X 10 200000
600 mg Clindamycin IP 150 mg Ampoule
511 1574 Clobazam Tablets IP 10 Each uncoated tablet contains: 15's 15's X 10 10000000
mg Clobazam IP 10 mg
512 1575 Clobetasol Propionate and Contains: 25g Tube 1's X 10 5000000
Gentamicin Cream Clobetasol Propionate 0.05% w/w
(0.05%w/w / 0.1%w/w) Gentamicin 0.1% w/w
513 1576 Clobetasol Propionate and Contains: 15g 1's X 20 2500000
Miconazole Nitrate Cream Clobetasol Propionate 0.05% w/w
(0.05%w/w / 2%w/w) Miconazole Nitrate 2% w/w
514 1577 Clobetasol Propionate and Contains: 10g 1 X 20 2500000
Neomycin Sulphate Cream Clobetasol Propionate 0.05% w/w
(0.05%w/w /0.5%w/w) Neomycin Sulphate 0.5% w/w
Salicylic Acid Ointment Clobetasol Propionate 0.05% w/w
(0.05%w/w / 3%w/w) Salicylic Acid 3% w/w
Salicylic Acid Ointment Clobetasol Propionate 0.05% w/w
(0.05%w/w / 6%w/w) Salicylic Acid 6% w/w
517 1580 Clobetasol Propionate, Contains: 15g 1's X 20 2500000
Gentamicin and Clobetasol Propionate 0.05% w/w
Miconazole Nitrate Cream Gentamicin 2% w/w
(0.05%w/w / 2%w/w / Miconazole Nitrate 0.1% w/w
0.1%w/w)
518 1581 Clopidogrel and Aspirin Each hard gelatin capsule contains: 15's 15's X 10 10000000
Capsules (150mg / 75mg) Clopidrogrel Bisulphate
Aspirin IP 75mg
(as gastro-resistant)
519 1582 Clotrimazole and Selenium Contains: 75ml 75g X 10 200000
Sulfate Suspension (1% / Clotrimazole 1% w/v
2.5%) Selenium Sulfate 2.5% w/v
520 1583 Clotrimazole Mouth Paint Contains: 25ml 25ml X 10 500000
(1% w/v) Clotrimazole 1%
In Glycerine and Propylene Glycol
base q.s
521 1584 Coenzyme Q10 Each film coated tablet contains: 10's 10's X 10 5000000
(Ubidocarenone) and L- Ubidocarenone 30 mg
Carnitine Tablets L-Carnitine L-Tartrate equivalent to
L-carnitine 500 mg
522 1585 Colistin (Colistimethate Each vial contains: 10ml Vial 1's X 10 200000
Sodium) Injection IP 1 Colistimethate Sodium IP 10,00,000
Million IU IU
as sterile powder for reconstitution
523 1586 Colistin (Colistimethate Each vial contains: 10ml Vial 1's X 10 200000
Sodium) Injection IP 4.5 Colistimethate Sodium IP 45,00,000
Million IU IU
as sterile powder for reconstitution
524 1587 Colistin Sulphate Oral Each pack contains: 30ml 30ml X 10 200000
Suspension IP 12.5 mg/5ml A. One bottle of Colistin sulphate
oral suapension IP 12.5mg/5ml
On reconstituted each 5 ml contains:
Colistin Sulphate IP equivalent to
Colostin 12.5 mg
B. One ampoule of Sterile Water for
Injection IP 25 ml
Net content: 12.5 g/ 30 ml
525 1588 Collagen Peptide Type I, Each film coated tablet contains: 15's 15's X 10 5000000
Sodium Hyaluronate, Chondroitin Sulfate Sodium 200 mg
Chondroitin Sulfate and Collagen Peptide Type I 40 mg
Vitamin C Tablets Sodium Hyaluronate 30 mg
Vitamin C 35
mg
526 1589 Combipack of Each strip contains: 6's 6's X 10 200000
Clarithromycin Tablets, A. Clarithromycin Tablets IP 500mg
Pantoprazole Tablets and (2 tablets)
Amoxycillin Tablets Each film coated tablet contains:
(500mg / 40mg / 750mg) Clarithromycin IP 500 mg
B. Pantoprazole Tablets IP 40mg (2

tablets)
Each enteric coated tablet contains:
Pantoprazole Sodium IP equivalent
to Pantoprazole 40mg
C. Amoxycillin Tablets 750mg (2

tablets)
Amoxycillin Trihydrate IP
equivalent to Amoxycillin 750mg
527 1590 Dabigatran Etexilate Each hard gelatin capsule contains: 10's 10's X 10 10000000
Mesilate Capsules 110 mg Dabigatran Etexilate Mesilate 126.83
mg
equivalent to Dabigatran etexilate
110mg
528 1591 Dabigatran Etexilate Each hard capsule contains: 10's 10's X 10 5000000
Mesilate Capsules 150 mg Dabigatran Etexilate Mesilate 172.95
mg
equivalent to Dabigatran etexilate
150mg
529 1592 Dapagliflozin Tablets 10 Each film coated tablet contains: 14's 14's x 10 5000000
mg Dapagliflozin propanediol
monohydrate
equivalent to Dapagliflozin 10 mg
530 1593 Desloratidine and Each film coated tablet contains: 10's 10's X 10 10000000
Montelukast Tablets (5mg / Desloratidine 5 mg
10mg) Montelukast Sodium equivalent to
Montelukast 10 mg
531 1594 Diclofenac Diethylamine, Contains: 30g Tube 30g Tube X 10000000
Thiocholchicoside, Diclofenac Diethylamine 1.16% w/w 10
Linseed Oil, equivalent to Diclofenac 1% w/w
Methylsalicylate and Thiocholchicoside 0.125% w/w
Menthol Gel Linseed Oil 3% w/w
Methylsalicylate 10% w/w
Menthol 5% w/w
532 1595 Diclofenac Injection IP 75 Each ml contains: 1ml 1 ml x 10 1200000
mg Diclofenac Sodium equivalent to Ampoule
Diclofenac 75 mg
533 1596 Diclofenac Potassium and Each uncoated tablets contains: 10's 10's X 10 1200000
metaxalone Tablets Diclofenac potassium 50mg
50/400mg Metaxalone 400mg
534 1597 Diclofenac Prolonged Each sustained release film coated 10's 10's X 10 5000000
release Tablets IP 75 mg tablet contains:
Diclofenac Sodium IP 75 mg
535 1598 Digestive Enzyme Tablets Each enteric coated tablet contains: 15's 15's X 10 2500000
(Pancreatin and Sodium Pancreatin 170 mg
Tauroglycocholate) (containing 15,000 units of Amylase
activity
4,000 units of Lipase activity
15,000 units of Protease ase activity)
Sodium Tauroglycocholate 65 mg
536 1599 Diltiazem Hydrochloride Each Hard gelatin capsule contains: 10's 10's X 10 10000000
Extended Release Capsules Diltiazem Hydrochloride 120 mg
120 mg (as extended release pellets)
537 1600 Diosmin Tablets Each film coated tablet contains: 10's 10's X 10 500000
(Micronised) Diosmin (micronised) 450 mg
Flavanoids exposed as hesperidine 50
mg
538 1601 Diphenoxylate HCL & Each Tablet Contains: 90's in 1 X 10 200000
Atropine sulphate Tablet Diphenoxylate HCL 2.5 mg Bottle
2.5/0.025mg equivalent to Diphenoxylate 2.3 mg
Atropine sulphate 0.025mg
equivalent to Atropine 0.01 mg
539 1602 Divalproex Tablets IP 500 Each enteric coated tablet contains: 10's 10's X 10 10000000
mg Divalproex Sodium equivalent to
Valproic Acid 500mg
540 1603 Dorzolamide and Timolol Contains: 5ml 5ml Drops X 1200000
Eye Drops IP (2% w/v / Dorzolamide Hydrochloride IP Drops 10
0.5% w/v) equivalent to
Dorzolamide 2% w/v
Timolol Maleate equivalent to
Timolol 0.5% w/v
541 1604 Dorzolamide Eye Drops IP Contains: 5ml 5ml Drops X 500000
2% w/v Dorzolamide Hydrochloride IP Drops 10
equivalent to
Dorzolamide 2% w/v
542 1605 Dosulepin (or Dothiepin) Each film coated tablet contains: 15's 15's X 10 10000000
Tablets 25 mg Dosulepin Hydrochloride 55 mg
(Formely Dothiapine Hydrochloride)
543 1606 Dosulepin (or Dothiepin) Each film coated tablet contains: 15's 15's X 10 2500000
Tablets 75 mg Dosulepin Hydrochloride 75 mg
(Formely Dothiapine Hydrochloride)
544 1607 Drotaverine Hydrochloride Each film coated tablet contains: 15's 15's X 10 5000000
Tablets IP 80 mg Drotaverine Hydrochloride IP 80 mg
545 1608 Efavirenz, Emtricitabine Each film coated tablet contains: 30's 30's x 10 200000
and Tenofovir Disoproxil Efavirenz IP 600mg
Fumarate Tablets IP Emtricitabine IP 200mg
(600mg / 200mg / 300mg) Tenofovir Disoproxil Fumarate IP
300mg
546 1609 Empagliflozin Tablets 100 Each film coated tablet contains: 10's 10's X 10 2500000
mg Empagliflozin 100 mg
547 1610 Empagliflozin Tablets 25 Each film coated tablet contains: 10's 10's X 10 5000000
mg Empagliflozin 25 mg
548 1611 Emtricitabine and Each film coated tablet contains: 30's 30's x 10 200000
Tenofovir Disoproxil Emtricitabine IP 200mg
Fumarate Tablets IP Tenofovir Disoproxil Fumarate IP
(200mg / 300mg) 300mg
549 1612 Entecavir Tablets IP 0.5 Each film coated tablet contains: 10's 10's X 10 1200000
mg Entecavir IP 0.5 mg
550 1613 Eplerenone Tablets 25 mg Each film coated tablet contains: 10's 10's X 10 5000000
Eplerenone 25 mg
551 1614 Ergotamine, caffeine, Each uncaoted tablet contains: 14's 14's x 10 5000000
Paracetamol and Ergotamine Tartrate 1 mg
Prochlorperazine Tablets Caffeine (Monohydrate) 100 mg
(1mg/100mg/250mg/2.5mg Paracetamol 250 mg
) Prochlorperazine Maleate 2.5 mg
552 1615 Erythromycin Estolate Each uncaoted tablet contains: 10's 10's X 10 200000
Tablets 500 mg Erythromycin Estolate 500 mg
553 1616 Etofylline (SR), Each uncoated bilayer tablet 10's 10's X 10 2500000
Theophylline (SR), contains:
Montelukast Tablets Etofylline 231mg
(231/69/10mg) Theophylline anhydrous equivalent
to theophylline hydrate 69mg
(As sustained release)
Montelukast sodium eq. to
Montelukast 10mg
554 1617 Etoricoxib and Paracetamol Each film coated tablet contains: 10's 10's X 10 5000000
Tablets (60mg / 325 mg) Etoricoxib 60 mg
Paracetamol 325 mg
555 1618 Etoricoxib and Each film coated tablet contains: 10's 10's X 10 5000000
Thiocolchicoside Tablets Etoricoxib 60 mg
(60mg / 4 mg) Thiocolchicoside 4 mg
556 1619 Eucalyptol Contains: 200ml 1's X 6 1200000
0.092%,Menthol Eucalyptol 0.092% w/v
0.042%,Methyl salicylate Menthol 0.042% w/v
0.060% and Thymol Methyl salicylate 0.060% w/v
0.064% Mouth wash Thymol 0.064% w/v
557 1622 Ferrous Ascorbate, Folic Each Film Coated Tablets contains: 10's 10's X 10 10000000
Acid & Zinc Sulphate Ferrous ascorbate equivalent to
Tablets Ferrous Iron 100mg
Folic Acid 1.5mg
Zinc sulphate monohydrate 22.5mg
558 1623 Fexofenadine Each 5 ml contains: 100ml 100ml X 10 200000
Hydrochloride Suspension Fexofenadine Hydrochloride 30 mg
(30mg/5ml)
559 1624 Flupentixol and Melitracen Each film coated tablet contains: 10's 10's X 10 1200000
Tablets (0.5mg/ 10mg) Flupentixol Hydrochloride equivalent
to Flupentixol 0.5 mg
Melitracen Hydrochloride equivalent
to Melitracen 10 mg
560 1625 Fluticasone Propionate Contains: 10g 1 X 20 2500000
Cream IP 0.05% Fluticasone Propionate IP 0.05%
w/w
561 1626 Formoterol Fumarate and Each activation delivers: 120 MD 1's X 10 5000000
Budesonide Inhaler Formoterol Fumarate 6 mcg
(6mcg/200mcg) (as Formoterol Fumarate Dihydrate)
Budesonide 200 mcg
562 1627 Formoterol Fumarate and Each activation delivers: 120 MD 1's X 10 2500000
Budesonide Inhaler Formoterol Fumarate 6 mcg
Budesonide 400 mcg
563 1628 Formoterol Fumarate and Each Capsule Contains: 30's 30's x 10 2500000
Budesonide Powder for Formoterol Fumarate 12 mcg
Inhalation IP (as Formoterol Fumarate Dihydrate)
(12mcg/400mcg) Budesonide 400 mcg
564 1630 Formoterol Fumarate and Each Hard Gelatin Capsule for Dry 30's 30's x 10 2500000
Budesonide Powder for Powder Inhalation Contains:
Inhalation IP Formoterol Fumarate 6 mcg
Budesonide 400 mcg
565 1631 Formoterol Fumarate and Each 2ml respules contains: 2ml 2ml X 10 1200000
Budesonide Respirator Formoterol Fumarate Dihydrate IP
Suspension (20mcg/ equivalent to Formoterol Fumarate
0.5mg) 20 mcg
Budesonide 0.5 mg
566 1632 Formoterol Fumarate and Each 2ml respules contains: 2ml 2ml X 10 500000
Budesonide Respirator Formoterol Fumarate Dihydrate IP
Suspension (20mcg/ 1mg) equivalent to Formoterol Fumarate
20 mcg
Budesonide 1 mg
567 1633 Formoterol Fumarate and Each Capsule Contains: 30's 30's x 10 5000000
Fluticasone Propionate Formoterol Fumarate 6 mcg
Powder for Inhalation (as Formoterol Fumarate Dihydrate)
(6mcg/250mcg) Fluticasone Propionate 250 mcg
568 1635 Framycetin Skin Cream 1 Contains: 30 g Tube 30g tube X 5000000
% Framycetin Sulphate 1% w/w 20
569 1636 Fungal Diastase with Ecah 10ml contains: 200ml 1's X 6 1200000
Carminatives Syrup Diastase (1:2000) 40 mg
(Fungal derived from Aspergillus
enzyme)
Cinnamon Oil 250 mcg
Caraway Oil 500 mcg
Cardamon Oil 500 mcg
570 1637 Fungal Diastase, Papain Each film coated tablet contains: 15's 15's X 10 1200000
and Activated Charcoal Fungal Diastase 180 mg
Tablets Papain 60 mg
Activated Charcoal 75 mg
571 1638 Fusidic Acid and Each g contains: 15g 1's X 20 2500000
Betamethasone Valerate Fusidic Acid 20 g
Cream (20% w/w / 0.1% Betamethasone Valerate 1 g
w/w)
572 1639 Gabapentin 100 mg and Each film-coated tablet contains: 15's 15's X 10 10000000
Nortryptyline 10 mg Tablet Gabapentin 100 mg
Nortryptyline 10 mg
Methylcobalamin 500 mg Gabapentin 300 mg
Tablet Methylcobalamin 500 mg
574 1641 Gabapentin 300 mg Each capsule contains: 15's 15's X 10 10000000
Capsule Gabapentin 300 mg
Nortryptyline 10 mg Tablet Gabapentin 400 mg
Nortryptyline 10 mg
576 1643 Glargine 100 IU Solution Cartridge of 3 ml solution for 3ml 3ml 10000000
injection/Pre-filled pen of 3ml cartridge cartridge X
solution for injection 10
577 1644 Glibenclamide 5 mg, Each film-coated tablet contains: 10's 10's X 10 10000000
Metformin 500 mg and Glibenclamide 5 mg
Pioglitazone 15 mg Tablet Metformin 500 mg Pioglitazone 15
mg
578 1645 Gliclazide 60mg and Each film-coated tablet contains: 10's 10's X 10 10000000
Metformin ER 500 mg Gliclazide 60mg Metformin 500 mg
(Extended Release)
579 1646 GLIMEPIRIDE + Each uncoated tablet contains: 10's 10's X 10 10000000
METFORMIN + Glimpride 2 mg
PIOGLITAZONE 2/500/15 Metformin 500 mg
mg tablet SR Pioglitazone 15 mg
580 1647 GLIMEPIRIDE + Each uncoated tablet contains: 10's 10's X 10 10000000
METFORMIN 3/850 mg Glimpride 3 mg
tablet SR Metformin 850 mg
581 1648 Glimpride 1mg tablet Each uncoated tablet contains: 15's 15's X 10 10000000
Glimpride 1 mg
582 1649 Glucosamine + Diacerein + Each film coated tablet contains: 10's 10's X 10 2500000
Methyl Sulfonyl Glucosamine 750 mg
Methane(MSM) Diacerein 50 mg
750/50/250 tablet Methyl Sulfonyl Methane(MSM)
250 mg
583 1650 Glucosamine 750 mg + Each fil coated tablet contains: 10's 10's X 10 1200000
Chondroitin 100 mg Tablet Glucosamine 750 mg
Chondroitin 100 mg
584 1651 Glucosamine Sulfate, Each Film coated tablets contains: 10's 10's X 10 5000000
Chondroitin Sulfat, Methyl Chondroitin Sulfat 750mg
Sulfonyl Chondroitin Sulfat 100mg
Methane(MSM),Vitamin Methylsulfinylmethane 250mg
&Minerals Tablets Vitamin D3 200IU
Calcium Ascorbate 50mg
Sodium Selenite pentahydrate
equivalent to elemental selenium
70mcg
Zinc Sulphate monohydrate
equivalent to elemental zinc 4mg
Manganese Sulphate equivalent to
elemental Manganese 3mg
Chronium Picolinate equivalent to
elemental Chronium 50mcg
Copper sulphate pentahydrate
equivalent to elemental copper 0.5mg
Sodium Borate equivalent to
elemental boron 0.5mg
Colloidal silicon dioxide equivalent
to elemental silicon 2mg
585 1654 Guaifenesin 100 Each 5 ml contains: 100ml 100ml X 10 5000000
mg,Dextromethorphan 10 Guaifenesin IP 100 mg
mg and Phenylephrine 25 Dextromethorphan IP 10 mg
mg Syrup Phenylephrine IP 25 mg
586 1655 Guaifenesin 100 mg, Each 5 ml contains: 100ml 100ml X 10 5000000
Dextromethorphan 5 mg, Guaifenesin IP 100 mg
Phenylephrine 1 mg and Dextromethorphan IP 5 mg
Chlorpheniramin 4 mg Phenylephrine IP 1 mg
Syrup Chlorpheniramin 4 mg
587 1656 Guaifenesin Each 5 ml contains: 100ml 100ml X 10 5000000
50mg,Terbutaline 1.25 mg Guaifenesin IP 50 mg
and Ambroxol 15 mg Terbutaline 1.25 mg
Syrup Ambroxol 15 mg
and Bromhexine 2 mg Terbutaline 1.25 mg Bromhexine 2
Expectorant mg
and Ambroxol 15 mg Terbutaline 1.5 mg
Syrup Ambroxol 15 mg
590 1659 Human Normal Human Normal Immunoglobulin for 100ml 100ml X 10 200000
Immunoglobulin I.V administration.
5% Solution I.V use only 1 ml solution contains:
5% Human Normal Immunoglobulin
591 1660 Human Normal Human Normal Immunoglobulin for 2ml vial 2ml X 10 200000
Immunoglobulin for I.M I.M administration.
administration. 1 ml solution contains:
1 ml solution contains: 16.5% Human Normal
16.5% Human Normal Immunoglobulin
Immunoglobulin
592 1661 Hydroxypropylmethylcellu Each ml contains: 10ml 1's X 10 2500000
lose (0.3% w/v) Eye Drop Hydroxypropylmethylcellulose 3mg
593 1662 Hydroxyzine 25mg Tablets Each Film-coated tablet contains: 15's 15's X 10 10000000
Hydroxyzine 25mg
594 1663 Hyoscine Butylbromide & Each uncoated tablet contains: 10's 10's X 10 1200000
Mefenamic acid Tablets IP Hyoscine Butylbromide IP 10mg
(10mg/250mg) Mefenamic acid IP 250 mg
595 1664 Ibuprofen (100mg) and Each ml contains: 100ml 100ml X 10 2500000
Paracetamol/Acetaminophe Ibuprofen 100mg
n (162.5mg) oral Paracetamol/Acetaminophen
suspension 162.5mg
596 1665 Indacaterol and Each capsule contains: 143 mcg 30 1 X 10 500000
Glycopyrronium Indacaterol maleate equivalent to 110 capsules
Inhalation powder,hard mcg Indacaterol and 63 mcg and 1
capsules 50/110 mcg Glycopyrronium Bromide BP inhaler
equivalent to 50 mcg
Glycopyrronium
597 1668 Iron, Folic Acid and Each Capsule contains: 10's 10's X 10 10000000
Vitamin B12 Capsules Carbonyl Iron 100 mg
Folic Acid 1.5 mg
Cynocobalamine (Vitamin B12) 15
mcg
598 1669 Isosobide 20mg and Each film-coated tablet contains: 10's 10's X 10 10000000
Hydralazine 37.5 mg Isosobide 20mg
Tablet Hydralazine 37.5 mg
599 1670 Isotretinoin 20 mg Capsule Each soft-Gelatin capsule contains: 10's 10's X 10 5000000
Isotretinoin 20 mg
600 1671 Ivabradine 5mg Tablet Each film-coated tablet contains: 15's 15's X 10 10000000
Ivabradine 5mg
601 1672 Ketoconazole 2 % Soap Each 75 gm pack of soap contains: 75g Pack 75g Pack X 2500000
Ketoconazole 2% w/v 20
602 1673 L- Methyle folate, Each Uncoated tablets contains: 10's 10's X 10 5000000
Methylcobalamin & Each Uncoated Dispersible tablets
vitamin B6 Tablets contains:
(2.8/2/25mg) L- Methyle folate 2.8mg
Pyridoxal -5 Phosphate 2 mg
Methylcobalamin 25mg
603 1674 L- Methyle folate, Each Uncoated Dispersible tablets 10's 10's X 10 10000000
Pyridoxal -5 Phosphate & contains:
Methylcobalamin Tablets L- Methyle folate 1mg
(1mg/0.5mg/1500mcg) Pyridoxal -5 Phosphate 0.5mg
Methylcobalamin 1500mcg
604 1675 L- Ornithine L-Aspartate Each 10ml contains: 10ml 1's X 10 200000
Infusion (5gm) L- Ornithine L-Aspartate 5g
605 1676 Lactitol 10 gm and Each 15 gm of Granules contains: 180g 1's X 6 2500000
Ispaghula 3.5 gm Granules Lactitol 10 gm
Ispaghula 3.5 gm
606 1678 L-carnitine, Each film coated tablet contains: 10's 10's X 10 5000000
Ubidecarenone, Lycopene L-Carnitine Fumarate
and Astaxanthin Tablets equivalent to L-Carnitine 340 mg
Ubidocarenone 50 mg
Zinc Ascorbate equivalent to
Elemental Zinc 5 mg
Lycopene (as 6% powder) 2.5 mg
Astaxanthin (as 10% powder) 8 mg
607 1679 Lecithin 1000 mg capsule Each soft gelatin capsule contains: 10's 10's X 10 200000
Lecithin 1000 mg
608 1680 Levetiracetam tablet 1000 Each film-coated tablet contains: 10's 10's X 10 10000000
mg Levetiracetam 1000 mg
611 1683 Levocetrizine Each film coated tablets contains: 15's 15's X 10 5000000
Dihydrochloride Tablets IP Levocetrizine Dihydrochloride IP
10MG 10mg
612 1684 Levodopa 100 mg and Each tablet contains: 10's 10's X 10 10000000
Carbidopa 25 mg Tablets Carbidopa 25 mg
Levodopa 100 mg
613 1685 Levodropropizine and Each 5 ml contains: 120ml 1's X 6 200000
Chlorpheniramine Maleate Levodropropizine 30mg
Syrup (30mg / 2mg) Chlorpheniramine Maleate 2mg
614 1686 Levosalbutamol & Each Capsule Contains: 30's 30's x 10 2500000
Beclomethasone Rotacaps Levosalbutamol Sulphate equivalent
100/100mcg to Levosalbutamol 100mcg
Beclomethasone Dipropionate
100mcg
615 1687 Levosalbutamol & Each Capsule Contains: 200 MDI 1's X 10 2500000
Beclomethasone Dipropionate 50mcg
616 1688 Levosalbutamol & Each Capsule Contains: 30's 30's x 10 2500000
Beclomethasone Dipropionate
100mcg
617 1689 Levosalbutamol and Each 2.5ml respules contains: 2.5ml 2.5ml X 10 1200000
Budesonide respules Levosalbutamol Hydrochloride Respules
1.25/0.5mg equivalent to
Levosalbutamol 1.25mg
Budesonide 0.5mg
618 1690 Levosalbutamol and Each Capsules contains: 30's 30's x 10 2500000
Ipratropium Rotacap Levosalbutamol sulphate equivalent
Ipratropium bromide equivalent to
ipratropium 40mcg
619 1691 Levosalbutamol Inhaler Each actuation delivers: 200 MDI 1's X 10 200000
50mcg Levosalbutamol Tartrate equivalent
to Levosalbutamol 50mcg
620 1692 Levosalbutamol respules Each 2.5ml respules contains : 2.5ml 2.5ml X 10 200000
0.63mg/2.5ml Levosalbutamol Sulphate equivalent Respules
to
Levosalbutamol 0.63mg
621 1693 Levosulpiride SR 75 mg Each soft-Gelatin capsule contains: 10's 10's X 10 1200000
and Rabeparazole EC 20 Levosulpiride 75 mg (Sustained
mg Capsule Release)
Rabeparazole 20 mg (Enteric coated
622 1694 Linagliptin and metformin Each Film coated tablets contains: 10's 10's X 10 5000000
2.5/1000mg Tablets Linagliptin 2.5mg
Metformin hydrochloride 1000mg
623 1695 Linagliptin and metformin Each Film coated tablets contains: 10's 10's X 10 5000000
2.5/500mg Tablets Linagliptin 2.5mg
Metformin hydrochloride 500mg
624 1696 Linagliptin Tablets 5mg Each Film Coated tablets contains: 10's 10's X 10 5000000
Linagliptin 5mg
625 1697 Linomycin Injection Each 2ml Contains: 2ml 2ml X 10 200000
300mg/2ml Linomycine hydrochloride equivalent
to
Linomycin 300mg
626 1698 Liquid paraffin and milk of Each 15ml contains: 200ml 1's X 6 2500000
magnesia Emulsion Liquid paraffin 3.75mg
3.75/11.25mg Milk of magnesia 11.25mg
627 1700 Measles Vaccine (Live), Measles Vaccine (Live) 1000ccid50 0.5ml vial 1's X 10 200000
Mumps Virus Vaccine and Mumps Virus Vaccine 5000ccid50
Rubella Vaccine (live) Rubella Vaccine (live) 1000ccid51
(1000ccid50 / 5000ccid50 /
1000ccid50)
628 1701 Megaldrate, Simethicone & Each 5ml contains: 170ml 1's X 6 2500000
Oxetacaine oral suspension Megaldrat 540mg
(540/50/10mg) Simethicone 50mg
Oxetacaine 10mg
629 1702 Meropenum Injection Each Vial Contains: Vial with 1's X 10 200000
500mg Meropenem (sterile) equivalent to WFI
meropenum 500mg
630 1703 Metadoxine, Silymarin, L- Each film coated tablets contains: 10's 10's X 10 2500000
Ornithin L- Aspartate Metadoxine 500mg
tablets (500/140/150mg) Silymarin 140mg
L- Ornithin L- Aspartate 150mg
631 1704 Methylcobalamin with Each Hard gelatin Capsule Contains: 10's 10's X 10 10000000
Alpha Lipoic Acid & B- Methylcobalamin 1500 mcg
Complex Capsules Alpha Lipoic acid 100mg
Thiamine Mononitrate 10mg
Pyridoxine 3mg
Folic acid 1.5mg
632 1705 Metoprolol Extended Each film-coated tablet contains: 10's 10's X 10 2500000
Release 25 mg and Metoprolol 25 mg
Ramipril 2.5 mg Tablet (Extended Release)
Ramipril 2.5 mg
633 1706 Metoprolol Extended Each film-coated tablet contains: 10's 10's X 10 2500000
Release 50 mg and Metoprolol 50 mg (Extended
Ramipril 5 mg Tablet Release)
Ramipril 5 mg
634 1707 Metoprolol Succinate Each hard gelatin capsules contains: 15's 15's X 10 10000000
extended release capsules Metoprolol Succinate Equivalent to
IP 50mg Metoprolol tartrate 50mg
635 1708 Metoprolol Succinate Each prolonged release film coated 15's 15's X 10 10000000
Prolonged release tablets tablets contains:
IP 25mg Metoprolol Succinate I.P. Equivalent
to Metoprolol tartrate 25mg
636 1709 Minoxidil 5% solution Each 60 ml solution contains: 60ml 60ml Bottle 1200000
Minoxidil 5% w/v Bottle X 10
637 1710 Minoxidil 5% and Each 60 ml solution contains: 60ml 60ml Bottle 500000
Finasteride 0.1% Minoxidil 5% w/v Bottle X 10
Finasteride 0.1% w/v
638 1711 Montelukast and Each 5ml contains: 60ml 60ml Bottle 1200000
Levocetirizine syrup Montelukast Sodium equivalent to Bottle X 10
4/2.5mg Montelukast 4mg
Levocetrizine Dihydrochloride 2.5mg
639 1712 Mosquito Repellent Cream Composition : 50g Tube 50g Tube X 2500000
N, N-Diethyl Benzamide 12% 20
w/w
Cream base
q.s.
640 1713 Moxonidine tablets 0.3mg Each Film coated tablets contains: 10's 10's X 10 5000000
Moxonidine 0.3mg
641 1714 Naproxen 250 mg and Each film-coated tablet contains: 10's 10's X 10 10000000
Domperidone 10 mg Tablet Naproxen 250 mg
Domperidone 10 mg
642 1715 Naproxen 500 mg and Each film-coated tablet contains: 10's 10's X 10 10000000
Domperidone 10 mg Tablet Naproxen 500 mg
Domperidone 10 mg
643 1716 Nebivolol 5 mg and S- Each uncoated tablet contains: 10's 10's X 10 1200000
Amlodipine 2.5 mg Tablet Nebivolol 5 mg
S- Amlodipine 2.5 mg
644 1717 Neomycin and Polymyxin Each contains: 5g Tube 5g Tube X 2500000
B Sulfates and Bacitracin Neomycin 3400 IU 20
Zinc Opthalmic Ointment Polymyxin B Sulfates 5000 IU
Bacitracin Zinc 400 IU
645 1718 Nicorandil Tablet IP 10mg Each uncoated tablet contains: 10's 10's X 10 10000000
Nicorandil 10 mg
646 1719 Nicorandil Tablet IP 5mg Each uncoated tablet contains: 10's 10's X 10 10000000
Nicorandil 5 mg
647 1720 Nicoumalone Tablets IP 1 Each uncoated tablet contains: 30's 30's x 10 10000000
mg Nicoumalone/Acenocoumarol IP
1mg
3mg
4mg
650 1723 Nifedipine tablet 10 mg Each sustained release film-coated 15's 15's X 10 10000000
tablet contains:
Nifedipine 10 mg
651 1724 Nimesulide 100 mg and Each uncoated tablet contains: 15's 15's X 10 500000
Paracetamol 500 mg Tablet Nimesulide 100 mg
Paracetamol 500 mg
652 1725 Nimesulide 100 Each film-coated tablet contains: 10's 10's X 10 5000000
mg,Paracetamol 325 mg Nimesulide 100 mg
and Serratiopeptidase 15 Paracetamol 325 mg
mg Tablet Serratiopeptidase 15 mg
653 1727 Ofloxacin 50 mg and Each 5 ml of suspension contains: 30ml 1 X 10 2500000
Ornidazole 125 mg Ofloxacin 50 mg
Suspension Ornidazole 125 mg
654 1728 Ofloxacin, Ornidazole, Composition: 15g tube 1's X 20 5000000
Terbinafine hydrochloride Ofloxacin 0.75%w/w
and clobetasol Propionate Ornidazole 2% w/w
Cream (0.75/2/1/0.05%) Terbinafine hydrochloride 1% w/w
Clobetasol Propionate 0.05%w/w
655 1729 Ofloxaxin 200mg and Each film-coated tablet contains: 10's 10's X 10 200000
Flavoxate 200 mg Tablet Ofloxaxin 200mg
Flavoxate 200 mg
656 1730 Olmesartan 40 mg Each film-coated tablet contains: 10's 10's X 10 2500000
,Amlodipine 5 mg and Olmesartan 40 mg
Hydroclorthiazide 12.5 mg Amlodipine 5 mg
Tablet Hydroclorthiazide 12.5 mg
657 1731 Olmesartan Medoxomil Each film coated tablet contains: 10's 10's X 10 5000000
and Chlorthalidone Tablets Olmesartan Medoxomil 20 mg
(20mg / 12.5mg) Chlorthalidone 12.5 mg
658 1732 Olmesartan Medoxomil Each film coated tablet contains: 10's 10's X 10 5000000
and Chlorthalidone Tablets Olmesartan Medoxomil 40 mg
(40mg / 12.5mg) Chlorthalidone 12.5 mg
659 1733 Omeprazole and Each Capsule contains: 15's 15's X 10 10000000
Domperidone Sustained Omeprazole 20 mg
Release Capsules (20mg / (as enteric coated pellets)
30mg) Domperidone 30 mg
(as sustained release pellets)
660 1734 Ondansetron tablets IP Each film coated tablets contains: 10's 10's X 10 1200000
4mg Ondasetron Hydrochloride IP
equvilant to
Ondasetron 4mg
661 1735 Orciprenaline Tablet 10 Each uncoated tablet contains: 10's 10's X 10 200000
mg Orciprenaline 10 gm
662 1736 Oseltamivir Phosphate Each Capsules Contains: 10's 10's X 10 200000
Capsule 75 mg Oseltamivir phosphate equvilant to
Olsetamivir 75mg
663 1737 Oxaceprol Capsules 200mg Each Capsule contains: 10's 10's X 10 200000
Oxaceprol Capsules 200mg
664 1738 Pancreatin 100 mg + Each enteric coated Tablet contains: 10's 10's X 10 200000
Ornithine 150 mg Tablet Pancreatin 100 mg
Ornithine 150 mg
665 1739 Pancreatin 10000 mg Each capsule contains: 10's 10's X 10 10000000
Capsule Pancreatin 10000 mg
666 1740 Pancreatin 25000 mg Each capsule contains: 10's 10's X 10 5000000
Capsule Pancreatin 25000 mg
667 1741 Pantoprazole and Each Hard gelatin capsule contains: 10's 10's X 10 10000000
Domperidone Capsules Pantoprazole Sodium equivalent to
(20mg / 10mg) Pantoprazole 20 mg
(in form of gastro resistant tablet)
Domperidone 10 mg
668 1742 Paracetamol Infusion IP Paracetamol 100 ml infusion 100ml 100ml X 10 200000
1.0% W/V contains:
Paracetamol 1000mg
669 1743 Paracetamol 100 mg/ml Each ml contains: 15ml 1's X 10 5000000
Drops Paracetamol IP 100 mg
670 1744 Paracetamol 125 Each ml of Drop contains: 15ml 1's X 10 5000000
mg,Phenylephrine 2.5 mg Paracetamol 125 mg
and Chlorpheniramine 1 Phenylephrine 2.5 mg
mg Drops Chlorpheniramine 1 mg
671 1745 Paracetamol 125 Each 5 ml of suspension contains: 60ml 60ml Bottle 5000000
mg,Phenylephrine 5 mg Paracetamol 125 mg Bottle X 10
and Chlorpheniramine 1 Phenylephrine 5 mg
mg Suspension Chlorpheniramine 1 mg
672 1746 Paracetamol 125 Each 5 ml of syrup contains: 60ml 60ml Bottle 200000
mg Syrup Chlorpheniramine 1 mg
673 1747 Paracetamol 162.5 mg and Each Film-coated tablet contains: 15's 15's X 10 200000
Tramadol 18.75 mg Tablet Paracetamol 162.5 mg
Tramadol 18.75 mg
674 1748 Paracetamol 250 mg, Each uncoated tablet contains: 10's 10's X 10 2500000
Caffeine 50 mg and Paracetamol 250 mg
Phenazone 150 mg Tablet Caffeine 50 mg
Phenazone 150 mg
675 1749 Paracetamol 250 Each 5 ml of suspension contains: 60ml 60ml Bottle 2500000
mg Suspension Chlorpheniramine 2 mg
676 1750 Paracetamol 325 mg and Each Film-coated tablet contains: 10's 10's X 10 10000000
Tramadol 37.5 mg Capsule Paracetamol 325 mg
Tramadol 37.5 mg
677 1751 Paracetamol 500 mg and Each uncoated tablet contains: 15's 15's X 10 5000000
Caffeine 25 mg Tablet Paracetamol 500 mg
Caffeine 25 mg
678 1752 Paracetamol 500 mg and Each Film-coated tablet contains: 10's 10's X 10 2500000
Chlorzoxazone 250 mg Paracetamol 500 mg
Tablet Chlorzoxazone 250 mg
679 1753 Paracetamol 500 Each Film-coated tablet contains: 10's 10's X 10 10000000
mg,Phenylephrine 10 mg Paracetamol 500 mg
mg Tablet Chlorpheniramine 2 mg
680 1755 Paracetamol IP 120 mg Each 5 ml contains: 60ml 60ml Bottle 200000
/5ml Suspension Paracetamol IP 120 mg Bottle X 10
681 1756 Paracetamol Oral Each 5 ml contains: 60ml 60ml Bottle 5000000
suspension 250mg/5ml Paracetamol 250mg Bottle X 10
682 1757 Paradichlorobenzene, Contains: 10ml 1's X 10 2500000
Benzocaine, Chlorbutol Paradichlorobenzene 2.0 % w/v
and Turpentine Oil Ear Benzocaine 2.7 % w/v
Drops Chlorbutol 5.0 % w/v
Turpentine Oil 15.0 % w/v
683 1758 Phenylephrine 5 Each 5 ml of suspension contains: 100ml 100ml X 10 2500000
mg,Chlorpheniramine 2 mg Phenylephrine 5 mg
and Dextromethorphan 10 Chlorpheniramine 2 mg
mg Syrup Dextromethorphan 10 mg
684 1759 Phenylephrine 5 Each 5 ml of suspension contains: 100ml 100ml X 10 2500000
mg,Chlorpheniramine 2 mg Phenylephrine 5 mg
and Dextromethorphan 15 Chlorpheniramine 2 mg
mg Syrup Dextromethorphan 15 mg
685 1760 Piracetam Tablet 800mg Each Film-coated tablet contains: 10's 10's X 10 10000000
Piracetam 800 mg
686 1761 Pirfenidone Tablet 200mg Each Film-coated tablet contains: 10's 10's X 10 200000
Piracetam 200 mg
687 1762 Polystyrene Sulfonate Each sachet contains : 15g 1's X 20 200000
Powder Polystyrene Sulfonate 15 gm
688 1763 Prazosin XL 5 mg Tablet Each film coated GITS tablet 30's 30's x 10 10000000
contains :
Prazosin 5 mg
689 1764 Pregabalin 75 mg and Each Film-coated tablet contains: 10's 10's X 10 5000000
Methylcobalamin 1500 Pregabalin 75 mg
mcg and Nortryptiline 10 Methylcobalamin 1500 mcg
mg Tablets Nortryptiline 10 mg
690 1765 Pregabalin 75 mg and Each Hard Gelatin capsule contains: 10's 10's X 10 5000000
Methylcobalamin 750 mcg Pregabalin 75 mg
Capsule Methylcobalamin 750 mcg
691 1767 Probiotic Microbes 5 mg Each capsule contains: 10's 10's X 10 2500000
Capsule Probiotic Microbes 5 mg
692 1768 Promethazine 1.5 mg and Each 5 ml of syrup contains: 60ml 60ml Bottle 500000
Pholcodine 1.5 mg Syrup Promethazine 1.5 mg Bottle X 10
Pholcodine 1.5 mg
693 1769 Prucalopride 2 mg Tablet Each Film-coated tablet contains: 10's 10's X 10 200000
Prucalopride 2 mg
694 1770 Prucalopride Tablets 1mg Each Film coated tablets contains: 10's 10's X 10 200000
Prucalopride 1mg
695 1771 Prucalopride Tablets 2mg Each Film coated tablets contains: 10's 10's X 10 200000
Prucalopride 2mg
696 1772 Prulifloxacin 600 mg Each Film-coated tablet contains: 5's 5's X 10 200000
Tablet Prulifloxacin 600 mg
697 1773 Quiniodochlor 250 mg Each uncoated tablet contains: 20's 20's X 10 200000
Tablet Quiniodochlor 250 mg
698 1774 Racecadotril 100 mg Each Hard Gelatin capsule contains: 15's 15's X 10 200000
Capsule Racecadotril 100 mg
699 1775 Ramipril and Metoprolol Each Uncoated Bilayer tablets 10's 10's X 10 2500000
Succinate Extend release contains:
tablet 2.5/25mg Ramipril 2.5mg
Metoprolol succinate 23.75mg
equivalent to metoprolol tartrate
25mg
700 1776 Ramosetron 5 mcg Tablet Each uncoated tablet contains: 10's 10's X 10 200000
Ramosetron 5 mcg
701 1777 Ranitidine 75 mg Syrup Each 5ml syrup contains: 100ml 100ml X 10 2500000
Ranitidine 75 mg
702 1778 Ranolazine 500 mg Tablet Each Film coated Extended Release 10's 10's X 10 10000000
tablet contains:
Ranolazine 500 mg
703 1779 Reteplase- Recombinant Each kit contains: Vial with 1's X 10 200000
Tissue Plasminogen Reteplase- Recombinant Tissue WFI
Activator (18mg) Plasminogen Activator 18mg
704 1780 Rivaroxaban Tablets 10mg Each Film Coated tablet contains: 30's 30's x 10 200000
Rivaroxaban 10mg
705 1781 Rivaroxaban Tablets 20mg Each Film Coated tablet contains: 14's 14's x 10 200000
Rivaroxaban 20mg
706 1782 Rosehip Extract, Each Capsule contains: 14's 14's x 10 5000000
DevilsClaw extract (20%) Rosehip Extract 275mg
& Boswella serrata Extract DevilsClaw extract (20%) 100mg
(65%) (275/100/307.5mg) Boswella serrata Extract (65%)
307.5mg
707 1783 Rosuvastatin and Each film coated tablets contains: 10's 10's X 10 1200000
Fenofibrates Tablets Rosuvastatin Calcium equivalent to
(20/160mg) Rosuvastatin 20mg
Fenofibrates 160mg
708 1784 Rosuvastatin tablets IP Each film coated tablets contains: 10's 10's X 10 10000000
40mg Rosuvastatin calcium IP equivalent
to
Rosuvastatine 40mg
709 1785 Rosuvastatin, Aspirin and Each hard gelatin capsule contains: 10's 10's X 10 10000000
Clopidogrel Capsules Rosuvastatin Calcium IP equivalent
(10mg / 75mg / 75mg) to
Rosuvastatin 10mg (as pellets)
Clopidrogrel Bisulphate equivalent to
Clopidrogrel 75mg (as pellets)
Aspirin IP 75mg (as enteric coated
pellets)
710 1786 Rosuvastatin, Aspirin and Each hard gelatin capsule contains: 10's 10's X 10 10000000
Clopidogrel Capsules Rosuvastatin Calcium IP equivalent
(20mg / 75mg / 75mg) to
Rosuvastatin 20mg (as pellets)
Clopidrogrel Bisulphate equivalent to
Clopidrogrel 75mg (as pellets)
Aspirin IP 75mg (as enteric coated
pellets)
711 1787 S (-) Amlodipine Tablets Each Uncoated tablets contains: 15's 15's X 10 2500000
IP 5mg S (-) Amlodipine Besylate IP
equivalent to
S (-) Amlodipine 5mg
712 1788 S (-) Metoprolol Succnate Each Prolonged - release film coated 10's 10's X 10 1200000
Prolonged - release tablets contains :
Tablets 25mg S (-) Metoprolol succinate 23.75 mg
equivalent to S (-) Metoprolol tartrate
25mg
713 1789 S(-) Amlodipine and Each uncaoted tablet contains: 15's 15's X 10 1200000
Atenolol Tablets (2.5mg/ S(-) Amlodipine Besylate
50mg) S(-) Amlodipine 2.5 mg
Atenolol 50 mg
714 1790 Saccharomyces Boulardii Each Capsule contains: 5's 5's X 10 2500000
Capsule 250mg Lyophylized Saccharomyces
Boulardi 250MG
715 1791 Saccharomyces Boulardii Each Sachet contains: 1's Sachet 1's Sachet X 200000
powder 250mg Lyophylized Saccharomyces 10
Boulardi 250MG
716 1792 Sacubitril and Valsartan Each film coated tablets contains: 14's 14's x 10 10000000
Tablets (24/26mg) Sacubitril 24mg
Valsartan 26mg
717 1793 Sacubitril and Valsartan Each film coated tablets contains: 14's 14's x 10 10000000
Tablets (49/51mg) Sacubitril 49mg
Valsartan 51mg
718 1794 Salbutamol Rotacaps Each Capsule contains: 30's 30's x 10 2500000
200mcg Salbutamol Sulphate equivalent to
Salbutamol 200mcg
719 1795 Salicylic acid, Dithranol & Contains: 30g Tube 30g tube X 1200000
Coal Tar Ointment Salicylic acid 1.15% w/w 20
(1.15%/1.15%/5.3%w/w) Dithranol 1.15% w/w
Coal Tar 5.3% w/w
720 1796 Salmeterol and Fluticasone Each Capsule contains: 30's 30's x 10 500000
Propionate Power for Salmeterol 50mcg
inhalation IP (50/100mcg) (As Salmeterol Xinafoate IP)
Fluticasone Propionate IP 100mg
721 1797 Saroglitazar Tablets 4mg Each Uncoated tablets contains: 10's 10's X 10 1200000
Saroglitazar 4mg
722 1798 Satranidazole & Ofloxacin Each film coated tablets contains: 10's 10's X 10 1200000
(300/200mg) Satranidazole 300mg
Ofloxacin 200mg
723 1800 Silver Nitrate and Contains: 15g tube 1's X 20 2500000
Chlorhexidine Gluconate Silver Nitrate 0.20%w/w
cream 0.20% w/w Chlorhexidine gluconate solution
0.20%w/w
724 1805 Sodium Valporate oral Each 5 ml contains: 200ml 1's X 6 200000
solution IP 200mg/5ml Sodium Valporate IP 200mg Plastic
bottel
725 1806 Sodium Valporate& Each film coated controlled release 10's 10's X 10 10000000
Valporic Acid Controlled tablets contains:
Release Tablets Sodium Valporate 200mg
(200/87mg) Valporic acid 87mg
726 1807 Sodium Valporate& Each film coated controlled release 10's 10's X 10 10000000
Valporic Acid Controlled tablets contains:
Release Tablets Sodium Valporate 333mg
(333/145mg) Valporic acid 145mg
727 1808 Spiramycin Tablets Each film Coated Tablets Contains: 10's 10's X 10 200000
(3.0MIU) Spiramycin 3.0 MIU
728 1809 Sucralfate Suspension Each 5ml contains: 200ml 1's X 6 1200000
1gm/5ml Sucralfate 1g Glass
Bottle
729 1810 Tacrolimus Ointment Composition: 10g tube 1 X 20 1200000
(0.1% w/w) Tacrolimus 0.1% w/w
730 1811 Telmisartan and Each Uncoated tablets contains: 10's 10's X 10 2500000
Amlodipine Tablets IP Telmisartan IP 80mg
(80/5mg) Amlodipine Besylate equivalent to
Amlodipine IP 5mg
731 1812 Telmisartan and Each film coated tablet contains: 10's 10's X 10 5000000
Cilnidipine Tablets (80mg Telmisartan 80 mg
/ 10mg) Cilnidipine 10 mg
732 1813 Telmisartan Tablets IP Each uncoated tablets contains: 10's 10's X 10 10000000
80mg Telmisartan IP 80mg
733 1814 Telmisartan, Each film coated tablet contains: 10's 10's X 10 2500000
Chlorthalidone and Telmisartan 40 mg
Amlodipine Tablets (40mg Chlorthalidone 12.5 mg
/ 12.5mg/ 5mg) Amlodipine Besilate equivalent to
Amlodipine 5 mg
734 1815 Telmisartan, Each film coated tablet contains: 10's 10's X 10 2500000
Chlorthalidone and Telmisartan 40 mg
Amlodipine Tablets (40mg Chlorthalidone 6.25 mg
/ 6.25mg/ 5mg) Amlodipine Besilate equivalent to
Amlodipine 5 mg
735 1816 Telmisartan, Cilnidipine Each film coated tablet contains: 10's 10's X 10 5000000
and Chlorthalidone Tablets Telmisartan 40 mg
(40mg / 10mg/ 6.25mg) Cilnidipine 10 mg
Chlorthalidone 6.25 mg
736 1817 Terbinafine Hydrochloride Each tube contais: 10g 1 X 20 2500000
IP Cream Terbinafine Hydrochloride IP 1%
w/w
Benzyl Alcohol (Preservative) IP 1%
w/w
Cream base q.s.
737 1818 Tetrabenazine Tablets Each uncoated tablets contains: 10's 10's X 10 200000
25mg Tetrabenzine 25mg
738 1819 Ticagrelor Tablets 90mg Each film coated tablets contains: 10's 10's X 10 10000000
Ticagrelor 90mg
739 1820 Timed release Capsules of Each Timed release capsule contains: 25's 1 X 10 2500000
Nitroglycerin 2.5mg Dilute nitroglycerin equivalent to Bottle
Nitroglycerine 2.5mg
740 1821 Tiotropium Bromide Each actuation delvers: 200 MDI 1's X 10 5000000
Inhalation IP (9mcg/dose) Triotropium Bromide monohydrate
IP
equivalent to tiotropium 9mcg
741 1822 Tiotropium powder for Each capsule contains: 1's 1's X 10 5000000
Inhalation IP (18mcg) Triotropium Bromide monohydrate
IP
equivalent to tiotropium 18mcg
742 1823 Tirofiban Hydrochloride Each 100 ml contains: 100ml 100ml X 10 200000
I.V. Injection (5mg/100ml) Tirofiban Hydrochloride 5mg Vial
743 1824 Tolvaptan Tablets 15mg Each Uncoated tablets contains: 10's 10's X 10 10000000
Tolvaptan IP 15mg
744 1825 Torsemide & Each Uncoated Tablet Contains: 15's 15's X 10 10000000
Spironolactone Tablets Torsemide 10mg
(10/50mg) Spironolactone 50mg
745 1826 Torsemide Tablets IP Each Uncoated Tablets contains: 15's 15's X 10 2500000
20mg Torsemide IP 20mg
746 1827 Torsemide Tablets IP Each Uncoated tablets contains: 15's 15's X 10 5000000
40mg Torsemide IP 40mg
747 1828 Torsemide Tablets IP 5mg Each Uncoated Tablets contains: 15's 15's X 10 5000000
Torsemide IP 5mg
748 1829 Travoprost Ophthaimic Each ml contains: 2.5ml 2.5ml X 10 500000

Solution (2.5ml) Travoprost 40µg
749 1830 Trimetazidine Each Capsule Contains: 10's 10's X 10 5000000
Hydrochloride controlled Trimetazidine Hydrochloride 60mg
Release Capsule 60mg (as con)
750 1831 Trypsin, Bromelain, Each Enteric coated tablet contains: 10's 10's X 10 2500000
Rutoside Trihydrate and Trypsin
Diclofenac Sodium Tablets 48mg
(48mg/90mg/ 100mg/ Bromelain 90mg
50mg) Rutoside Trihydrate 100mg
Diclofenac Sodium 50mg
751 1832 Undenatured Collagen Each Hard gelatin capsule contains: 10's 10's X 10 2500000
Type II Capsules 40 mg Undenatured Collagen II 40 mg
(Yielding Total Collagen 10 mg)
(Yielding Undenatured Collagen
Type II 1.2 mg)
752 1833 Ursodeoxycholic Acid Each Uncoated tablets contains: 15's 15's X 10 5000000
Tablets IP 150mg Ursodeoxycholic Acid IP 150mg
753 1834 Valacyclovir Tablets Each film coated tablet contains : 3's 3's X 10 1200000
1000mg Valacyclovir Hydrochloride
equivalent to Valacyclovir 1000mg
754 1837 Vildagliptin 50 mg and Each Film coated tablet contains: 15's 15's X 10 10000000
Metformin Hydrochloride Vildagliptin
850 mgTablets 50mg
Metformin Hydrochloride
850mg
755 1841 Vitamin D3 Oral Solution Each 5ml Syrup contains: 5ml 1 X 10 10000000
(60000 IU) Cholecalciferol 60000 IU
(In nano droplet form)
756 1842 Vitamine B Complex Each ampoule contains: 2ml 2ml X 10 10000000
injection (IM/IV) Use Thiamine (Vit. B1) 10mg
Riboflavin (Vit. B2) 4mg
Nicotinamide 40mg
Pyridoxine (Vit. B6) 4mg
Dexpanthenol 6mg
Biotin 0.5mg
Cynocobalamin (Vit. B12) 8mcg
757 1843 Voglibose, Glimepride and Each Uncoated Bilayered tablet 10's 10's X 10 10000000
Metformin Hydrochloride contains:
Sustained Release Tablets Voglibose 0.2mg
(0.2mg/1mg/500mg) Glimepride 1mg
Metformin Hydrochloride 500mg
(In sustained Release form)
760 1846 Zoledronic Acid Injection Each vial contains : 5ml 1 X 10 200000
IP 4 mg/5ml Zoledronic Acid IP equivalent to
Zoledronic Acid(anhydrous) 4mg
Mannitol 220mg
761 1848 Etophyllin and Each ml contains: 2ml 2ml X 10 200000
Theophylline Injection Etofylline 84.7 mg
(84.7mg+25.3 mg) per ml Theophylline anhydrous equivalent
to
Theophylline hydrate 25.3 mg
762 1849 Vitamin-C Chewable Each uncoated chewable tablet 10's 10's X 10 10000000
Tablets 500mg contains:
Ascorbic Acid IP 200 mg
Sodium Ascorbate IP 338 mg
equivalent to Ascorbic Acid 300 mg
-------------------------------------------
Annexure – XIII
{Ref:- clause 19(K)}
For All the tendered drugs, bidder must comply the shelf life of each quoted
drugs in accordance with the “Schedule - P” of Drugs and Cosmetics Rules,
1945. In case drugs/medicines not covered in “Schedule P” of the Drugs and
Cosmetics Rules, 1945, the bidder must supply these drug/medicine with
minimum 24 months shelf life.
Note: Bidders must declare the required shelf-life detail in Para VI of Annexure II.
ANNEXURE- XIV
Ref. Clause No. 1(ii) C
(Shape, Colour, Packing Type etc. of drugs)
Sl. Drug Generic Name of Drug Unit Size Shape and Packing PVC
No. Code Size of type Colour /
Tablets/ bottle
Capsule / unit shape
pack type
1 3 Pregabalin Capsules IP 75 mg 10's Standard size Blister Transparent
2 6 Chlorzoxazone, Diclofenac and 10's Oval Blister Milky White
Paracetamol Tablets (500 mg + 325
mg + 50 mg)
3 9 Diclofenac Sodium Sustained Release 10's Round Blister Transparent
Tablets IP 100 mg biconvex
4 10 Diclofenac Sodium Injection IP 3ml Ampule Mono- Transparent
25mg/ml Ampoule carton
5 11 Diclofenac Gastro-Resistant Tablets 10's Round Blister Transparent
IP 50 mg biconvex
6 14 Ibuprofen and Paracetamol Tablets IP 10's Oval Blister Transparent
(400 mg + 325 mg)
7 15 Ibuprofen Tablets IP 200 mg 10's Round Blister Transparent
biconvex
8 16 Ibuprofen Tablets IP 400 mg 15's Round Blister Transparent
biconvex
9 17 Indomethacin Capsules IP 25 mg 10's Round ALU- Silver
biconvex ALU
10 18 Azithromycin Tablets IP 250 mg 6's Oval /Round Blister Transparent
11 22 Paracetamol Pediatric Oral 60ml Plastic bottle Round Amber
Suspension IP 125 mg/5 ml Bottle
12 24 Pentazocine Injection IP 30 mg/ml 1ml Ampule Mono- Transparent
Ampoule carton
13 26 Tramadol Hydrochloride Injection 2ml Ampule Mono- Amber
100 mg/2 ml Ampoule carton
14 28 Tramadol Tablets 50mg 10's Round ALU- Silver
biconvex ALU
15 29 Acyclovir Tablets IP 400 mg 10's Oval Strip Silver
16 30 Amikacin Injection IP 100 mg/2 ml 2ml Vial Vial Mono- Transparent
carton
carton
carton
19 36 Amoxycillin and Potassium 30ml Plastic bottle Round milky White
Clavulanate Oral Suspension (200 mg
+ 28.5 mg)/5 ml
20 37 Amoxycillin and Potassium Vial with Glass vial Mono- Transparent
Clavulanate Injection 300 mg WFI carton
21 38 Amoxycillin and Potassium Vial with Glass vial Mono- Standard
Clavulanate Injection 600 mg WFI carton Market
22 40 Amoxycillin and Cloxacillin Capsules 10's Standard size Blister Transparent
(250 mg + 250 mg)
23 42 Amoxycillin Trihydrate Dispersible 10's Round Strip Silver
Tablets IP 125 mg biconvex
24 47 Azithromycin Oral Suspension 15ml Plastic bottle Round milky White
(100mg/ 5ml)
25 48 Azithromycin 100 mg Dispersible 10's Round Blister Transparent
Tablets biconvex
26 52 Cefadroxil Tablets IP 500 mg 10's Oval Strip Silver
27 58 Cefoperazone Injection IP 1 g Vial with Glass vial Mono- Transparent
WFI carton
28 62 Cefotaxime Sodium Injection IP 1000 Vial with Glass vial Mono- Transparent
mg WFI carton
29 64 Cefotaxime Sodium Injection IP 500 Vial with Glass vial Mono- Transparent
mg WFI carton
30 65 Cefpodoxime Proxetil Dispersible 10's Round Strip Silver
Tablets 100 mg biconvex
31 66 Cefpodoxime Tablets IP 200 mg 10's Oval /Round Strip Silver
32 73 Cefotaxime Sodium and Sulbactam Vial with Glass vial Mono- Transparent
Sodium Injection (250mg + 125mg) WFI carton
33 78 Cefuroxime Axetil Tablets IP 500 mg 10's Round Strip Silver
biconvex
34 79 Cefuroxime Axetil Tablets IP 250 mg 10's Oval Strip Silver
35 82 Cephalexin Capsules IP 500mg 10's Standard size Blister Transparent
36 83 Ciprofloxacin and Tinidazole Tablets 10's Oval Blister Transparent
(250mg+300mg)
37 88 Co-trimoxazole (Sulphamethoxazole 50ml Plastic bottle Round Amber
200mg and Trimethoprim 40mg per
5ml) Oral Suspension IP
38 89 Co-trimoxazole (Sulphamethoxazole 10's Oval Blister Transparent
800mg and Trimethoprim 160mg)
Tablets IP
39 90 Co-trimoxazole (Sulphamethoxazole 10's Oval Blister Transparent
100mg and Trimethoprim 20mg)
Tablets IP
40 92 Doxycycline Capsules IP 100mg 10's Standard size Blister Transparent
41 93 Erythromycin Stearate Tablets IP 10's Oval /Round Blister Transparent
250mg
42 94 Gentamicin Sulphate Injection IP 80 2ml Glass vial Mono- Transparent
mg/ 2ml carton
43 95 Levofloxacin Tablets IP 250mg 10's Oval /Round Blister Purple
44 99 Norfloxacin Tablets IP 400 mg 10's Oval Blister Transparent
45 100 Ofloxacin and Ornidazole Tablets 10's Oval Blister Transparent
(200mg + 500mg)
46 104 Roxithromycin Oral Suspension (50 30ml Plastic bottle Round Amber
mg/ 5ml)
47 106 Roxithromycin Tablets IP 300 mg 10's Round ALU- Silver
biconvex ALU
48 110 Adapalene 0.1%w/w Gel 15g tube Lami tubes Standard milky White
49 112 Beclomethasone Dipropionate 0.025 15g tube Lami tubes Standard milky White
% w/w, Clotrimazole 1 % w/w and
Gentamicin Sulphate 0.1 % w/w
Cream
50 115 Calamine Lotion 100ml Plastic bottle Round Standard
Market
51 120 Fusidic Acid Cream 2 % w/w 5g tube Lami tubes Standard milky White
52 126 Povidone-Iodine Solution IP 10 % 500ml Plastic bottle Round Amber
w/v
53 127 Povidone-Iodine Solution IP 5 % w/v 100ml Plastic bottle Round Amber
54 131 Silver Sulphadiazine Cream IP 1% 20g Lami tubes Standard milky White
w/w 20 g
55 132 Silver Sulphadiazine Cream IP 1% 500g Lami tubes Standard milky White
w/w 500 g
56 133 Glibenclamide Tablets IP 2.5 mg 10's Scored oval Blister Transparent
57 136 Gliclazide Tablets IP 80 mg 10's Round Blister Dark
biconvex pink/Transpare
nt
58 158 Etoposide Injection IP 100 mg/5 ml Vial Glass vial Mono- Transparent
carton
59 163 Tamoxifen Citrate Tablets IP 10 mg 10's Round ALU- Silver
biconvex ALU
60 164 Tamoxifen Citrate Tablets IP 20 mg 10's Round ALU- Silver
biconvex ALU
61 178 Albendazole and Ivermectin Tablets 1's Oval Blister Yellow/Orange
(400mg + 6mg)
62 184 Paracetamol and Dicyclomine 10's Round Blister Lightt Blue
Hydrochloride Tablets (325mg + biconvex
20mg)
63 186 Domperidone Tablets IP 10 mg 10's Round Blister Transparent
biconvex
64 192 Famotidine Tablets IP 40 mg 14's Round Blister Transparent
biconvex
65 194 Hyoscine Butylbromide Tablets IP 10 10's Round Blister Lilac
mg biconvex
66 195 Isapgol Husk IP 200 gm 200g standard jar Standard Standard
tetrapack Market
67 197 Lactulose Solution (10g per 15ml) 100ml Plastic bottle Round Transparent
68 199 Metoclopramide Tablets IP 10 mg 10's Round Blister Transparent
biconvex
69 200 Metoclopramide Injection IP 5mg/ml 2ml Glass vial Mono- Transparent
carton
70 206 Omeprazole and Domperidone 10's Standard size Blister Transparent
Capsules IP (20mg + 10mg)
71 207 Omeprazole Capsules IP 20 mg 10's Standard size Strip Silver
72 210 Ornidazole Tablets IP 500mg 10's Oval Blister Transparent
73 214 Rabeprazole and Domperidone 10's Standard size ALU- Silver
Sustained Release Capsules (20mg + ALU
30mg)
74 215 Rabeprazole Gastro Resistant Tablets 10's Round ALU- Silver
IP 20 mg biconvex ALU
75 217 Ranitidine Tablets IP 150 mg 10's Round Strip Silver
biconvex
76 218 Ranitidine Tablets IP 300 mg 10's Round Strip Silver
biconvex
77 220 Calcium with Vitamin D3 Tablets IP 10's Oval Blister Silver
(500mg+250IU) Metalized
78 227 Polyvitamin Tablets NFI 10's Plastic bottle Standard Standard
(Prophylactic) Market
79 231 Vitamin B-Complex Tablets (B1 10's Round Strip Dark Amber
100mg, B2 10mg, B3 45mg, B5 biconvex
50mg, B6 3mg, B12 15mcg)
80 232 Vitamin B-Complex Syrup 200 ml Plastic bottle Round Amber
neck
81 233 Vitamin-C Chewable Tablets 100mg 10's Round Strip Silver
biconvex
82 235 Budesonide Respules 0.5 mg/ml 2ml Standard size Standard Standard
Market
83 236 Budesonide Inhaler 100mcg 200 MDI Standard size Standard Standard
Market
84 238 Budesonide Inhaler 200mcg 200 MD Standard size Standard Standard
Market
85 244 Etophyllin and Theophylline Injection 2ml Glass vial Mono- Amber
(84.7mg+25.3 mg) carton
86 251 Montelukast Sodium Tablets IP 10mg 10's Round Blister Transparent
biconvex
87 252 Montelukast Sodium and 10's Round ALU- Silver
Levocetrizine Tablets IP (10mg + biconvex ALU
5mg)
88 255 Salbutamol Inhalation IP 100 200 MD Glass vial Standard Transparent
mcg/puff
89 256 Salbutamol Tablets IP 2mg 10's Round Blister Transparent
biconvex
90 259 Salbutamol Syrup IP 2mg /5ml 100ml Plastic bottle Round Amber
91 261 Adenosine Injection IP 6 mg/ 2ml 2ml Ampule Mono- Amber
carton
92 266 Atorvastatin Tablets IP 10mg 10's Round Blister Lightt Blue
biconvex
93 269 Clopidogrel Tablets IP 75mg 10's Round Blister light green
biconvex
94 272 Diltiazem Tablets IP 60 mg 10's Round Blister Green
biconvex
95 273 Dobutamine Injection 250mg/20ml Vial Glass vial Mono- Amber
carton
96 274 Dopamine Hydrochloride Injection 5ml Vial Glass vial Mono- Amber
200 mg/5ml carton
97 275 Enalapril Tablets IP 5 mg 10's Round Blister milky White
biconvex
98 276 Enoxaparin Injection IP 40 mg/0.4 ml 0.4ml Glass vial Mono- Amber
PFS carton
99 277 Enoxaparin Injection IP 60 mg/0.6 ml 0.6ml Glass vial Mono- Amber
PFS carton
100 278 Frusemide Injection IP 10 mg/ml 2ml Glass vial Mono- Transparent
carton
101 279 Frusemide Tablets IP 40 mg 10's Round Blister light green
biconvex
102 281 Heparin Sodium Injection IP 5000 5ml Vial Glass vial Standard Transparent
IU/ml
103 286 Lisinopril Tablets IP 5mg 10's Round Blister Green
biconvex
104 287 Losartan and Hydrochlorothaizide 10's Round Blister violet
Tablets IP (50mg + 12.5mg) biconvex
105 288 Losartan Tablets IP 25mg 10's Round Blister Silver
biconvex
106 295 Simvastatin Tablets IP 10mg 10's Round Strip Silver
biconvex
107 296 Simvastatin Tablets IP 20mg 10's Round Strip Silver
biconvex
108 298 Telmisartan and Hydrochlorothiazide 10's Round Strip Silver
Tablets IP (40mg+12.5 mg) biconvex
109 301 Tranexamic Acid Tablets IP 500 mg 10's Oval /Round Blister Blue
110 305 Chloroquine Phosphate Tablets IP 10's Oval /Round Blister Green
250 mg
111 312 Oral Rehydration Salts 20.5 g Sachet 1's Sachet Sachet Sachet
(WHO Formula)
112 329 Prednisolone Tablets IP 5 mg 15's Oval /Round Blister Purple
113 330 Prednisolone Tablets IP 10 mg 10's Oval /Round Blister Amber
114 332 Thyroxine Sodium Tablets IP 100 100's Round Bottle milky White
mcg Bottle biconvex
115 334 Dexamethasone Injection 4mg/ml 2ml Glass vial Mono- Amber
carton
116 338 Atropine Sulphate Injection IP 1ml Glass vial Mono- Amber
0.6mg/ml Ampoule carton
117 344 Ciprofloxacin Eye Drops IP 0.3% w/v 5ml FFS Plastic Standard milky White
bottle type
118 345 Gentamicin Eye Drops IP 0.3% w/v 10ml FFS Plastic Standard milky White
bottle type
119 352 Bupivacaine Hydrochloride Injection 20ml Vial Glass vial Mono- Transparent
IP 5 mg/ml carton
120 357 Lignocaine and Adrenaline Injection 30ml Vial Glass vial Mono- Transparent
IP (2%w/v and 1:80000) carton
121 358 Propofol Injection 10 mg/ml 10ml Vial Glass vial Mono- Transparent
carton
122 359 Tetanus Vaccine 0.5ml Glass vial Mono- Transparent
Ampoule carton
123 368 Gliclazide Extended release Tablets 10's Round Blister Purple
60 mg biconvex
124 372 Metformin Hydrochloride Prolonged 10's Oval PVC Transparent
release Tablets IP 500 mg Blister
125 384 Itraconazole Capsules 100 mg 4's Standard size ALU- Silver
ALU
126 386 Diethylcarbamazine Tablets IP 50 mg 30's Round Blister Transparent
biconvex
127 392 Griseofulvin Tablets IP 250 mg 10's Oval /Round Blister Amber
128 396 Amphotericin B Injection IP 50 20ml Vial Glass vial Mono- Transparent
mg/Vial carton
129 403 CLINDAMYCIN INJ IP 300 MG/2 2ml Glass vial Mono- Transparent
ML carton
130 404 LINEZOLID INFUSION 600 300g Plastic bottle Round Transparent
MG/300 ML
131 410 Trastuzumab Injection 440 mg With 1's Glass vial Mono- Transparent
Wfi carton
132 418 Rosuvastatin Tablets IP 20 mg 10's Round Blister Yellow/Orange
biconvex
133 419 Ointment Of Heparin Sodium and 20g Lami tubes Blister Transparent
Benzyl Nicotinate
134 424 Carvedilol Tablets IP 3.125 mg 10's Round Blister Transparent
biconvex
135 425 Diltiazem Sustained Release Tablets 10's Round Blister Green
90 mg biconvex
136 426 Acenocoumarol Tablets 2 mg 30's Round ALU- Silver
biconvex ALU
137 427 S(-)Amlodipine Tablets IP 2.5 mg 10's Round Strip Silver
biconvex
138 430 Amiodarone Tablets IP 200 mg 10's Oval Blister Transparent
139 431 Ramipril and Hydrochlorothiazide 10's Round Strip Silver
Tablets IP (5mg+12.5 mg) biconvex
140 434 Propranolol Tablets IP 40 mg 10's Oval /Round Blister Transparent
141 438 Indapamide Tablets IP 1.5 mg 10's Round Blister Transparent
biconvex
142 442 Fenofibrate Tablets IP 160 mg 10's Round ALU- Silver
biconvex ALU
143 443 Isosorbide Dinitrate Tablets IP 5 mg 50's Round Blister Transparent
biconvex
144 444 Enalapril and Hydrochlorothiazide 30's Round Strip Silver
Tablets IP (10mg + 25mg) biconvex
145 446 Amlodipine and Hydrochlorothiazide 10's Round Blister Transparent
Tablets (5mg + 12.5mg) biconvex
146 447 MOXONIDINE TABLETS 0.3 MG 10's Round ALU- Silver
biconvex ALU
147 448 Ramipril and Amlodipine Tablets 10's Round Strip Silver
(5mg + 5mg) biconvex
148 449 Spironolactone Tablets IP 25 mg 15's Round Strip Silver
biconvex
149 451 Streptokinase Injection IP 15,00,000 10ml Vial Glass vial Mono- Transparent
IU with carton
Diluent
150 452 Warfarin Tablets IP 5 mg 10's Round Blister Transparent
biconvex
151 453 Bisoprolol and Hydrochlorothiazide 10's Round Blister Dark Blue
Tablets IP (5mg + 6.25mg) biconvex
152 454 Valsartan Tablets IP 80 mg 10's Round ALU- Silver
biconvex ALU
153 455 Verapamil Tablets IP 80 mg 10's Round ALU- Silver
biconvex ALU
154 458 Labetalol Injection IP 5 mg/ml 4ml Glass vial Mono- Transparent
Ampoule carton
155 459 Hydroquinone, Mometasone and 20g Tube Lami tubes Standard milky White
Tretinoin Cream (2% + 0.1% +
0.025%)
156 461 Betamethasone Valerate and 20g Tube Lami tubes Standard milky White
Neomycin Sulfate Cream (0.1% W/W
and 0.5% W/W)
157 462 Betamethasone Valerate and 30g Tube Lami tubes Standard milky White
Clioquinol Cream BP (0.12% W/W+
3% W/W)
158 466 Ursodeoxycholic Acid Tablets IP 300 10's Modified ALU- Silver
mg rectangle ALU
159 467 Dicyclomine and Mefenamic Acid 10's Oval /Round Blister Transparent
Tablets (10mg + 250mg)
160 468 Bacillus Clausii Spores Suspension 2 5ml Plastic bottle Round Standard
Billion/5ml Market
161 470 Diastase and Pepsin Liquid 200 ML Plastic bottle Round Standard
Market
162 477 Chlordiazepoxide and Clidinium 10's Round ALU- Silver
Bromide Tablets (5mg+2.5mg) biconvex ALU
163 480 Enteric-Coated Esomeprazole and 10's Standard size ALU- Silver
Sustained Release Levosulpiride ALU
Capsules (40mg+75mg)
164 481 Rifaximin Tablets 400 mg 10's Modified Blister Transparent
rectangle
165 483 Loperamide Capsules IP 2 mg 10's Standard size Blister Transparent
166 485 Promethazine Tablets IP 25 mg 10's Round Blister Transparent
biconvex
167 486 Pancreatin and Activated 10's Oval Blister Transparent
Dimethicone Tablets (170mg+80mg)
168 487 Dicyclomine Hydrochloride and 30g Plastic bottle Round Amber
Dimethicone Suspension
(10mg+40mg)
169 489 Sulfasalazine Delayed Release 10's Modified Blister Yellow/Orange
Tablets 1000mg rectangle
170 491 Itopride Tablets 50 mg 10's Round Strip Silver
biconvex
171 494 ISPAGHULA HUSK IP 100 GM 100g standard jar Standard Standard
Tetrapack Market
172 496 Dydrogesterone Tablets IP 10 mg 10's Round Blister Amber
biconvex
173 499 Norethisterone Tablets IP 5 mg 10's Round Blister Transparent
biconvex
174 501 Betamethasone Sodium Phosphate 20's Round Blister Transparent
Tablets IP 0.5 mg biconvex
175 503 METHYLPREDNISOLONE Vial with Glass vial Mono- Amber
SODIUM SUCCINATE INJECTION WFI carton
1000 MG PER VIAL
176 505 Carbimazole Tablets 10 mg 100's Round Blister Transparent
Bottle biconvex
177 507 Carbimazole Tablets IP 5 mg 10's Round Blister Transparent
biconvex
178 509 Hydroxychloroquine Tablets IP 200 10's Oval /Round Blister Transparent
mg
179 513 Piroxicam Capsules IP 20 mg 10's Standard size Blister Transparent
180 522 Alfacalcidol Soft Gelatin Capsules 10's Standard size Blister Transparent
0.25 mcg
181 523 Naproxen Tablets IP 500 mg 15's Oval Blister Transparent
182 528 Paracetamol, Phenylephrine and 10's Round Blister Purple
Chlorpheniramine Tablets biconvex
(325mg+10mg+2mg)
183 529 Levosalbutamol and Ipratropium 2.5ml Standard size Standard Standard
Respules (1.25mcg+500mcg) type Market
184 530 Formoteral and Budesonide Rotacaps 30's Standard size Standard Standard
(6mcg+200mcg) type Market
185 532 Salmeterol and Fluticasone Rotacaps 30's Standard size Standard Standard
186 534 Salbutamol and Beclomethasone 30's Standard size Standard Standard
Respicaps (400mcg + 200mcg) type Market
187 537 Ambroxol Hydrochloride and 100ml Plastic bottle Round Amber
Levosalbutamol Sulphate Syrup
188 538 Theophylline Tablets 400 mg 10's Oval Blister Transparent
189 539 Acetylcysteine Tablets 600 mg 10's Oval Blister Transparent
190 540 Levosalbutamol and Budesonide 2ml Standard size Standard Standard
Respules (1.25mg+1mg) type Market
191 541 Acebrophylline Capsules 100 mg 10's Standard size Blister Dark green
192 542 Saline Nasal Drops (Sodium Chloride 20 ml FFS Plastic Standard milky White
0.65% w/v) bottle type
193 543 Menthol (55 mg ± 5.) Cinnamon (12.5 10's Standard size Blister Transparent
mg ± 2) and Pine Oil (112.5 mg ± 1)
Soft Capsules
194 544 FLUTICASONE PROPIONATE 2ml Standard size Standard Standard
RESPULE 0.5 MG/2ML type Market
195 555 Doxofylline Tablets IP 400 mg 10's Modified Blister Transparent
rectangle
196 556 Montelukast and Fexofenadine 10's Oval /Round ALU- Transparent
Hydrochloride Tablets (10mg + ALU
120mg)
197 558 Fluticasone and Azelastine Nasal 120 MD Standard size Standard Standard
Spray (27.5mcg + 140mcg) type Market
198 559 Salbutamol and Theophylline Tablets 30's Round Blister Transparent
(2mg+100mg) biconvex
199 560 Fluticasone Propionate Nasal Spray 120 MD Standard size Standard Standard
50 mcg type Market
200 561 Levosalbutamol Syrup (1mg/5Ml) 100ml Plastic bottle Round Amber
201 563 Oxymetazoline Nasal Drops (0.5 mg 10ml Standard size Standard Standard
/ml) type Market
202 564 Tiotropium Bromide and Formoterol 15's Standard size Standard Standard
Fumarate Dihydrate Rotacaps type Market
(18mcg+12mcg)
203 565 Tiotropium Bromide, Formoterol 15's Standard size Standard Standard
Fumarate Dihydrate and Ciclesonide type Market
Rotacaps (18mcg+12mcg+400mcg)
204 566 Ipratropium Bromide Respirator 15ml Standard size Standard Standard
Solution 250mcg type Market
205 567 Salbutamol and Ipratropium Inhaler 200 MDI Standard size Standard Standard
206 568 Salmeterol and Fluticasone 100 MD Standard size Standard Standard
Propionate Inhaler IP type Market
(25mcg+250mcg)
207 574 Rabies Vaccine, Human IP 1ml with Glass vial Mono- Transparent
Diluent carton
208 582 Vitamins A,C,D,E,And B Complex 200 ML Plastic bottle Round Amber
and Minerals Syrup neck
209 583 Cyproheptadine Tablets IP 4 mg 10's Round Blister Transparent
biconvex
210 586 Methylcobalamin, L- Cartinine L- 10's Almond shape Strip Dark Amber
Tartrate and Folic Acid Tablets
(1500mcg+500mg+1.5mg)
211 592 L-Lysine + Multivitamins (Vit- 200 ML Plastic bottle Round Amber
B1,B2,B3,B5,B6 ) Syrup neck
212 593 Folic Acid, Cyanocobalamine and 10ml Ampule Mono- Amber
Nicotinamide Injection carton
(15mg+500mcg+200mg)
213 594 Glucose Powder 75g Tetra Standard Standard Standard
Pack Market type Market
214 595 Thiamine, Pyridoxine Hcl and 2ml Ampule Mono- Amber
Cyanocobalamin Injection carton
(100mg+50mg+1000mcg)
215 599 Pregabalin Tablets 75 mg 10's Round PVC Transparent
Blister
216 608 Betamethasone Dipropionate and 20g Tube Lami tubes Standard milky White
Salicylic Acid Ointment
217 609 Silver Nitrate and Chlorhexidine 15g tube Lami tubes Standard milky White
Gluconate Cream
218 610 Paracetamol, Phenylephrine 60ml Plastic bottle Round Amber
Hydrochloride and Cetirizine Bottle neck
Dihydrochloride Suspension
(125mg+5mg+2mg)
219 612 Povidone-Iodine Powder 5% W/W 10g Standard Standard Standard
Container Market type Market
220 625 Bromhexine Hydrochloride and 15's Round Blister Transparent
Phenylephrine Hydrochloride Tablets biconvex
(8mg + 5mg)
221 628 Etophylline and Theophylline 10's Oval Blister Transparent
Prolonged Release Tablets
(231mg+69mg)
222 629 Inhalent Softgel 10's Standard size Blister Transparent
Caps(Camphor25mg+Clorothymol 5
mg+Eucalyptus130mg+Menthol
55mg+Turpentine oil110mg
223 631 Etamsylate Tablets 500 mg 10's Oval Blister Blue
224 632 Etamsylate Tablets 250 mg 10's Oval Blister Yellow/Orange
225 640 Nimesulide Gel 1% W/W 20g Tube Lami tubes Standard milky White
226 643 Paracetamol 125mg+ CPM 1 mg + 60ml Plastic bottle Round Amber
Sodium Citrate 60mg in a flavour Bottle
syrup base
227 644 Phenylephrine Hydrochloride 5.00mg 15ml FFS Plastic Standard milky White
Chlorpheniranmine Maleate 2.00mg Bottle bottle type
Drops
228 645 Nimesulid, Paracetamol and 10's Oval Blister milky White
Chlorzoxazone Tablets
(100mg+325mg+375mg)
229 648 Diclofenac dethylamine 35g Tin Tin Standard milky White
BP1.16%Linseed Oil BP3% spray
w/wMethylsalicylate
IP10%w/wMenthol IP5% w/wSpray
230 655 Pepsin and Fungal Diastase Enyme 200 ml Plastic bottle Round Amber
Syrup Mix Fruit Flavour (7.5mg + neck
12.5mg per 5ml)
231 656 Diastase and Pepsin Enzyme Drops 15ml Plastic bottle Round Amber
232 664 Mouth Ulcer Gel (Choline Salicylate 10g Lami tubes Standard milky White
Sodium 9% W/V, Benzalkonium
Chloride 0.01% W/W)
233 665 Vitamin B Complex and Ascorbic 10's Standard size Strip Silver
Acid Capsules
234 666 Pheniramine Maleate Injection IP 2ml Plastic bottle Round Amber
22.75 mg
235 668 Multivitamin Drops 15ml Plastic bottle Round Amber
neck
236 676 Triamcinolone Acetonide 0.1 % w/w 10g Lami tubes Standard milky White
buccal paste
237 677 Flupentixol Tablets 0.5 mg 10's Round ALU- Silver
biconvex ALU
238 679 Nalidixic Acid Tablets IP 500 mg 10's Oval Blister Transparent
239 680 Finasteride Tablets IP 5mg 10's Round ALU- Silver
biconvex ALU
240 681 Phenazopyridine Hydrochloride 10's Round ALU- Silver
Tablet 100mg biconvex ALU
241 686 Magaldrate 400mg + Simethicone 170ml Plastic bottle Round Amber
20mg/5ml Oral Suspension IP
242 687 Lactulose 10 gm per15 ml 200 ml Plastic bottle Round milky White
243 689 Clotrimazole Vaginal Tablets IP 10's Oval Blister Transparent
100mg
244 691 Ofloxacin Eye Drops 0.3%W/V 10ml FFS Plastic Standard milky White
bottle type
245 692 Olopatadine Hydrochloride 10ml FFS Plastic Standard milky White
Ophthalmic Solution 0.1% W/V bottle type
246 693 Tropicamide Eye Drops IP 1% W/V 5ml FFS Plastic Standard milky White
Drops bottle type
247 696 Polymyxin B Sulphate, 5ml FFS Plastic Standard milky White
Chloramphenicol and Dexamethsone Drops bottle type
Eye/Ear Drops (5000 IU + 4mg +
1mg)
248 697 Sulphacetamide Eye Drop 10 % W/V 10ml FFS Plastic Standard milky White
bottle type
249 699 Acyclovir Eye Ointment IP 3% W/W 5g Tube Lami tubes Standard milky White
250 701 Pilocarpine Eye Drops IP 2% W/V 10ml FFS Plastic Standard milky White
bottle type
251 705 Levofloxacin Infusion IP 500 mg/100 100ml Plastic bottle Round Transparent
ml
252 707 Piroxicam Dispersible Tablets 10 mg 10's Round Blister Light Blue
biconvex
253 709 Piroxicam Injection 20 mg 1ml Glass vial Mono- Transparent
Ampoule carton
254 710 Piroxicam Injection 40 mg 2ml Glass vial Mono- Transparent
carton
255 715 Glycerin IP 98%W/W 50g in Plastic bottle Round Transparent
Bottle
256 720 Ringer Lactate Infusion 500ml in Plastic bottle Round Transparent
FFS
bottle
257 725 Dextrose IV Fluid IP 5% W/V 500ml in Plastic bottle Round Transparent
FFS
bottle
258 726 Dextrose IV Fluid 10% W/V 500ml Plastic bottle Round Transparent
FFS
Bottle
259 734 Dehydroepiandrosterone 10's Standard size ALU- Dark Blue
(Micronized) 25 mg Capsule ALU
260 736 Megestrol Acetate Tablets IP 40mg 10's Round ALU- Transparent
biconvex ALU
261 739 Cefuroxime Tablets IP 125mg 6's Round Strip Silver
biconvex
262 746 Valganciclovir Hydrochloride USP 10's Oval Blister Transparent
450 mg tablet
263 757 Cefuroxime Injection IP 1500mg Vial with Glass vial Mono- Transparent
WFI carton
264 762 Nortriptyline Tablets IP 25mg 10's Round Blister Transparent
biconvex
265 768 Acetazolamide Tablets IP 250mg 10's Round Blister Yellow/Orange
biconvex
266 769 Acetyl Salicylic Acid (Aspirin)Tablet 14's Round Strip Silver
325mg biconvex
267 779 Alpha Lipoic acid 100mg Vit. D3 10's Plastic bottle Round Amber
1000 IU Folic acid 1.5mg Pyridoxine
3mg Methylcobalamin 1500mcg
268 781 Alprazolam and Fluoxetine Tablets 10's Round Blister Transparent
(0.25mg+20mg) biconvex
269 786 Amitriptyline Hydrochloride Tablets 10's Round Blister purple
IP 10mg biconvex
270 791 Atenolol and Amlodipine Tablets 14's Round Blister Lilac
(25mg+5mg) biconvex
271 793 Atenolol Tablets 25 mg 14's Round Blister Transparent
biconvex
272 796 Atorvastatin 10mg, Aspirin (Ec) 10's Standard size Strip Silver
75mg Capsules
273 800 Bacitracin-Neomycin Sulphacetamide 10g Standard Standard Standard
Dusting Powder Powder Market type Market
274 804 Betamethasone Injection IP 4 mg/Ml 1ml Glass vial Mono- Transparent
Ampoule carton
275 806 Bicalutamide Tablets IP 50mg 10's Round Blister Transparent
biconvex
276 811 Bromfenac Sodium Eye Drops 0.09% 5ml FFS Plastic Standard milky White
w/v Drops bottle type
277 815 Calcitriol Capsules IP 0.25mcg 10's Standard size Blister Transparent
278 816 Calcium Acetate Tablets 667mg 10's Oval Blister Transparent
279 817 Calcium Carbonate 1250 Mg Vitamin 10's Plastic bottle Round milky White
D3 250 Iu Magnesium Oxide 40 Mg neck
Manganese Sulphate 1.8 Mg Zinc
280 818 Calcium Gluconate Injection IP 10 % 10ml Glass vial Mono- Transparent
carton
281 829 Chloramphenicol Eye Ointment IP 5g Tube Lami tubes Standard milky White
1%W/W
282 835 Glucosamine Sulphate and 10's Modified Blister Transparent
Chondroitin Tablets (500mg+400mg) rectangle
283 838 Cilostazol Tablets IP 50mg 10's Round Blister Transparent
biconvex
284 860 Dextromethorphan Hydrobromide 50ml Plastic bottle Round Amber
Syrup IP Bottle
285 866 Diazepam Injection IP 5mg/ml 2ml Glass vial Mono- Transparent
carton
286 868 Dicyclomine Hcl (Dicycloverine) 2ml Glass vial Mono- Transparent
Injection IP 10mg/ml carton
287 875 Donepezil Hydrochloride Tablets IP 10's Round Blister Transparent
10mg biconvex
288 881 Ebastine Tablets IP 10mg 10's Round ALU- Transparent
biconvex ALU
289 884 Erythromycin Estolate Suspension 60ml Plastic bottle Round Amber
125 Mg/5ml Bottle
290 897 Fluticasone Propionate and 120 MDI Standard Standard Standard
Formoterol Fumarate Inhaler Market type Market
(250mcg + 6mcg)
291 910 Human Chorionic Gonadotrophin Vial with Standard Standard Standard
5000 IU Powder For Inj. With solvent solvent Market type Market
292 912 Hydrochlorothiazide Tablets 12.5mg 10's Round Blister Transparent
biconvex
293 916 Imatinib Mesylate Tablets IP 400mg 10's Oval ALU- Silver
ALU
294 922 Isopropyl Alcohol (70%) (Spirit) 100ml Plastic bottle Round Transparent
bottle
295 923 Isosorbidemononitrate Tablets IP 10's Round Blister Transparent
20mg biconvex
296 924 Isoxsuprine Hydrochloride Tablets 50's Round Blister Transparent
10mg biconvex
297 932 Latanoprost Eye Drops IP 2.5ml FFS Plastic Standard milky White
0.005%W/V (50mcg/ml) bottle type
298 933 Leflunomide Tablets IP 20mg 10's Round Blister Transparent
biconvex
299 934 Lenalidomide Capsules 10mg 10's Standard size Blister Transparent
300 935 Letrozole Tablets 2.5mg 10's Round Blister Transparent
biconvex
301 938 Levocarnitine Injections 1gm 5ml Vial Glass vial Mono- Amber
carton
302 939 Levocarnitine Tablets 500mg 10's Oval Strip Transparent
303 944 Levosalbutamol Hydrochloride 120 MDI Standard Standard Standard
Inhaler 50mcg Market type Market
304 947 Lithium Carbonate Prolonged Release 10's Oval Blister Transparent
Tablets IP 450mg
305 948 Lorazepam Tablets IP 1mg 10's Round Blister Transparent
biconvex
306 951 Lycopene 1000 mcg, Vitamin A 2500 200 ml Plastic bottle Round Amber
IU, Vitamin E 10 IU, Selenium 35 neck
mcg and Vitamin C 50mg
307 957 Memantine Hydrochloride Tablets IP 10's Round Blister Transparent
10mg biconvex
308 968 Mirtazapine Tablets IP 15 mg 10's Round ALU- Silver
biconvex ALU
309 972 Mycophenolate Mofetil Tablets IP 10's Oval Blister Transparent
500mg
310 975 Nebivolol and Hydrochlorothiazide 10's Round Blister Transparent
311 976 Nebivolol Tablets IP 2.5mg 10's Round Blister Red
biconvex
312 978 Nepafenac Eye Drop 0.1% W/V 5ml FFS Plastic Standard milky White
Drops bottle type
313 986 Nitrazepam Tablets I.P 10mg 10's Round Strip Silver
biconvex
314 987 Nitrofurantoin Tablets I.P 100mg 10's Round Blister Transparent
biconvex
315 992 Olmesartan Tablets 20mg 10's Round Strip Silver
biconvex
316 996 Oxcarbazepine Tablets IP 300mg 10's Oval Blister Amber
317 1005 Phenobarbitone Tablets IP 30mg 30's Round Blister Transparent
biconvex
318 1008 Phytomenadione (Vitamin K1) 0.5ml Glass vial Mono- Amber
Injection 1 mg/0.5Ml Ampoule carton
319 1009 Pioglitazone Tablets IP 15 mg 10's Round Blister Milky white
biconvex
320 1011 Piracetam Syrup 500mg/5ml 100ml Plastic bottle Round Amber
321 1024 Promethazine Injection IP 25 mg/ml 2ml Glass vial Mono- Transparent
carton
322 1031 Quetiapine Fumarate Tablets IP 10's Round Blister Transparent
200mg biconvex
323 1038 Recombinant Human Erythropoietin Vial Standard Standard Standard
Injection 2000 IU Market type Market
324 1041 Risperidone and Trihexiphenidyl 10's Round Blister Transparent
Tablets (4mg+2mg) biconvex
325 1042 Risperidone Tablets 4mg 10's Round Blister Transparent
biconvex
326 1060 Sodium Valproate Gastro-Resistant 10's Oval /Round Blister Transparent
Tablets IP 300mg
327 1068 Sucralfate and Oxetacain Suspension 100ml Plastic bottle Round Amber
(1g + 10mg per 10ml)
328 1069 Sulphacetamide Sodium Eye Drop I.P 10ml FFS Plastic Standard milky White
20% W/V bottle type
329 1072 Tamsulosine Prolonged-Release 10's Standard size Blister Transparent
Capsule IP 0.4 mg
330 1074 Telmisartan and Hydrochlorothiazide 10's Round Strip Silver
Tablets (80mg+12.5mg) biconvex
331 1081 Tizanidine Tablets IP 2 mg 10's Round Blister Transparent
biconvex
332 1087 Trihexyphenidyl Hydrochloride 10's Round Blister Transparent
Tablets 2mg (Benzhexol Hcl Tablets biconvex
IP 2mg)
333 1088 Trimetazidine Hydrochloride 10's Round Blister Transparent
Modified Release Tablets 35 mg biconvex
334 1097 Vitamin A Capsule 25000 IU 30's Standard size Blister Transparent
335 1106 Metoprolol Succinate Extended 10's Round Strip Silver
Release and Telmisartan Tablets biconvex
(50mg + 40mg)
336 1108 Sildenafil Tablets 100 mg 4's Diamond Blister Dark
shape pink/Transpare
nt
337 1110 Clobazam Tablet IP 5mg 10's Round Blister Transparent
biconvex
338 1123 Clomipramine Hydrochloride Sr 10's Round Blister Transparent
Tablets 75mg biconvex
339 1124 Fluvoxamine Maleate Tablets IP 10's Round Blister Transparent
100mg biconvex
340 1149 Lisinopril Tablets IP 10mg 15's Round Blister Green
biconvex
341 1152 Carbamazepine Sustained Release 10's Round Strip Silver
Tablets IP 200mg biconvex
342 1154 Diethylcarbamazine Citrate Tablets IP 30's Round Blister Transparent
100mg biconvex
343 1156 Metoprolol Succinate Extended 7's Round Blister Light Blue
Release and Amlodipine Besilate biconvex
Tablets (25mg + 5mg)
344 1162 Betamethasone Cream 0.1 % w/w 20g Tube Lami tubes Standard milky White
345 1166 Mefenamic Acid Tablets 250 mg 10's Oval /Round Blister Transparent
346 1167 Mefenamic Acid Tablets 500 mg 10's Oval Blister Transparent
347 1168 Ketorolac Injection IP 30mg/ml 1ml Vial Glass vial Mono- Amber
carton
348 1170 Acetylcysteine Injection 200 mg/ml 2ml Glass vial Mono- Amber
Ampoule carton
s
349 1186 Cyclosporin Capulses IP 25mg 5's Standard size Blister Transparent
350 1187 Cyclosporine Capsules IP 100 mg 5's Standard size Blister Transparent
351 1191 Glycopyrrolate Injection IP 0.2mg 1ml Glass vial Mono- Amber
Ampoule carton
352 1203 Protamine Injection 10mg/ml 5ml Glass vial Mono- Amber
Vial/Amp carton
oule
353 1219 Amino Acid Solution For IV 200 ml 200ml Plastic bottle Round Amber
Bottle Glass
Bottle
354 1220 Oseltamivir Capsules 75mg 10's Round ALU- Silver
biconvex ALU
355 1221 Thyroxine Sodium Tablets 50mcg 100's Round Bottle milky White
Bottle biconvex
356 1225 Orlistat Capsules 120 mg 10's Standard size Blister Transparent
357 1226 Triamcinolone Injection 40mg/ml Vial with Glass vial Mono- Amber
Diluent carton
358 1227 Triamcinolone Tablets IP 4 mg 10's Round Blister Transparent
biconvex
359 1228 Gabapentin and Amitriptyline Tablets 10's Oval Blister Transparent
(300mg + 10mg)
360 1231 Vitamin E Acetate and Levocarnitine 10's Oval Strip Transparent
Tablets (200 mg + 150 mg)
361 1237 Methyldopa Tablets IP 500 mg 10's Oval Blister Red
362 1238 Prazosin Hydrochloride Sustained 30's Round Blister Transparent
Release Tablets 2.5 mg biconvex
363 1240 Gliclazide and Metformin 10's Oval Blister Transparent
Hydrochloride Tablets (80mg +
500mg)
364 1241 Cefaclor Dispersible Tablets 250 mg 10's Oval ALU- Silver
ALU
365 1248 Haematinic Syrup Of Iron,Folic Acid 200ml Plastic bottle Round Amber
and Vitamin bottle neck
B12(32mg+0.5mg+7.5mcg) 200 ml
366 1251 Vitamin B6 (Pyridoxine 10's Round Blister Dark Amber
Hydrochloride) Tablets IP 100mg biconvex
367 1252 Suspension of Calcium Phosphate 200 ml Plastic bottle Round Amber
With Vitamin D3 and Viatmin B12 neck
(82 mg + 200 Iu + 2.5 mcg)
368 1254 Diphenhydramine 13-15 mg. + 100ml Plastic bottle Round Amber
Ammonium Chloride 135-150 mg + Bottle
Sodium Citrate 57-85mg. + Menthol
0.9-2.6mg IP Cough Syrup
369 1257 Allylestrenol Tablets 5 mg 10's Round Blister Orange
biconvex
370 1283 Chlorthalidone Tablets 6.25 mg 10's Round Blister Transparent
biconvex
371 1284 Cilnidipine and Telmisartan Tablets 10's Round Strip Silver
(10 mg + 40 mg) biconvex
372 1298 Donepezil Tablets 5 mg 10's Round Blister pink
biconvex
373 1306 Escitalopram and Clonazepam 10's Round ALU- Silver
Tablets (5mg +0.5mg) biconvex ALU
374 1310 Faropenem Tablets 200 mg 6's Round ALU- Silver
biconvex ALU
375 1311 Fenofibrate Tablets 145 mg 10's Round ALU- Silver
biconvex ALU
376 1315 Fluticasone Furoate Nasal Spray 27.5 120 MDI Standard Standard White
mcg Market
377 1328 Isoxsuprine Injection IP 5 mg 2ml Vial Glass vial Mono- Transparent
carton
378 1341 Mebendazole Tablets 100 mg 6's Round Blister Transparent
biconvex
379 1342 Mebeverine Hydrochloride Tablets 10's Round ALU- Silver
200mg biconvex ALU
380 1344 Meropenem and Sulbactam Injection Vial with Glass vial Mono- Transparent
1.5g (1000mg+500mg) WFI carton
381 1345 Meropenem Injection 500 mg Vial with Glass vial Mono- Transparent
WFI carton
382 1353 Mirtazepine Tablets 7.5 mg 10's Round ALU- Silver
biconvex ALU
383 1359 Naproxen Tablets 250 mg 15's Oval /Round ALU- Silver
ALU
384 1367 Olmisartan, Amlodipine and 10's Round ALU- Silver
Hydroclorthiazide Tablets biconvex ALU
(20mg+5mg+12.5mg)
385 1375 Phenobarbitone Tablets 60 mg 30's Round Blister Transparent
biconvex
386 1382 Prasugrel Tablets 10 mg 10's Round ALU- Silver
biconvex ALU
387 1383 Pregabalin and Nortriptyline Tablets 10's Round Blister Orange
(75mg+10 mg) biconvex
388 1384 Quetiapine Tablets 25 mg 10's Round ALU- Silver
biconvex ALU
389 1392 Rosuvastatin and Aspirin Capsules 10's Standard size Strip Silver
(10mg + 75mg)
390 1396 Sertaconazole Cream 2%w/w 15g Lami tubes Standard Milky white
391 1408 Tamsulosin and Finasteride Tablets 15's Round ALU- Silver
(0.4mg+5mg) biconvex ALU
392 1409 Teicoplanin Injection 400 mg 1ml Vial Glass vial Mono- Transparent
carton
393 1410 Telmisartan, Amlodipine and 10's Round Strip Silver
Hydroclorthiazide Tablets biconvex
(40mg+5mg+12.5mg)
394 1411 Telmisartan and Chlorthalidone 10's Round strip Silver
395 1414 Terlipressin Injection 1000 mcg (1 10ml Vial Glass vial Mono- Transparent
mg)/10ml carton
396 1431 Valethamate Injection 8 mg/ml (For 1ml Glass vial Mono- Transparent
IM/IV use) Ampoule carton
397 1432 Tobramycin Eye Drops 0.3% 5ml Vial FFS Plastic Standard Milky white
bottle
398 1448 Lamotrigine Dispersible Tablets IP 10's Oval /Round Blister Silver
100mg
399 1449 Enzyme syrup mixed fruit flavour 200 ml Plastic bottle Round Amber
neck
400 1450 Pyrantel Pamoate oral Suspension IP 10ml Plastic bottle Round Amber
250mg/5ml
401 1451 Theophylline Controlled release 10's Oval Blister Transparent
tablets 400 mg
402 1452 Pyridoxine Hydrochloride Sustained 10's Round Blister Dark Amber
release tablets 100mg biconvex
403 1453 Levetiracetam Syrup 100 mg 100ml Plastic bottle Round Amber
404 1454 Terbutaline Sulphate and Bromhexine 100ml Plastic bottle Round Amber
Hydrochloride Syrup
405 1455 L-Arginine Granules 3g 5g sachet Standard Sachet BPPI artwork
406 1456 Itraconazole Capsules 200 mg 4's Round Alu-Alu Silver
407 1458 Sodium Chloride Injection IP 500ml IV FFS Plastic Standard milky White
0.9%w/v fluid bottle type
plastic
container
408 1461 Vildagliptin Tablets 50mg 15's Round ALU- Silver
ALU
409 1462 Vildagliptin and Metformin Tablets 15's Oval ALU- Silver
(50mg+500mg) ALU
410 1463 Vildagliptin and Metformin Tablets 15's Oval ALU- Silver
(50mg+1000mg) ALU
411 1473 Hand Sanitizer 100 ml Each pack 1’s with Plastic bottle Round Transparent
contains: 70% v/v Ethanol and 0.5% Flip top
w/v Chlorhexidine Gluconate cap
contains: 70% v/v Ethanol and 0.5% Dispenser
w/v Chlorhexidine Gluconate Pump cap
contains: 70% v/v Ethanol and 0.5% Dispenser
w/v Chlorhexidine Gluconate Pump cap
414 1479 Canagliflozin Tablets 100 mg 10's Round Blister Transparent
415 1480 Glimepiride 0.5 mg and Metformin 10's OVAL ALU- SILVER
SR 500 mg ALU
416 1481 Glimepiride 1 mg and Metformin PR 10's OVAL ALU- SILVER
1000 mg Tablet ALU
1000 mg Tablet ALU
1000 mg Tablet ALU
419 1484 Lactitol Syrup 10gm/15ml 200ml Plastic bottle Bottle Amber
420 1485 Mesalazine PR Tablet IP 1200mg 10's OVAL ALU- SILVER
ALU
421 1486 Propranolol ER 40 mg Capsule 10's Round Blister Transparent
422 1487 Selenium Sulphide Shampoo 2.5% 120ml Cylindrical Plastic Blue
w/v with flip lid Bottle
423 1488 Acarbose Tablets IP 25 mg 10's Round Blister Transparent
424 1489 Acebrophylline 100mg and 10's OVAL ALU- SILVER
Acetylcysteine 600mg Tablets ALU
425 1490 Acebrophylline Sustained Release 10's OVAL ALU- SILVER
Tablets 200 mg ALU
426 1491 Aceclofenac and Paracetamol Tablets 10's OVAL ALU- SILVER
(100mg / 325mg) ALU
427 1492 Aceclofenac Sustained release and 10's Standard Size Blister SILVER
Enteric coated Rabeprazole Sodium
Capsules (200mg / 20mg)
428 1493 Aceclofenac, Paracetamol & 10's OVAL ALU- SILVER
Thiocolchicoside Tablets ALU
(4/100/500mg)
429 1494 Aceclofenac, Paracetamol and 10's OVAL ALU- SILVER
Rabeprazole Tablets (100mg / 325mg ALU
/ 10mg)
430 1495 Aceclofenac, Paracetamol and 10's OVAL ALU- SILVER
Tizanidine Tablets (100mg / 325mg / ALU
10mg)
431 1496 Aciclovir Dispersible Tablets IP 400 5's OVAL ALU- SILVER
mg ALU
432 1497 Acitretin Capsules IP 25 mg 10's Standard Size Blister SILVER
433 1498 Acotiamide Tablets 100mg 10's ROUND Blister Transparent
434 1499 Adalimumab 40mg/0.8 ml 0.8ml Standard Size stanadard standard
(For subcutaneous use only) prefilled pack
syringe
435 1500 Aflibercept Injection (2mg/0.05ml) 1ml Standard Size Mono- standard
Ampoule carton
436 1501 Amantadine Hydrochloride Capsules 15's Standard Size Blister SILVER
IP 100 mg
437 1502 Amiodarone Tablets IP 100 mg 10's ROUND Blister Transparent
438 1503 Amlodipine Besilate and Bisoprolol 10's ROUND Blister Transparent
Fumarate Tablets (5mg / 5mg)
439 1504 Amorolfine Cream 0.25% w/w 30g Tube Lami tubes Mono- Milky White
carton
440 1505 Amoxycillin and Potassium 30ml Bottle Bottle Transparent
Clavulanate Oral Suspension IP Bottle
(400mg / 57mg)
441 1506 Amoxycillin and Potassium 10ml Bottle Bottle transparent
Clavulanate Oral Suspension IP
(80mg / 11.4mg)
442 1507 Amoxycillin, Dicloxacillin with 10's Standard Size Blister SILVER
Lactic Acid Bacillus Capsules
(250mg/ 250mg/ 2.5 billion)
443 1508 Ampicillin and Cloxacillin Capsules 10's Standard Size Blister SILVER
(250mg / 250mg)
444 1509 Ampicillin and Di-Cloxacillin 10's Standard Size Blister SILVER
445 1510 Anti-D (Rho) Immunoglobulin 1ml Vial Standard Size stanadard standard
(Monoclonal) 300 mcg pack
446 1511 Antioxidant Capsules 30's Standard Size Blister SILVER
447 1512 Apremilast Tablets 10mg 10's ROUND Blister Transparent
448 1513 Apremilast Tablets 20mg 10's ROUND Blister Transparent
449 1514 Apremilast Tablets 30 mg 10's ROUND Blister Transparent
450 1515 Atorvastatin and Aspirin Capsules 15's Standard Size Blister SILVER
(10mg / 150mg)
451 1516 Atorvastatin and Clopidogrel 10's Standard Size Blister SILVER
452 1517 Atorvastatin, Clopidogrel and Aspirin 10's Standard Size Blister SILVER
Capsules (20mg / 75mg / 75mg)
453 1518 AZILSARTAN & 10's ROUND Blister Transparent
+CHLORTHALIDONE Tablet
40/6.25MG
454 1519 Azilsartan Medoxomil 40 mg and 10's ROUND Blister Transparent
Chlorthlidone12.5 mg Tablets
455 1520 Azilsartan Medoxomil Tablets 40mg 10's ROUND Blister Transparent
456 1521 Azithromycin Oral Suspension IP 200 15ml Bottle Bottle Amber
mg
457 1522 Beclomethasone and Clotrimazole 20g Tube Lami tubes Mono- Milky White
Cream (0.025%w/w / 1% w/w) carton
458 1523 Beclomethasone and Clotrimazole 30ml Standard Size Mono- Milky White
Lotion (0.025%w/v / 1% w/v) carton
459 1524 Bepotastine Besilate Tablets 10mg 10's ROUND Blister Transparent
460 1525 Betahistine Tablets IP 16 mg 15's ROUND Blister Transparent
461 1526 Betahistine Tablets IP 24 mg 15's ROUND Blister Transparent
462 1527 Betamethasone Valerate, Gentamicin 20g Tube Lami tubes Mono- Milky White
and Miconazole Nitrate Cream carton
(0.12%w/w / 0.1%w/w / 2%w/w)
463 1528 Bilastine Tablet 20mg 10's ROUND Blister Transparent
464 1529 Bimatoprost Ophthalmic Solution 3ml Standard Size Plastic white
0.01% w/v Bottle
465 1530 Bimatoprost Ophthalmic Solution 3ml Standard Size Plastic white
0.03% w/v Bottle
466 1531 Bisoprolol Fumarate Tablets 2.5 mg 10's ROUND Blister Transparent
467 1532 Botulinum Toxin Type A 100 IU Vial Standard Size stanadard standard
pack
468 1533 Brimonidine Tartrate and Timolol 5ml Standard Size Plastic white
maleate ophthalmic Solution Bottle
(0.2/0.5% W/V)
469 1534 Brimonidine Tartrate Eye drops IP 5ml Standard Size Plastic white
0.1% w/v Drops Bottle
470 1535 Budesonide Respules 0.5 mg 2ml Standard Size stanadard standard
pack
471 1536 Calcitriol and Calcium Capsules (0.25 15's Standard Size Blister SILVER
mcg/ 200mg)
472 1537 Calcium and Vitamin D3 Capsules 10's Standard Size Blister SILVER
473 1538 Calcium citrate Malate, Calcitriol and 10's OVAL Blister Transparent
Vitamin K2-7 Tablets
(250mg/0.25mcg/50mcg)
474 1539 Calcium Gluconate and calcium 10ml Standard Size Mono- standard
Lactobionate Injection 50mg/87.5mg carton
475 1540 Calcium(from Coral Grains) and 10's OVAL Blister Transparent
Vitamin D-3 Tablets (500mg/ 500IU)
476 1541 Calcium, Calcitriol and Vitamin K2-7 10's Standard Size Blister SILVER
Capsules (1250mg/ 0.25mcg/ 45mcg)
477 1542 Calcium, Magnesium, zinc and 200ml Bottle Bottle transparent
Vitamin D-3 Oral Suspension
478 1543 Camylofin Dihydrochloride and 15's OVAL Blister Transparent
Paracetamol Tablets (25mg / 300 mg)
479 1544 Capsules of Coenzyme Q10 with 10's Standard Size Blister SILVER
Lycopene, Selenium and Omega-3
Fatty Acids
480 1545 Carboxymethlycellulose Eye drops 10ml Standard Size stanadard Sea Green
1% w/v pack
481 1546 Cefixime and Azithromycin Tablets 10's OVAL ALU- SILVER
(200mg / 250mg) ALU
482 1547 Cefixime and Ornidazole Tablets 10's OVAL ALU- SILVER
(200mg / 500mg) ALU
483 1548 Cefixime Oral Suspension IP 100 mg/ 30ml Bottle Bottle Transparent
5ml
ml
5ml
486 1551 Cefoperazone and Sulbactum Vial with Standard Size Mono- standard
Injection (1000mg / 500mg) WFI carton
487 1552 Cefoperazone and Sulbactum Vial with Standard Size Mono- standard
Injection (2000mg / 1000mg) WFI carton
488 1553 Cefpodoxime Oral Suspension IP 30ml Bottle Bottle Transparent
100mg
489 1554 Ceftriaxone and Tazobactum Vial with Standard Size Mono- standard
Injection (250mg / 31.25mg) WFI carton
490 1555 Ceftriaxone Injection IP 2 g Vial with Glass vial Mono- Transparent
WFI carton
491 1556 Cephalexin Extended Release Tablets 10's Glass vial Mono- Transparent
750mg carton
492 1557 Cerebroprotein Hydrolysate Injection Vial with Standard Size Mono- standard
30mg WFI carton
493 1558 Cerebroprotein Hydrolysate Injection Vial with Standard Size Mono- standard
60mg WFI carton
494 1559 Chloramphenicol Capsules IP 250 mg 10's Standard Size Blister SILVER
495 1560 Chloramphenicol Capsules IP 500 mg 10's Standard Size Blister SILVER
496 1561 Chloramphenicol, Beclomethasone 5ml Standard Size STANDA WHITE
Dipropionate, Clotrimazole and Drops RD PACK
Lidocaine Ear Drops
497 1562 Chlordiazepoxide and Amitriptyline 10's ROUND Blister Transparent
Hydrochloride Tablets (5mg /
12.5mg)
498 1563 Chlorhexidine Gluconate 100ml Cylindrical Plastic Transparent
Solution IP 2.5% v/v Hand rub with flip lid Bottle
499 1564 Cholecalciferol ChewableTablets 4'S Standard Size STANDA STANDARD
(60000 IU) RD PACK
500 1565 Cilnidipine Tablets IP 10 mg 10's ROUND Blister Transparent
501 1566 Cilnidipine Tablets IP 5 mg 10's ROUND Blister Transparent
502 1567 Cinitapride and Pantoprazole 10's Standard Size Blister SILVER
503 1568 Cinnarizine Tablets IP 75mg 20's ROUND Blister Transparent
504 1569 Ciprofloxacin and Dexamethasone 10ml Standard Size STANDA white
Eye/Ear Drops (0.3% w/v / 0.01% RD
w/v)
505 1570 Citicoline and Piracetam Tablets 10's OVAL ALU- SILVER
(500mg /800mg) ALU
506 1571 Clidinium Bromide, 10's OVAL ROUND Transparent
Chlordiazepoxide and Dicyclomine
Hydrochloride Tablets (2.5mg / 5mg /
10mg)
507 1572 Clindamycin and Nicotinamide Gel 15g Lami tubes Mono- Milky White
(1%w/w / 4%w/w) carton
508 1573 Clindamycin Injcetion IP 600 mg 4ml Standard Size STANDA standard
Ampoule RD
PACJK
509 1574 Clobazam Tablets IP 10 mg 15's ROUND Blister Transparent
510 1575 Clobetasol Propionate and 25g Tube Lami tubes Mono- Milky White
Gentamicin Cream (0.05%w/w / carton
0.1%w/w)
511 1576 Clobetasol Propionate and 15g Lami tubes Mono- Milky White
Miconazole Nitrate Cream carton
(0.05%w/w / 2%w/w)
512 1577 Clobetasol Propionate and Neomycin 10g Lami tubes Mono- Milky White
Sulphate Cream (0.05%w/w carton
/0.5%w/w)
513 1578 Clobetasol Propionate and Salicylic 20g Tube Lami tubes Mono- Milky White
Acid Ointment (0.05%w/w / 3%w/w) carton
514 1579 Clobetasol Propionate and Salicylic 20g Tube Lami tubes Mono- Milky White
Acid Ointment (0.05%w/w / 6%w/w) carton
515 1580 Clobetasol Propionate, Gentamicin 15g Lami tubes Mono- Milky White
and Miconazole Nitrate Cream carton
(0.05%w/w / 2%w/w / 0.1%w/w)
516 1581 Clopidogrel and Aspirin Capsules 15's Standard Size Blister SILVER
(150mg / 75mg)
517 1582 Clotrimazole and Selenium Sulfate 75ml Bottle Plastic WHITE
Suspension (1% / 2.5%) Bottle
518 1583 Clotrimazole Mouth Paint (1% w/v) 25ml GLASS Bottle Bottle Amber
519 1584 Coenzyme Q10 (Ubidocarenone) and 10's OVAL ALU- SILVER
L-Carnitine Tablets ALU
520 1585 Colistin (Colistimethate Sodium) 10ml Vial Standard Size Mono- standard
Injection IP 1 Million IU carton
521 1586 Colistin (Colistimethate Sodium) 10ml Vial Standard Size Mono- standard
Injection IP 4.5 Million IU carton
522 1587 Colistin Sulphate Oral Suspension IP 30ml Bottle Bottle Amber
12.5 mg/5ml
523 1588 Collagen Peptide Type I, Sodium 15's OVAL ALU- SILVER
Hyaluronate, Chondroitin Sulfate and ALU
Vitamin C Tablets
524 1589 Combipack of Clarithromycin 6's Standard Size Blister SILVER
Tablets, Pantoprazole Tablets and
Amoxycillin Tablets (500mg / 40mg /
750mg)
525 1590 Dabigatran Etexilate Mesilate 10's Standard Size Blister SILVER
Capsules 110 mg
526 1591 Dabigatran Etexilate Mesilate 10's Standard Size Blister SILVER
Capsules 150 mg
527 1592 Dapagliflozin Tablets 10 mg 14's ROUND Blister Transparent
528 1593 Desloratidine and Montelukast 10's ROUND Blister Transparent
Tablets (5mg / 10mg)
529 1594 Diclofenac Diethylamine, 30g Tube Lami tubes Mono- Milky White
Thiocholchicoside, Linseed Oil, carton
Methylsalicylate and Menthol Gel
530 1595 Diclofenac Injection IP 75 mg 1ml Standard Size Mono- Transparent
Ampoule carton
531 1596 Diclofenac Potassium and metaxalone 10's OVAL ALU- SILVER
Tablets 50/400mg ALU
532 1597 Diclofenac Prolonged release Tablets 10's ROUND Blister Transparent
IP 75 mg
533 1598 Digestive Enzyme Tablets (Pancreatin 15's ROUND Blister Transparent
and Sodium Tauroglycocholate)
534 1599 Diltiazem Hydrochloride Extended 10's Standard Size Blister SILVER
Release Capsules 120 mg
535 1600 Diosmin Tablets (Micronised) 10's ROUND Blister Transparent
536 1601 Diphenoxylate HCL & Atropine 90's in Standard Size Blister SILVER
sulphate Tablet 2.5/0.025mg Bottle
537 1602 Divalproex Tablets IP 500 mg 10's ROUND Blister Transparent
538 1603 Dorzolamide and Timolol Eye Drops 5ml Standard Size Standard white
IP (2% w/v / 0.5% w/v) Drops pack
539 1604 Dorzolamide Eye Drops IP 2% w/v 5ml Standard Size standrad white
Drops pack
540 1605 Dosulepin (or Dothiepin) Tablets 25 15's ROUND Blister Transparent
mg
541 1606 Dosulepin (or Dothiepin) Tablets 75 15's ROUND Blister Transparent
mg
542 1607 Drotaverine Hydrochloride Tablets IP 15's ROUND Blister Transparent
80 mg
543 1608 Efavirenz, Emtricitabine and 30's OVAL standrad standard
Tenofovir Disoproxil Fumarate pack
Tablets IP (600mg / 200mg / 300mg)
544 1609 Empagliflozin Tablets 100 mg 10's ROUND Blister Transparent
545 1610 Empagliflozin Tablets 25 mg 10's ROUND Blister Transparent
546 1611 Emtricitabine and Tenofovir 30's OVAL standrad STANDARD
Disoproxil Fumarate Tablets IP pack
(200mg / 300mg)
547 1612 Entecavir Tablets IP 0.5 mg 10's ROUND Blister Transparent
548 1613 Eplerenone Tablets 25 mg 10's ROUND Blister Transparent
549 1614 Ergotamine, caffeine, Paracetamol 14's OVAL ALU- SILVER
and Prochlorperazine Tablets ALU
(1mg/100mg/250mg/2.5mg)
550 1615 Erythromycin Estolate Tablets 500 10's ROUND Blister Transparent
mg
551 1616 Etofylline (SR), Theophylline (SR), 10's OVAL ALU- SILVER
Montelukast Tablets (231/69/10mg) ALU
552 1617 Etoricoxib and Paracetamol Tablets 10's OVAL ALU- SILVER
(60mg / 325 mg) ALU
553 1618 Etoricoxib and Thiocolchicoside 10's ROUND Blister TRANSPARE
Tablets (60mg / 4 mg) NT
554 1619 Eucalyptol 0.092%,Menthol 200ml Bottle Plastic Amber
0.042%,Methyl salicylate 0.060% and Bottle
Thymol 0.064% Mouth wash
555 1622 Ferrous Ascorbate, Folic Acid & 10's OVAL ALU- SILVER
Zinc Sulphate Tablets ALU
556 1623 Fexofenadine Hydrochloride 100ml Bottle Bottle Transparent
Suspension (30mg/5ml)
557 1624 Flupentixol and Melitracen Tablets 10's ROUND Blister Transparent
(0.5mg/ 10mg)
558 1625 Fluticasone Propionate Cream IP 10g Lami tubes Mono- Milky White
0.05% carton
559 1626 Formoterol Fumarate and Budesonide 120 MD Lami tubes Mono- Milky White
Inhaler (6mcg/200mcg) carton
560 1627 Formoterol Fumarate and Budesonide 120 MD Standard Size standard standard
Inhaler (6mcg/400mcg) pack
561 1628 Formoterol Fumarate and Budesonide 30's Standard Size standard standard
Powder for Inhalation IP pack
(12mcg/400mcg)
562 1630 Formoterol Fumarate and Budesonide 30's Standard Size standard standard
Powder for Inhalation IP pack
(6mcg/400mcg)
563 1631 Formoterol Fumarate and Budesonide 2ml Standard Size standard standard
Respirator Suspension (20mcg/ pack
0.5mg)
564 1632 Formoterol Fumarate and Budesonide 2ml Standard Size standard standard
Respirator Suspension (20mcg/ 1mg) pack
565 1633 Formoterol Fumarate and Fluticasone 30's Standard Size standard SILVER
Propionate Powder for Inhalation
(6mcg/250mcg)
566 1635 Framycetin Skin Cream 1 % 30 g Tube Lami tubes Mono- Milky White
carton
567 1636 Fungal Diastase with Carminatives 200ml Plastic bottle Bottle Amber
Syrup
568 1637 Fungal Diastase, Papain and 15's OVAL ALU- SILVER
Activated Charcoal Tablets ALU
569 1638 Fusidic Acid and Betamethasone 15g Lami tubes Mono- Milky White
Valerate Cream (20% w/w / 0.1% carton
w/w)
570 1639 Gabapentin 100 mg and Nortryptyline 15's ROUND Blister Transparent
10 mg Tablet
571 1640 Gabapentin 300 mg and 10's OVAL ALU- SILVER
Methylcobalamin 500 mg Tablet ALU
572 1641 Gabapentin 300 mg Capsule 15's OVAL ALU- SILVER
ALU
573 1642 Gabapentin 400 mg and Nortryptyline 10's OVAL ALU- SILVER
10 mg Tablet ALU
574 1643 Glargine 100 IU Solution 3ml Standard Size standard standard
cartridge pack
575 1644 Glibenclamide 5 mg, Metformin 500 10's OVAL ALU- SILVER
mg and Pioglitazone 15 mg Tablet ALU
576 1645 Gliclazide 60mg and Metformin ER 10's OVAL ALU- SILVER
500 mg ALU
577 1646 GLIMEPIRIDE + METFORMIN + 10's OVAL ALU- SILVER
PIOGLITAZONE 2/500/15 mg tablet ALU
SR
578 1647 GLIMEPIRIDE + METFORMIN 10's OVAL ALU- SILVER
3/850 mg tablet SR ALU
579 1648 Glimpride 1mg tablet 15's ROUND Blister Transparent
580 1649 Glucosamine + Diacerein + Methyl 10's OVAL ALU- SILVER
Sulfonyl Methane(MSM) 750/50/250 ALU
tablet
581 1650 Glucosamine 750 mg + Chondroitin 10's OVAL ALU- SILVER
100 mg Tablet ALU
582 1651 Glucosamine Sulfate, Chondroitin 10's OVAL ALU- SILVER
Sulfat, Methyl Sulfonyl ALU
Methane(MSM),Vitamin &Minerals
Tablets
583 1654 Guaifenesin 100 100ml Plastic bottle Bottle Amber
mg,Dextromethorphan 10 mg and
Phenylephrine 25 mg Syrup
584 1655 Guaifenesin 100 mg, 100ml Plastic bottle Bottle Amber
Dextromethorphan 5 mg,
Phenylephrine 1 mg and
Chlorpheniramin 4 mg Syrup
585 1656 Guaifenesin 50mg,Terbutaline 1.25 100ml Plastic bottle Bottle Amber
mg and Ambroxol 15 mg Syrup
586 1657 Guaifenesin 50mg,Terbutaline 1.25 100ml Bottle Bottle Amber
mg and Bromhexine 2 mg
Expectorant
587 1658 Guaifenesin 50mg,Terbutaline 1.5 mg 100ml Plastic bottle Round Amber
and Ambroxol 15 mg Syrup neck
588 1659 Human Normal Immunoglobulin 100ml Standard Size standard standard
5% Solution I.V use only pack
589 1660 Human Normal Immunoglobulin for 2ml vial Standard Size standard standard
I.M administration. pack
1 ml solution contains:
16.5% Human Normal
Immunoglobulin
590 1661 Hydroxypropylmethylcellulose (0.3% 10ml FFS Plastic Standard milky White
w/v) Eye Drop bottle type
591 1662 Hydroxyzine 25mg Tablets 15's ROUND Blister Transparent
592 1663 Hyoscine Butylbromide & 10's OVAL Blister Transparent
Mefenamic acid Tablets IP
(10mg/250mg)
593 1664 Ibuprofen (100mg) and 100ml Bottle Bottle tranparent
Paracetamol/Acetaminophen
(162.5mg) oral suspension
594 1665 Indacaterol and Glycopyrronium 30 Standard Size standard standard
Inhalation powder,hard capsules capsules pack
50/110 mcg and 1
inhaler
595 1668 Iron, Folic Acid and Vitamin B12 10's Standard Size Blister SILVER
Capsules
596 1669 Isosobide 20mg and Hydralazine 37.5 10's ROUND Blister Transparent
mg Tablet
597 1670 Isotretinoin 20 mg Capsule 10's Standard Size Blister SILVER
598 1671 Ivabradine 5mg Tablet 15's ROUND Blister Transparent
599 1672 Ketoconazole 2 % Soap 75g Pack Standard Size standard standard
pack
600 1673 L- Methyle folate, Methylcobalamin 10's ROUND Blister Transparent
& vitamin B6 Tablets (2.8/2/25mg)
601 1674 L- Methyle folate, Pyridoxal -5 10's OVAL ALU- SILVER
Phosphate & Methylcobalamin ALU
Tablets (1mg/0.5mg/1500mcg)
602 1675 L- Ornithine L-Aspartate Infusion 10ml Standard Size STANDA standard
(5gm) RD PACK
603 1676 Lactitol 10 gm and Ispaghula 3.5 gm 180g Standard Size standard standard
Granules pack
604 1678 L-carnitine, Ubidecarenone, 10's OVAL ALU- SILVER
Lycopene and Astaxanthin Tablets ALU
605 1679 Lecithin 1000 mg capsule 10's Standard Size Blister SILVER
606 1680 Levetiracetam tablet 1000 mg 10's OVAL ALU- SILVER
ALU
607 1681 Levetiracetam tablet 250 mg 10's ROUND Blister Transparent
608 1682 Levetiracetam tablet 750 mg 10's OVAL ALU- SILVER
ALU
609 1683 Levocetrizine Dihydrochloride 15's OVAL Blister Transparent
Tablets IP 10MG
610 1684 Levodopa 100 mg and 10's ROUND Blister Transparent
Carbidopa 25 mg Tablets
611 1685 Levodropropizine and 120ml Plastic bottle Round Amber
Chlorpheniramine Maleate Syrup neck
(30mg / 2mg)
612 1686 Levosalbutamol & Beclomethasone 30's Standard Size standard standard
Rotacaps 100/100mcg pack
613 1687 Levosalbutamol & Beclomethasone 200 MDI Standard Size standard standard
614 1688 Levosalbutamol & Beclomethasone 30's Standard Size Standard standard
615 1689 Levosalbutamol and Budesonide 2.5ml Standard Size standrad standard
respules 1.25/0.5mg Respules pack
616 1690 Levosalbutamol and Ipratropium 30's Standard Size Standard standard
Rotacap 100/40mcg pack
617 1691 Levosalbutamol Inhaler 50mcg 200 MDI Standard Size standard standard
pack
618 1692 Levosalbutamol respules 2.5ml Standard Size standard standard
0.63mg/2.5ml Respules pack
619 1693 Levosulpiride SR 75 mg and 10's OVAL ALU- SILVER
Rabeparazole EC 20 mg Capsule ALU
620 1694 Linagliptin and metformin 10's OVAL ALU- SILVER
2.5/1000mg Tablets ALU
621 1695 Linagliptin and metformin 2.5/500mg 10's OVAL ALU- SILVER
Tablets ALU
622 1696 Linagliptin Tablets 5mg 10's ROUND Blister Transparent
623 1697 Linomycin Injection 300mg/2ml 2ml Standard Size Mono- standard
carton
624 1698 Liquid paraffin and milk of magnesia 200ml Bottle Bottle tarnsparent
Emulsion 3.75/11.25mg
625 1700 Measles Vaccine (Live), Mumps 0.5ml vial Standard Size standard standard
Virus Vaccine and Rubella Vaccine pack
(live) (1000ccid50 / 5000ccid50 /
1000ccid50)
626 1701 Megaldrate, Simethicone & 170ml Bottle Bottle transparent
Oxetacaine oral suspension
(540/50/10mg)
627 1702 Meropenum Injection 500mg Vial with Standard Size Mono- standard
WFI carton
628 1703 Metadoxine, Silymarin, L- Ornithin 10's OVAL ALU- SILVER
L- Aspartate tablets (500/140/150mg) ALU
629 1704 Methylcobalamin with Alpha Lipoic 10's Standard Size Blister SILVER
Acid & B- Complex Capsules
630 1705 Metoprolol Extended Release 25 mg 10's ROUND Blister Transparent
and Ramipril 2.5 mg Tablet
631 1706 Metoprolol Extended Release 50 mg 10's ROUND Blister Transparent
and Ramipril 5 mg Tablet
632 1707 Metoprolol Succinate extended 15's Standard Size Blister SILVER
release capsules IP 50mg
633 1708 Metoprolol Succinate Prolonged 15's ROUND Blister SILVER
release tablets IP 25mg
634 1709 Minoxidil 5% solution 60ml Standard Size standard standard
Bottle pack
635 1710 Minoxidil 5% and Finasteride 0.1% 60ml Standard Size standard standard
Bottle pack
636 1711 Montelukast and Levocetirizine syrup 60ml Plastic bottle Round Amber
4/2.5mg Bottle neck
637 1712 Mosquito Repellent Cream 50g Tube Lami tubes Mono- Milky White
carton
638 1713 Moxonidine tablets 0.3mg 10's ROUND Blister Transparent
639 1714 Naproxen 250 mg and Domperidone 10's ROUND Blister Transparent
10 mg Tablet
640 1715 Naproxen 500 mg and Domperidone 10's OVAL ALU- SILVER
10 mg Tablet ALU
641 1716 Nebivolol 5 mg and S- Amlodipine 10's ROUND Blister Transparent
2.5 mg Tablet
642 1717 Neomycin and Polymyxin B Sulfates 5g Tube Standard Size standard standard
and Bacitracin Zinc Opthalmic pack
Ointment
643 1718 Nicorandil Tablet IP 10mg 10's ROUND Blister Transparent
644 1719 Nicorandil Tablet IP 5mg 10's ROUND Blister Transparent
645 1720 Nicoumalone Tablets IP 1 mg 30's ROUND Blister Transparent
648 1723 Nifedipine tablet 10 mg 15's ROUND Blister Transparent
649 1724 Nimesulide 100 mg and Paracetamol 15's OVAL Blister tarnsparent
500 mg Tablet
650 1725 Nimesulide 100 mg,Paracetamol 325 10's OVAL Blister TRANSPARE
mg and Serratiopeptidase 15 mg NT
Tablet
651 1727 Ofloxacin 50 mg and Ornidazole 125 30ml Bottle Bottle tarnsparent
mg Suspension
652 1728 Ofloxacin, Ornidazole, Terbinafine 15g tube Lami tubes Mono- Milky White
hydrochloride and clobetasol carton
Propionate Cream (0.75/2/1/0.05%)
653 1729 Ofloxaxin 200mg and Flavoxate 200 10's OVAL Blister Transparent
mg Tablet
654 1730 Olmesartan 40 mg ,Amlodipine 5 mg 10's ROUND Blister Transparent
and Hydroclorthiazide 12.5 mg Tablet
655 1731 Olmesartan Medoxomil and 10's ROUND Blister Transparent
Chlorthalidone Tablets (20mg /
12.5mg)
656 1732 Olmesartan Medoxomil and 10's ROUND Blister Transparent
12.5mg)
657 1733 Omeprazole and Domperidone 15's Standard Size Blister SILVER
Sustained Release Capsules (20mg /
30mg)
658 1734 Ondansetron tablets IP 4mg 10's ROUND Blister Transparent
659 1735 Orciprenaline Tablet 10 mg 10's ROUND Blister Transparent
660 1736 Oseltamivir Phosphate Capsule 75 mg 10's Standard Size Blister SILVER
661 1737 Oxaceprol Capsules 200mg 10's Standard Size Blister SILVER
662 1738 Pancreatin 100 mg + Ornithine 150 10's OVAL Blister Transparent
mg Tablet
663 1739 Pancreatin 10000 mg Capsule 10's OVAL ALU- SILVER
ALU
664 1740 Pancreatin 25000 mg Capsule 10's OVAL ALU- SILVER
ALU
665 1741 Pantoprazole and Domperidone 10's Standard Size Blister SILVER
666 1742 Paracetamol Infusion IP 1.0% W/V 100ml Standard Size standard standard
pack
667 1743 Paracetamol 100 mg/ml Drops 15ml Standard Size standard standard
pack
668 1744 Paracetamol 125 mg,Phenylephrine 15ml Standard Size standard standard
2.5 mg and Chlorpheniramine 1 mg pack
Drops
669 1745 Paracetamol 125 mg,Phenylephrine 5 60ml Bottle Bottle Amber
mg and Chlorpheniramine 1 mg Bottle
Suspension
670 1746 Paracetamol 125 mg,Phenylephrine 5 60ml Plastic bottle Round Amber
mg and Chlorpheniramine 1 mg Bottle neck
Syrup
671 1747 Paracetamol 162.5 mg and Tramadol 15's ROUND Blister Transparent
18.75 mg Tablet
672 1748 Paracetamol 250 mg, Caffeine 50 mg 10's OVAL OVAL tarnsparent
and Phenazone 150 mg Tablet
673 1749 Paracetamol 250 mg,Phenylephrine 5 60ml Bottle Bottle Amber
mg and Chlorpheniramine 2 mg Bottle
Suspension
674 1750 Paracetamol 325 mg and Tramadol 10's ROUND Blister Transparent
37.5 mg Capsule
675 1751 Paracetamol 500 mg and Caffeine 25 15's OVAL Blister transparent
mg Tablet
676 1752 Paracetamol 500 mg and 10's OVAL Blister transparent
Chlorzoxazone 250 mg Tablet
677 1753 Paracetamol 500 mg,Phenylephrine 10's OVAL Blister Transparent
10 mg and Chlorpheniramine 2 mg
Tablet
678 1755 Paracetamol IP 120 mg /5ml 60ml Bottle Bottle Amber
Suspension Bottle
679 1756 Paracetamol Oral suspension 60ml Bottle Bottle Amber
250mg/5ml Bottle
680 1757 Paradichlorobenzene, Benzocaine, 10ml Standard Size standard standard
Chlorbutol and Turpentine Oil Ear pack
Drops
681 1758 Phenylephrine 5 100ml Plastic bottle Round Amber
mg,Chlorpheniramine 2 mg and neck
Dextromethorphan 10 mg Syrup
682 1759 Phenylephrine 5 100ml Plastic bottle Round Amber
mg,Chlorpheniramine 2 mg and neck
Dextromethorphan 15 mg Syrup
683 1760 Piracetam Tablet 800mg 10's OVAL Blister Transparent
684 1761 Pirfenidone Tablet 200mg 10's OVAL Blister Transparent
685 1762 Polystyrene Sulfonate Powder 15g Standard Size standard standard
pack
686 1763 Prazosin XL 5 mg Tablet 30's OVAL Blister Transparent
687 1764 Pregabalin 75 mg and 10's OVAL ALU- SILVER
Methylcobalamin 1500 mcg and ALU
Nortryptiline 10 mg Tablets
688 1765 Pregabalin 75 mg and 10's OVAL ALU- SILVER
Methylcobalamin 750 mcg Capsule ALU
689 1767 Probiotic Microbes 5 mg Capsule 10's Standard Size Blister SILVER
690 1768 Promethazine 1.5 mg and Pholcodine 60ml Plastic bottle Round Amber
1.5 mg Syrup Bottle neck
691 1769 Prucalopride 2 mg Tablet 10's ROUND Blister Transparent
692 1770 Prucalopride Tablets 1mg 10's ROUND Blister Transparent
693 1771 Prucalopride Tablets 2mg 10's ROUND Blister Transparent
694 1772 Prulifloxacin 600 mg Tablet 5's OVAL ALU- SILVER
ALU
695 1773 Quiniodochlor 250 mg Tablet 20's OVAL Blister Transparent
696 1774 Racecadotril 100 mg Capsule 15's Standard Size Blister SILVER
697 1775 Ramipril and Metoprolol Succinate 10's ROUND Blister Transparent
Extend release tablet 2.5/25mg
698 1776 Ramosetron 5 mcg Tablet 10's ROUND Blister Transparent
699 1777 Ranitidine 75 mg Syrup 100ml Plastic bottle Round Amber
neck
700 1778 Ranolazine 500 mg Tablet 10's OVAL ALU- SILVER
ALU
701 1779 Reteplase- Recombinant Tissue Vial with Standard Size standard standard
Plasminogen Activator (18mg) WFI pack
702 1780 Rivaroxaban Tablets 10mg 30's ROUND Blister Transparent
703 1781 Rivaroxaban Tablets 20mg 14's ROUND Blister Transparent
704 1782 Rosehip Extract, DevilsClaw extract 14's Standard Size Blister SILVER
(20%) & Boswella serrata Extract
(65%) (275/100/307.5mg)
705 1783 Rosuvastatin and Fenofibrates Tablets 10's OVAL ALU- SILVER
(20/160mg) ALU
706 1784 Rosuvastatin tablets IP 40mg 10's ROUND Blister Transparent
707 1785 Rosuvastatin, Aspirin and 10's Standard Size Blister SILVER
Clopidogrel Capsules (10mg / 75mg /
75mg)
708 1786 Rosuvastatin, Aspirin and 10's Standard Size Blister SILVER
Clopidogrel Capsules (20mg / 75mg /
75mg)
709 1787 S (-) Amlodipine Tablets IP 5mg 15's ROUND Blister Transparent
710 1788 S (-) Metoprolol Succnate Prolonged - 10's ROUND Blister Transparent
release Tablets 25mg
711 1789 S(-) Amlodipine and Atenolol Tablets 15's OVAL Blister Transparent
(2.5mg/ 50mg)
712 1790 Saccharomyces Boulardii Capsule 5's Standard Size Blister SILVER
250mg
713 1791 Saccharomyces Boulardii powder 1's Sachet Standard Size sachet SILVER
250mg
714 1792 Sacubitril and Valsartan Tablets 14's ROUND Blister Transparent
(24/26mg)
715 1793 Sacubitril and Valsartan Tablets 14's ROUND Blister Transparent
(49/51mg)
716 1794 Salbutamol Rotacaps 200mcg 30's Standard Size Standard standard
pack
717 1795 Salicylic acid, Dithranol & Coal Tar 30g Tube Lami tubes Mono- Milky White
Ointment (1.15%/1.15%/5.3%w/w) carton
718 1796 Salmeterol and Fluticasone 30's Standard Size Standard standard
Propionate Power for inhalation IP pack
(50/100mcg)
719 1797 Saroglitazar Tablets 4mg 10's ROUND Blister Transparent
720 1798 Satranidazole & Ofloxacin 10's OVAL ALU- SILVER
(300/200mg) ALU
721 1800 Silver Nitrate and Chlorhexidine 15g tube Lami tubes Mono- Milky White
Gluconate cream 0.20% w/w carton
722 1805 Sodium Valporate oral solution IP 200ml Standard Size standard standard
200mg/5ml Plastic pack
bottel
723 1806 Sodium Valporate& Valporic Acid 10's OVAL ALU- SILVER
Controlled Release Tablets ALU
(200/87mg)
724 1807 Sodium Valporate& Valporic Acid 10's OVAL ALU- SILVER
Controlled Release Tablets ALU
(333/145mg)
725 1808 Spiramycin Tablets (3.0MIU) 10's ROUND Blister Transparent
726 1809 Sucralfate Suspension 1gm/5ml 200ml Glass bottle Bottle Transparent
Glass
Bottle
727 1810 Tacrolimus Ointment (0.1% w/w) 10g tube Lami tubes Mono- Milky White
carton
728 1811 Telmisartan and Amlodipine Tablets 10's ROUND Blister Transparent
IP (80/5mg)
729 1812 Telmisartan and Cilnidipine Tablets 10's ROUND Blister Transparent
(80mg / 10mg)
730 1813 Telmisartan Tablets IP 80mg 10's ROUND Blister Transparent
731 1814 Telmisartan, Chlorthalidone and 10's ROUND Blister Transparent
Amlodipine Tablets (40mg / 12.5mg/
5mg)
732 1815 Telmisartan, Chlorthalidone and 10's ROUND Blister Transparent
Amlodipine Tablets (40mg / 6.25mg/
5mg)
733 1816 Telmisartan, Cilnidipine and 10's ROUND Blister Transparent
10mg/ 6.25mg)
734 1817 Terbinafine Hydrochloride IP Cream 10g Lami tubes Mono- Milky White
carton
735 1818 Tetrabenazine Tablets 25mg 10's ROUND Blister Transparent
736 1819 Ticagrelor Tablets 90mg 10's ROUND Blister Transparent
737 1820 Timed release Capsules of 25's Standard Size Standard standard
Nitroglycerin 2.5mg Bottle pack
738 1821 Tiotropium Bromide Inhalation IP 200 MDI Standard Size standard standard
(9mcg/dose) pack
739 1822 Tiotropium powder for Inhalation IP 1's Standard Size Standard standard
(18mcg) pack
740 1823 Tirofiban Hydrochloride I.V. 100ml Standard Size Mono- Ide Ii Greel
Injection (5mg/100ml) Vial carton
741 1824 Tolvaptan Tablets 15mg 10's ROUND Blister Transparent
742 1825 Torsemide & Spironolactone Tablets 15's ROUND Blister Transparent
(10/50mg)
743 1826 Torsemide Tablets IP 20mg 15's ROUND Blister Transparent
746 1829 Travoprost Ophthaimic Solution 2.5ml Standard Size standard standard
(2.5ml) pack
747 1830 Trimetazidine Hydrochloride 10's Standard Size Blister SILVER
controlled Release Capsule 60mg
748 1831 Trypsin, Bromelain, Rutoside 10's OVAL ALU- SILVER
Trihydrate and Diclofenac Sodium ALU
Tablets (48mg/90mg/ 100mg/50mg)
749 1832 Undenatured Collagen Type II 10's Standard Size Blister SILVER
Capsules 40 mg
750 1833 Ursodeoxycholic Acid Tablets IP 15's ROUND Blister Transparent
150mg
751 1834 Valacyclovir Tablets 1000mg 3's ROUND Blister Transparent
752 1837 Vildagliptin 50 mg and Metformin 15's OVAL ALU- SILVER
Hydrochloride 850 mgTablets ALU
753 1841 Vitamin D3 Oral Solution (60000 IU) 5ml Standard Size standard standard
pack
754 1842 Vitamine B Complex injection 2ml ampoule standard standard
(IM/IV) Use pack
755 1843 Voglibose, Glimepride and 10's ROUND Blister Transparent
Metformin Hydrochloride Sustained
Release Tablets
(0.2mg/1mg/500mg)
756 1844 Voglibose, Glimepride and 10's OVAL ALU- SILVER
Metformin Hydrochloride Sustained ALU
Release Tablets
(0.2mg/2mg/1000mg)
757 1845 Voglibose, Glimepride and 10's OVAL ALU- SILVER
Metformin Hydrochloride Sustained ALU
Release Tablets (0.3mg/2mg/1000mg)
758 1846 Zoledronic Acid Injection IP 4 5ml Standard Size Mono- standard
mg/5ml carton
759 1848 Etophyllin and Theophylline Injection 2ml Ampule Mono- Transparent
(84.7mg+25.3 mg) per ml carton
760 1849 Vitamin-C Chewable Tablets 500mg 10's Oval /Round Strip Silver
-----------------------------
.
Sd/-
Manager (Procurement)
For & on behalf of BPPI
Ph: 011-49431812

BPPI Proc Tender-156 - 17072020

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

BPPI Proc Tender-156 - 17072020

Uploaded by

Copyright:

Available Formats

Tender Ref. No.

: BPPI/DRUG/RC-156/2020 Dated: 17/07/2020

BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA

e- TENDER FOR SUPPLY OF DRUGS

LAST DATE FOR ONLINE SUBMISSION OF TENDER: 10/08/2020

FOR SUPPLY OF DRUGS TO BUREAU OF PHARMA PSU OF INDIA

Tender Reference BPPI/DRUG/RC-156/2020 Dt.

Date of availability of tender documents On 17/07/2020 (Friday)

Address for Communication Bureau of Pharma PSUs of India,

2. Sh. Manik Bera,

3. Sh. Pritam Singh

41. ANNEXURE - IX (BARCODE REQUIREMENTS) 47

42. ANNEXURE - X (Bank Guarantee format for submission of EMD) 53

43. ANNEXURE - XI (Letter of acceptance of tender for Rate Contract) 54

44. ANNEXURE - XII (Details of requirements for Drugs) 55

e-TENDER FOR RATE CONTRACT FOR THE SUPPLY OF DRUGS TO

BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA (BPPI)

PRADHAN MANTRI BHARTIYA JANAUSHADHI PARIYOJANA (PMBJP) is the initiative of

The Bids are to be submitted in two Parts i.e.

3. ELIGIBILITY CRITERIA (TECHNICAL BID -COVER “A”):

Account Details for National Electronic Fund Transfer (NEFT):

B) Documentary evidence of the constitution of the company/firm/Proprietorship such as Memorandum

5. PRICE BID – “COVER-B” (Financial Bid/BOQ)

6. EARNEST MONEY DEPOSIT:

7. GUIDELINES FOR THE PREPARATION OF TENDER:

9. AMENDMENT OF TENDER DOCUMENTS:

10. METHOD OF SUBMISSION OF TENDER:

12. OPENING OF TENDER:

14. INSPECTION OF MANUFACTURING FACILITIES:

16. AWARD OF CONTRACT:

For the above purpose the following procedures will be adopted

19. SUPPLY CONDITIONS:

22. QUALITY TESTING & QUALITY CONTROL:

24. HANDLING & TESTING CHARGES:

25. LIQIDATED DAMAGES & OTHER PENALTIES:

27. BLACKLISTING IN THE EVENT OF WITHDRAWAL FROM THE TENDER,

C) Quality Test by Statutory Authorities:

D) Procedure for Blacklisting:

28. SAVING CLAUSE:

29. RESOLUTION OF DISPUTES

A) ARBITRATION AND JURISDICTION;

30. CONTACTING THE BPPI BY THE BIDDER:

31. FRAUDULENT AND CORRUPT PRACTICES:

Name of authorized signatory: ………………………………………………….

Signature of authorized signatory: ……………………………………………….

(1) Signed: ……………………………………….

(2) Signed: ……………………………………….

To be attested by the Notary

DETAILS OF E.M.D SUBMITTED

UPLOAD THE SCANNED COPY OF DRAFT/ PAY ORDER/BANK GURANTEE/NEFT RECEIPT

(I) It is certified that M/s................................………is a Private Ltd./Ltd.

Sl. No. Financial Year Turnover in Crore (Rs.)

TOTAL Rs........................................ Lakhs

Average Turnover per annual Rs........................................ Lakhs

It is certified that M/S …………………………….(Name of company and

(III) It is certified that M/s ____________________________ has Production &

(IV) Further, It is certified that M/S ………………………………is Micro and Small

Date: Name: …………………………………………

Sl. No. Details Required

Place: Company Seal (Name of the person signing & designation)

CERTIFIED THAT THE PARTICULARS FURNISHED ABOVE BY THE COMPANY ARE

Signature of the authorized official of the bank

Bank Seal with address: